Sentence,class,file
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/b6/ircmj-18-09-31439.PMC5253224.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/8c/nihms842148.PMC5253237.pdf
2015. http://dx.doi.org/10.1016/j.jenvrad.,OADS,/arxiv_data1/oa_pdf/d4/8c/nihms842148.PMC5253237.pdf
"Developmental  Cognitive  Neuroscience  23  (2017)  39–44 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Childhood  poverty is associated  with  altered  hippocampal  function and  visuospatial memory in adulthood Elizabeth  R.  Duvala,∗,  Sarah  N.  Garﬁnkelb,  James  E.  Swaina,c,e,  Gary  W.  Evansd, Erika K.  Blackburnd,  Mike  Angstadta,  Chandra  S.  Sripadaa,  Israel  Liberzona aDepartment  of  Psychiatry,  University  of  Michigan  Health  System,  Ann  Arbor,  MI,  USA bDepartment of Psychology,  University  of  Sussex,  East  Sussex,  UK cChild  Study  Center,  Yale  University,  New  Haven,  CT,  USA dCollege  of  Human  Ecology,  Cornell  University,  Ithaca,  NY,  USA eDepartment  of  Psychiatry,  Stony  Brook  University  Medical  Center,  Stony  Brook,  NY,  USA a r  t  i  c  l  e  i  n  f  o Article  history: Received  7  June  2016 Received  in  revised  form 20  November  2016 Accepted  21 November 2016 Available online  27  November  2016 Keywords:Visuospatial memory HippocampusfMRIChildhood povertya  b  s  t  r  a  c  t Childhood  poverty  is  a  risk  factor  for  poorer  cognitive  performance  during  childhood  and  adulthood.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
Previous  studies demonstrate  that  hippocampus  might  be  especially  vulnerable  to http://dx.doi.org/10.1016/j.dcn.2016.11.006 1878-9293/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"Process.,  Available  at:  http://www.ncbi.nlm.nih.gov/pubmed/27350001 .",OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"7  (2),  55–71,  Available  at:  http://www.ncbi.nlm.nih.gov/pubmed/24864002 .",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"Neuropsychologia  49  (7),  2060–2070,  Available  at: http://www.ncbi.nlm.nih.gov/pubmed/21477602 (Accessed  June  7,  2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"83  (1),  6–15, Available at: http://www.ncbi.nlm.nih.gov/pubmed/22277003 (Accessed September  10,  2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"106  (16),  6545–6549,  Available at:  http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"1110  (1),  166–174,  Available  at: http://www.ncbi.nlm.nih.gov/pubmed/16879809  (Accessed  May  26,  2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"13  (2),  65–73,  Available  at:  http://www.pubmedcentral.nih.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"PLoS One  6  (5),  e18712,  Available  at:  http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3087752&tool=pmcentrez&rendertype=abstract (Accessed  June  3,  2014).",OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"Psychiatry,  1–9,  Available  at: http://www.ncbi.nlm.nih.gov/pubmed/24993057 (Accessed  July  9,  2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"60  (1),  9–26,  Available  at:  http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"9  (June),  1–8,  Available  at:  http://journal.frontiersin.org/Article/10.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"110  (46),18442–18447,  Available  at:  http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"57  (8),  948–960,  http://dx.doi.org/10.1002/dev.21325 .",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"Funct., 1–10, Available at:  http://www.ncbi.nlm.nih.gov/pubmed/24189776  (Accessed  June  18,  2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"109  (8), 2854–2859,  Available  at:  http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"JAMA  Pediatrics  167 (12),  1135–1142,  Available  at:  http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=4001721&tool=pmcentrez&rendertype=abstract (Accessed July  15,  2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"10  (6),  434–445,  Available  at: http://www.ncbi.nlm.nih.gov/pubmed/19401723 (Accessed  July  9,  2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"16  (S1),  S7–S19,  Available  at:  http://www.ncbi.nlm.nih.gov/ pubmed/12404531 .",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"Psychoneuroendocrinology  16  (1–3),  85–103, Available at: http://www.ncbi.nlm.nih.gov/pubmed/1961847 .",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"10  (4),  464–480, Available  at:  http://www.ncbi.nlm.nih.gov/pubmed/17552936  (Accessed  July 10, 2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"23  (17),  R764–R773,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"Neuropsychopharmacology  39  (9),  2244–2251,  Available  at:  http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"19,  51–57,  http://dx.doi.org/10.1016/j.dcn.2016.02.001 .",OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"7  (August),  436,  Available  at:  http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3743067&tool=pmcentrez&rendertype=abstract (Accessed  August  28,  2014).",OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC5253253.pdf
"Developmental  Cognitive  Neuroscience  23  (2017)  26–38 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Using  fNIRS to examine  occipital  and  temporal  responses  to  stimulus repetition  in young infants: Evidence  of  selective  frontal  cortex involvement Lauren  L.  Embersona,∗,  Grace  Cannonb,  Holly  Palmeric,  John  E.  Richardsd, Richard N. Aslinc aPrinceton  University,  United  States bUniversity  of  Houston,  United  States cUniversity  of  Rochester,  United  States dUniversity  of  South  Carolina,  United  States a r t  i  c  l  e  i  n  f  o Article history: Received  28  April  2016 Received  in  revised  form  6  September  2016 Accepted  11  November  2016 Available  online  15  December  2016 Keywords:Repetition suppression VisualAuditoryFacesSpeechWordsfNIRSFrontal cortex Cross-modala b  s  t  r  a  c  t How does the developing  brain  respond  to  recent  experience?",Non-OADS,/arxiv_data1/oa_pdf/b1/05/main.PMC5253300.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/05/main.PMC5253300.pdf
http://dx.doi.org/10.1016/j.dcn.2016.11.002 1878-9293/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/05/main.PMC5253300.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/05/main.PMC5253300.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the online version, at  http://dx.doi.org/10.1016/j.dcn.2016.11.002 .",OADS,/arxiv_data1/oa_pdf/b1/05/main.PMC5253300.pdf
https://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/8c/28/jgc-13-11-883.PMC5253403.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/16/f5/ircmj-18-09-25995.PMC5253431.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/4a/ircmj-18-09-35382.PMC5253432.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/15/ircmj-18-09-18570.PMC5253433.pdf
Secondary Statistics About Diabetes 2015. http://www.diabetes.org/diabetes-basics/statistics/ 4.,Non-OADS,/arxiv_data1/oa_pdf/bc/09/bmjdrc-2016-000297.PMC5253437.pdf
"This is a national charity group set up in April 2015 in Coventry, UK, with the main aim to increase awareness about BAD(http://bamsupportuk.org).",Non-OADS,/arxiv_data1/oa_pdf/09/0b/bmjgast-2016-000116.PMC5253456.pdf
http://data.unicef.org/child-health/diarrhoeal-disease.html (accessed 8 Aug 2016) 4.,Non-OADS,/arxiv_data1/oa_pdf/41/b0/bmjgast-2016-000124.PMC5253457.pdf
(Updated 9 April 2014) https://www.medicines.org.uk/emc/medicine/27109/SPC/Hidrasec+Infant+10mg+granules+for+oral+suspension/#PHARMACOKINETIC_PROPS(accessed 25 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/41/b0/bmjgast-2016-000124.PMC5253457.pdf
http://www.pediatriconcall.com/fordoctor/Conference_abstracts/racecadotrial.asp(accessed 20 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/41/b0/bmjgast-2016-000124.PMC5253457.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/52/ircmj-18-09-37574.PMC5253460.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/a8/ircmj-18-09-35421.PMC5253461.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/95/ircmj-18-09-36982.PMC5253509.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/2a/95/ircmj-18-09-36982.PMC5253509.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs311 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/95/ircmj-18-09-36982.PMC5253509.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.CASE REPORTS IN PLASTIC SURGERY AND HAND SURGERY, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/ae/c3/icrp-4-009.PMC5253514.pdf
"1, 9 –12 http://dx.doi.org/10.1080/23320885.2016.1278170",Non-OADS,/arxiv_data1/oa_pdf/ae/c3/icrp-4-009.PMC5253514.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.CASE REPORTS IN PLASTIC SURGERY AND HAND SURGERY, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/2a/4d/icrp-4-005.PMC5253515.pdf
"1, 5 –8 http://dx.doi.org/10.1080/23320885.2016.1278169",Non-OADS,/arxiv_data1/oa_pdf/2a/4d/icrp-4-005.PMC5253515.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.CASE REPORTS IN PLASTIC SURGERY AND HAND SURGERY, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/2e/09/icrp-4-001.PMC5253516.pdf
"1, 1 –4 http://dx.doi.org/10.1080/23320885.2016.1275646",Non-OADS,/arxiv_data1/oa_pdf/2e/09/icrp-4-001.PMC5253516.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011845).,Non-OADS,/arxiv_data1/oa_pdf/0a/f4/bmjopen-2016-011845.PMC5253518.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/fe/bmjqir.u211253.w4618.PMC5253519.pdf
https://www.rcophth.ac.uk/training/undergraduate-ophthalmology/ 3.,Non-OADS,/arxiv_data1/oa_pdf/a3/fe/bmjqir.u211253.w4618.PMC5253519.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012923).,Non-OADS,/arxiv_data1/oa_pdf/9a/22/bmjopen-2016-012923.PMC5253520.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.7j21m.,OADS,/arxiv_data1/oa_pdf/9a/22/bmjopen-2016-012923.PMC5253520.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013474).,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
Registration details: Our protocol was registered prospectively with the Open Science Framework(https://osf.io/kv9hu/).INTRODUCTION Social media has gained unprecedented popularity worldwide.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
The ﬁnal protocol was regis- tered prospectively with the Open Science Framework on 6 September 2016 (https://osf.io/kv9hu/).,OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
"http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/comm35a-eng.htm 4 Tricco AC, et al.BMJ Open 2017; 7:e013474.",OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
"Internet use by individuals, by type of activity (Internet users at home) 2010 [updated 10 May 2010. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/comm29a-eng.htm 4.",OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
2016. http://www.who.int/medicines/areas/ quality_safety/safety_efficacy/pharmvigi/en/ 17.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
Canada: Knowledge Translation Program; 2016. http://knowledgetranslation.net/ 26.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
Available from: http://joannabriggs.org/assets/docs/sumari/Reviewers-Manual_Methodology-for-JBI-Scoping-Reviews_2015_v2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
http://www.hc-sc.gc.ca/dhp-mps/index-eng.php 30.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
http://www.merriam-webster.com/ dictionary/crowdsourcing 32.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
2015. https://www.cadth.ca/resources/finding-evidence/grey-matters 34.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
WEB-RADR: Recognising Adverse Drug Reactions 2016. https://web-radr.eu/ 36.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/bmjopen-2016-013474.PMC5253521.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-015045).,Non-OADS,/arxiv_data1/oa_pdf/34/90/bmjopen-2016-015045.PMC5253522.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/34/90/bmjopen-2016-015045.PMC5253522.pdf
4. http://seer.cancer.gov/statfacts/html/lungb.html.5.,Non-OADS,/arxiv_data1/oa_pdf/34/90/bmjopen-2016-015045.PMC5253522.pdf
"Bethesda, MD: National Cancer Institute, 2012. http://seer.cancer.gov/csr/1975_2009_pops09/ 8.",Non-OADS,/arxiv_data1/oa_pdf/34/90/bmjopen-2016-015045.PMC5253522.pdf
A detailed description of procedures and methods is found at http://www.ntnu.edu/hunt.,Non-OADS,/arxiv_data1/oa_pdf/dd/ef/bmjopen-2016-013142.PMC5253523.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013720).,Non-OADS,/arxiv_data1/oa_pdf/a3/b5/bmjopen-2016-013720.PMC5253525.pdf
Data were downloaded from the Centers for Disease Control and Preventionwebsite (ftp://ftp.cdc.gov/pub).,OADS,/arxiv_data1/oa_pdf/a3/b5/bmjopen-2016-013720.PMC5253525.pdf
Data sharing statement Data were downloaded from the Centers for Disease Control and Prevention Website (ftp://ftp.cdc.gov/pub).,OADS,/arxiv_data1/oa_pdf/a3/b5/bmjopen-2016-013720.PMC5253525.pdf
https://wwwn.cdc.gov/nchs/nhanes/search/ nhanes05_06.aspx (accessed 14 Jul 2016).,OADS,/arxiv_data1/oa_pdf/a3/b5/bmjopen-2016-013720.PMC5253525.pdf
"Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. http://www.cdc.gov/nchs/data_access/data_linkage/mortality.htm (accessed 14 Jul2016).",Non-OADS,/arxiv_data1/oa_pdf/a3/b5/bmjopen-2016-013720.PMC5253525.pdf
"Division of Adult and CommunityHealth, 2000. http://www.cdc.gov/hrqol/pdfs/mhd.pdf (accessed 14Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/a3/b5/bmjopen-2016-013720.PMC5253525.pdf
"Center on Budget and Policy Priorities, 2015. http://www.cbpp.org/sites/default/files/atoms/files/11-28-11pov_0.pdf (accessed 27 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/a3/b5/bmjopen-2016-013720.PMC5253525.pdf
http://www.ncbi.nlm.nih.gov/books/NBK25528/ (accessed27 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/a3/b5/bmjopen-2016-013720.PMC5253525.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011580).,Non-OADS,/arxiv_data1/oa_pdf/ab/95/bmjopen-2016-011580.PMC5253526.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/95/bmjopen-2016-011580.PMC5253526.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013227).,Non-OADS,/arxiv_data1/oa_pdf/cf/02/bmjopen-2016-013227.PMC5253528.pdf
2016. http://www.who.int/classifications/icd/en/(accessed 28 Jan 2016).,OADS,/arxiv_data1/oa_pdf/cf/02/bmjopen-2016-013227.PMC5253528.pdf
2014. http://www.adelaide.edu.au/apmrc/research/projects/category/about_aria.html(accessed 7 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/cf/02/bmjopen-2016-013227.PMC5253528.pdf
2014. http://www.aihw.gov.au/deaths/leading-causes-of-death/(accessed 28 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/cf/02/bmjopen-2016-013227.PMC5253528.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-014112).,Non-OADS,/arxiv_data1/oa_pdf/9e/62/bmjopen-2016-014112.PMC5253529.pdf
http://www.selfcareforum.org/wp-content/uploads/2013/04/7-Cough.pdf (accessed Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/9e/62/bmjopen-2016-014112.PMC5253529.pdf
http://www.statista.com/statistics/415982/over-the-counter-sales-for-cough-cold-sore-throat-in-great-britain/ (accessed Mar2016).,Non-OADS,/arxiv_data1/oa_pdf/9e/62/bmjopen-2016-014112.PMC5253529.pdf
"R Foundation for Statistical Computing, 2013. http://www.R-project.org/ (accessed Jan 2014)).",Non-OADS,/arxiv_data1/oa_pdf/c8/0f/bmjopen-2016-011213.PMC5253531.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011781).,Non-OADS,/arxiv_data1/oa_pdf/34/ed/bmjopen-2016-011781.PMC5253532.pdf
Funding The work is supported by the research programme ‘Governing Obesity ’ funded by the University of Copenhagen Excellence Programme for Interdisciplinary Research (http://www.go.ku.dk).,Non-OADS,/arxiv_data1/oa_pdf/34/ed/bmjopen-2016-011781.PMC5253532.pdf
http://www.ssi.dk/Forskning/Forskningsomraader/Epidemiologi/BSMB/onsker%20du%20at%20forske/Hvordan%20soge%20om%20data.aspx.,OADS,/arxiv_data1/oa_pdf/34/ed/bmjopen-2016-011781.PMC5253532.pdf
http://www.oecd.org/eco/growth/ OECD-Note-EquivalenceScales.pdf 011 (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/34/ed/bmjopen-2016-011781.PMC5253532.pdf
http://www.ssi.dk/English/RandD/Research%20areas/Epidemiology/DNBC/Publications%20on%20Background%20and%20Methods/Validation%20of%20height%20weight%20and%20waist%20circumference.aspx (accessed18 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/34/ed/bmjopen-2016-011781.PMC5253532.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011437).,Non-OADS,/arxiv_data1/oa_pdf/bc/b4/bmjopen-2016-011437.PMC5253533.pdf
2010.http://www.arbejdsmiljoforskning.dk/~/media/Projekter/AH2012/AH-2012-spoergeskema-endelig-version.pdf 30.,Non-OADS,/arxiv_data1/oa_pdf/0f/60/bmjopen-2016-013251.PMC5253534.pdf
2012. http://www.arbejdsmiljoforskning.dk/~/media/Projekter/AH2012/AH-2012-spoergeskema-endelig-version.pdf 34.,Non-OADS,/arxiv_data1/oa_pdf/0f/60/bmjopen-2016-013251.PMC5253534.pdf
2005. http://www.arbejdsmiljoforskning.,Non-OADS,/arxiv_data1/oa_pdf/0f/60/bmjopen-2016-013251.PMC5253534.pdf
Secondary Guidelinesfor Data Processing and Analysis of the International PhysicalActivity Questionnaire 2005. https://sites.google.com/site/theipaq/scoring-protocol 41.,Non-OADS,/arxiv_data1/oa_pdf/0f/60/bmjopen-2016-013251.PMC5253534.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/ae/b1/bmjopen-2016-013224.PMC5253537.pdf
XXI; 1980. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/National_PV_Centres_Map/en.,Non-OADS,/arxiv_data1/oa_pdf/ae/b1/bmjopen-2016-013224.PMC5253537.pdf
http://www.boe.es/boe/dias/2013/07/27/pdfs/BOE-A-2013-8191.pdf (accessed 23 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/ae/b1/bmjopen-2016-013224.PMC5253537.pdf
http://www.ingesa.msc.es/estadEstudios/documPublica/CMBD-2001.htm (accessed 23 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/ae/b1/bmjopen-2016-013224.PMC5253537.pdf
http://www.msssi.gob.es/organizacion/ministerio/organizacion/sgralsanidad/dgcbssnsyfF.htm (accessed 22 May2016).,Non-OADS,/arxiv_data1/oa_pdf/ae/b1/bmjopen-2016-013224.PMC5253537.pdf
http://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/criterios-anticoagulantes-orales.pdf (accessed 22 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/ae/b1/bmjopen-2016-013224.PMC5253537.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013967).,Non-OADS,/arxiv_data1/oa_pdf/18/de/bmjopen-2016-013967.PMC5253538.pdf
"For these studies, if outcomes at different or s everal time-points are reported, we will choose the outcomes at the time- point closest to 52 weeks.Table 2 Dose range of medication included in the network meta-analysis for children/adolescents, according to the FDA whenever possible (as retrieved in https://dailymed.nlm.nih.gov/dailymed/ or http://www.accessdata.fda.gov/; other source:Arnsten et al 72) Drug Min.",Non-OADS,/arxiv_data1/oa_pdf/18/de/bmjopen-2016-013967.PMC5253538.pdf
"When end point scores are not reported but change scores are, we will use theTable 3 Dose range of medication included in the network meta-analysis for adults, according to the FDA whenever possible (as retrieved in https://dailymed.nlm.nih.gov/dailymed/ or http://www.accessdata.fda.gov/; other sources:http://integratedcare-nw.org/docs/PCPtraining/AdultADHDSummary-Recommendations.pdf; Arnsten et al 72) Drug Min.",Non-OADS,/arxiv_data1/oa_pdf/18/de/bmjopen-2016-013967.PMC5253538.pdf
"ClinicalTrials.gov 8. http://www.fda.gov/ 9. http://www.ema.europa.eu The following search terms will be used for PubMed: (‘Attention De ﬁcit Disorder with Hyperactivity ’(Mesh) OR adhd(tiab) OR hkd(tiab) OR addh(tiab) ORhyperkine*(tiab) OR ‘attention de ﬁcit*’(tiab) OR hyper- activ*(tiab) OR hyperactiv*(tiab) OR overactive(tiab) OR inattentive(tiab) OR impulsiv*(tiab)) AND(‘Amphetamines ’(Mesh) OR ‘Bupropion ’(Mesh) OR ‘Clonidine ’(Mesh) OR ‘Methylphenidate ’(Mesh) OR ‘Dexmethylphenidate ’(Mesh) OR ‘Guanfacine ’(Mesh) OR Adderall(tiab) OR Amphetamine(tiab) OR Desoxyn* (tiab) OR Phenopromin(tiab) OR Amfetamine(tiab) OR Phenamine(tiab) OR Centramina(tiab) OR Fenamine(tiab) OR Levoamphetamine(tiab) OR Dexamfetamine (tiab) OR Dexamphetamine(tiab) OR Dexedrine(tiab) OR Dextroamphetamine(tiab) OR DextroStat(tiab)OR Oxydess(tiab) OR Methylamphetamine(tiab) OR Methylenedioxyamphetamine(tiab) OR Methamphetamine(tiab) OR Chloroamphetamine(tiab)OR Metamfetamine(tiab) OR Deoxyephedrine(tiab) OR Desoxyephedrine(tiab) OR Ecstasy(tiab) OR Atomoxetine(tiab) OR Biphentin(tiab) OR Bupropion(tiab) OR Amfebutamone(tiab) OR Zyntabac(tiab) OR Quomen(tiab) OR Wellbutrin(tiab) OR Zyban(tiab) OR Catapres*(tiab) OR Clonidine(tiab) OR Klofenil(tiab)OR Clofenil(tiab) OR Chlophazolin(tiab) OR Gemiton (tiab) OR Hemiton(tiab) OR Isoglaucon(tiab) OR Klofelin(tiab) OR Clopheline(tiab) OR Clofelin(tiab)OR Dixarit(tiab) OR Concerta(tiab) OR Daytrana(tiab) OR Methylphenidate(tiab) OR Equasym(tiab) OR Methylin(tiab) OR Tsentedrin(tiab) OR Centedrin(tiab)OR Phenidylate(tiab) OR Ritalin*(tiab) OR Duraclon (tiab) OR Elvanse(tiab) OR Focalin(tiab) OR Dexmethylphenidate(tiab) OR Guanfacine(tiab) OREstulic(tiab) OR T enex(tiab) OR Kapvay(tiab) OR 6 Cortese S, et al.BMJ Open 2017; 7:e013967.",Non-OADS,/arxiv_data1/oa_pdf/18/de/bmjopen-2016-013967.PMC5253538.pdf
cochrane.org/network-meta-analysis-toolkit); the codes and description of the methodology can be foundin http://www.mtm.uoi.gr/index.php/stata-routines-for- network-meta-analysis.,OADS,/arxiv_data1/oa_pdf/18/de/bmjopen-2016-013967.PMC5253538.pdf
2008. http://www.nice.org.uk/CG72 14.,Non-OADS,/arxiv_data1/oa_pdf/18/de/bmjopen-2016-013967.PMC5253538.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 51.",OADS,/arxiv_data1/oa_pdf/18/de/bmjopen-2016-013967.PMC5253538.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013761).,Non-OADS,/arxiv_data1/oa_pdf/24/04/bmjopen-2016-013761.PMC5253540.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013460).,Non-OADS,/arxiv_data1/oa_pdf/c2/ee/bmjopen-2016-013460.PMC5253541.pdf
Clinical Guideline 147. https://www.nice.org.uk/guidance/cg147 (accessedSep 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/ee/bmjopen-2016-013460.PMC5253541.pdf
University of Kent (United Kingdom) 2013. http://www.pssru.ac.uk/ project-pages/unit-costs/2013/ (accessed Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/ee/bmjopen-2016-013460.PMC5253541.pdf
Guide to the methods of technology appraisal 2013. https://www.nice.org.uk/process/pmg9/chapter/foreword (accessed Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/ee/bmjopen-2016-013460.PMC5253541.pdf
http://savi.shef.ac.uk/SAVI/ (accessed Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/ee/bmjopen-2016-013460.PMC5253541.pdf
http://digital.nhs.uk/catalogue/PUB15751 (accessed Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/ee/bmjopen-2016-013460.PMC5253541.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012625).,Non-OADS,/arxiv_data1/oa_pdf/3a/05/bmjopen-2016-012625.PMC5253542.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3a/05/bmjopen-2016-012625.PMC5253542.pdf
"Cancer Research UK, 2014. http://publications.cancerresearchuk.org/downloads/Product/CS_REPORT_INCIDENCE.pdf 2.",Non-OADS,/arxiv_data1/oa_pdf/3a/05/bmjopen-2016-012625.PMC5253542.pdf
2014. http://publications.cancerresearchuk.org/publicationformat/ formatfactsheet/keyfactsall.html 3.,Non-OADS,/arxiv_data1/oa_pdf/3a/05/bmjopen-2016-012625.PMC5253542.pdf
http://www.health.org.uk/sites/health/files/ HelpingPeopleHelpThemselves.pdf (accessed 1 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/3a/05/bmjopen-2016-012625.PMC5253542.pdf
http://gov.wales/docs/dhss/publications/140117canceren.pdf (accessed 25 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/3a/05/bmjopen-2016-012625.PMC5253542.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014105).,Non-OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
"After information was col- lected, theoretical recreational drug-HAART interactionswere checked with daily-practice interaction databases: ‘http://www.hiv-druginteractions.org ’by the University of Liverpool 24and ‘Drug interaction Search ’by Micromedex Solutions, 2015 Truven Health Analytics.",OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
"Global statistics, 2015. http://www.unaids.org/sites/default/files/ media_asset/20150901_FactSheet_2015_en.pdf 2.",OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
2016. http://www.unaids.org/sites/default/files/country/ documents/ESP_narrative_report_2016.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
2015. http://www.msssi.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/InformeVIH_SIDA_2015.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
2015. http://www.emcdda.europa.eu/system/files/publications/974/TDAT15001ENN.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
"World Health Organization, 2014. http://www.who.int/hiv/pub/guidelines/keypopulations/en/ 11.",Non-OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
http://www.hiv-druginteractions.org/ 25.,Non-OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
2015. http://www.emcdda.europa.eu/ 27.,Non-OADS,/arxiv_data1/oa_pdf/86/c8/bmjopen-2016-014105.PMC5253545.pdf
"UNESCO Institute for Statistics, 2011. http://www.uis.unesco.org/Education/Pages/international-standard-classification-of-education.aspx (accessed 26 Oct 2016).",Non-OADS,/arxiv_data1/oa_pdf/d1/40/bmjopen-2016-014485.PMC5253546.pdf
Data collection and storage The Dutch intervention platform will be created using the LifeGuide software (https://www.lifeguideonline.org).,Non-OADS,/arxiv_data1/oa_pdf/5d/00/bmjopen-2016-015479.PMC5253547.pdf
Thewebsite of http://www.thuisarts.nl has been developed by the Dutch College of GPs in 2011 in order to offer patients reliable medical information and to supportGPs.,Non-OADS,/arxiv_data1/oa_pdf/5d/00/bmjopen-2016-015479.PMC5253547.pdf
22. https://www.cbs.nl/nl-nl/nieuws/2013/50/internetgebruik-ouderen- fors-toegenomen (30 November 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/00/bmjopen-2016-015479.PMC5253547.pdf
2011. https://www.zorginstituutnederland.nl/binaries/content/documents/zinl-www/documenten/publicaties/overige- publicaties/1602-richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg-bijlagen/Richtlijn+voor+het+uitvoeren+van+economische+evaluaties+in+de+gezondheidszorg+(verdiepingsmodules).pdf (30 November 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/00/bmjopen-2016-015479.PMC5253547.pdf
41. https://www.z-index.nl/g-standaard (30 November 2016).42.,Non-OADS,/arxiv_data1/oa_pdf/5d/00/bmjopen-2016-015479.PMC5253547.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013037).,Non-OADS,/arxiv_data1/oa_pdf/3c/d9/bmjopen-2016-013037.PMC5253548.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/d9/bmjopen-2016-013037.PMC5253548.pdf
http://www.hscic.gov.uk2015 4.,Non-OADS,/arxiv_data1/oa_pdf/3c/d9/bmjopen-2016-013037.PMC5253548.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org (accessed 8Jun 2016).30.",OADS,/arxiv_data1/oa_pdf/3c/d9/bmjopen-2016-013037.PMC5253548.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/bmjopen-2016-012663.PMC5253550.pdf
2007. http://www.bapen.org.uk/ofnsh/OrganizationOfNutritionalSupportWithinHospitals.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/bmjopen-2016-012663.PMC5253550.pdf
2006. https://www.nice.org.uk/guidance/cg32 3.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/bmjopen-2016-012663.PMC5253550.pdf
2010. http://www.ncepod.org.uk/2010report1/downloads/PN_report.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/bmjopen-2016-012663.PMC5253550.pdf
http://www.espen.org/files/PIIS0261561414002349.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/bmjopen-2016-012663.PMC5253550.pdf
2012. http://www.cdc.gov/nhsn/acute-care-hospital/clabsi/index.html14.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/bmjopen-2016-012663.PMC5253550.pdf
2009. https://www2.rcn.org.uk/__data/assets/pdf_file/0005/435587/ICS_Levels_of_Critical_Care_for_Adult_Patients_2009.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/bmjopen-2016-012663.PMC5253550.pdf
"Malnutrition Universal Screening Tool, 2011. http://www.bapen.org.uk/pdfs/must/must_full.pdf 8 Dyson JK, et al.BMJ Open 2017; 7:e012663.",Non-OADS,/arxiv_data1/oa_pdf/03/3d/bmjopen-2016-012663.PMC5253550.pdf
Antisepsis study design Detailed methods for the ASPREE ‘principal ’study are described in the ASPREE protocol available on the aspree.org website —http://www.aspree.org/AUS/aspree- content/aspree-study- details/aspree-materials.aspx/ andin the ASPREE methods paper.,Non-OADS,/arxiv_data1/oa_pdf/37/d5/bmjopen-2016-013636.PMC5253551.pdf
2016. http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf 41.,OADS,/arxiv_data1/oa_pdf/37/d5/bmjopen-2016-013636.PMC5253551.pdf
2016. http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf 42.,OADS,/arxiv_data1/oa_pdf/37/d5/bmjopen-2016-013636.PMC5253551.pdf
doi:10.1136/bmjopen-2016- 012992 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012992).,Non-OADS,/arxiv_data1/oa_pdf/d8/d3/bmjopen-2016-012992.PMC5253552.pdf
http://www.fhi.no (accessed 5 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/d8/d3/bmjopen-2016-012992.PMC5253552.pdf
https://www.fhi.no/en/op/public-health-report-2014/health –disease/ antibiotic-resistance-in-norway —p/ (accessed 6 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/d8/d3/bmjopen-2016-012992.PMC5253552.pdf
http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/index.aspx (accessed 6 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/d8/d3/bmjopen-2016-012992.PMC5253552.pdf
"Oslo: Helse- og omsorgsdepartementet, 2016.17. http://helsedirektoratet.no/publikasjoner/nasjonale-faglige-retningslinjer- for-antibiotikabruk-i-primerhelsetjenesten/Publikasjoner/IS-2030_nett_low.pdf (accessed 6 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/d8/d3/bmjopen-2016-012992.PMC5253552.pdf
"ISBN 3 –900051 –07–0, URL http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/70/13/bmjopen-2016-015568.PMC5253555.pdf
"ISBN 3 –900051 – 07–0, URL http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/70/13/bmjopen-2016-015568.PMC5253555.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/70/13/bmjopen-2016-015568.PMC5253555.pdf
Secondary basic functions for poweranalysis 2015. https://cran.r-project.org/web/packages/pwr/pwr.pdf 29.,Non-OADS,/arxiv_data1/oa_pdf/70/13/bmjopen-2016-015568.PMC5253555.pdf
"http://www.icmje.org/icmje-recommendations.pdf 10 Ribeiro DC, et al.BMJ Open 2017; 7:e015568.",Non-OADS,/arxiv_data1/oa_pdf/70/13/bmjopen-2016-015568.PMC5253555.pdf
"performed and face shape of a patient can be normal- ised with respect to ethnicity, age and sex matched mean.8The photographs will be taken by the local (trained) medical photographer, using their own 2D camera and a centrally provided 3D camera: the VECTRA M3 Imaging System, manufactured by Can ﬁeld Scienti ﬁc (http://www.can ﬁeldsci.com).",Non-OADS,/arxiv_data1/oa_pdf/d3/19/bmjopen-2016-013237.PMC5253556.pdf
2011. http://www.appliedclinicaltrialsonline.com/print/211800?page=full 11.,Non-OADS,/arxiv_data1/oa_pdf/d3/19/bmjopen-2016-013237.PMC5253556.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014498).,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/bmjopen-2016-014498.PMC5253557.pdf
26. http://aclandanatomy.com/MultimediaPlayer.aspx?,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/bmjopen-2016-014498.PMC5253557.pdf
27. http://southtees.nhs.uk/content/uploads/MICB4531-V1-Osteoarthritis- Thumb-Joint-9.pdf (accessed 6 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/bmjopen-2016-014498.PMC5253557.pdf
31. https://www.physiotherapyexercises.com/ (acessed 29 Jun 2016).32.,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/bmjopen-2016-014498.PMC5253557.pdf
42. http://www.nrc.gov/reading-rm/doc-collections/fact-sheets/ bio-effects-radiation.html (accessed 23 Sep 2016).43.,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/bmjopen-2016-014498.PMC5253557.pdf
Global status report on noncommunicable diseases 2010. http://www.who.int/nmh/publications/ncd_report2010/en/ (accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/67/2a/bmjopen-2016-014353.PMC5253559.pdf
"Leading Causes of Death, 2013. http://www.aihw.gov.au/deaths/leading-causes-of-death/(accessed Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/67/2a/bmjopen-2016-014353.PMC5253559.pdf
2012. https://heartfoundation.org.au/images/uploads/publications/Absolute-CVD-Risk-Full-Guidelines.pdf (accessed Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/67/2a/bmjopen-2016-014353.PMC5253559.pdf
2014. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4839.0main+features32012-13 (accessed May 2016).,Non-OADS,/arxiv_data1/oa_pdf/67/2a/bmjopen-2016-014353.PMC5253559.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012654).,Non-OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
http://publichealth.lacounty.gov/chronic/docs/CHLA_CTG_one_sheet_FINAL_8.5x11.pdf(accessed 20 Mar 2016).,OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
"Los Angeles County Department of Public Health, 2011. http://publichealth.lacounty.gov/ha/reports/habriefs/2007/obese_cities/obesity_2011fs.PDF (accessed 5 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
"Field Research Corporation, 2011. http://www.field.com/fieldpollonline/subscribers/Rls2367.pdf (accessed 5 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
"Field Research Corporation, 2012. http://www.field.com/fieldpollonline/subscribers/Rls2408.pdf (accessed 5 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
"Field Research Corporation, 2013. http://www.field.com/ fieldpollonline/subscribers/Rls2436.pdf (accessed 5 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
"Los Angeles County, Department of Public Health, 2010. http://www.publichealth.lacounty.gov/epi/docs/Life%20Expectancy% 20Final_web.pdf (accessed 5 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
https://www.cdc.gov/nchs/data/nhanes/nhanes_07_ 08/whq07_08_eng.pdf (accessed 5 Aug 2016).,OADS,/arxiv_data1/oa_pdf/a8/9c/bmjopen-2016-012654.PMC5253563.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013346).,Non-OADS,/arxiv_data1/oa_pdf/62/a6/bmjopen-2016-013346.PMC5253564.pdf
http://www.socialstyrelsen.se/register/halsodataregister/ patientregistret/inenglish 14.,Non-OADS,/arxiv_data1/oa_pdf/62/a6/bmjopen-2016-013346.PMC5253564.pdf
15. http://www.scb.se/en_/ (in English) 16.,Non-OADS,/arxiv_data1/oa_pdf/62/a6/bmjopen-2016-013346.PMC5253564.pdf
http://www.skl.se/vi_ arbetar_med//halsaochvard/kvalitetsutveckling/medicinska- indikationer (accessed Jun 2012).,OADS,/arxiv_data1/oa_pdf/62/a6/bmjopen-2016-013346.PMC5253564.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012360).,Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
"Whenhospital prices for drugs were missing, a search was per- formed through the Italian Pharmaceutical Database (http://www.federfarma.it) reporting cost data for theNational Healthcare Service.",OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
19. http://www.sanita24.ilsole24ore.com/pdf2010/Sanita2/_Oggetti_ Correlati/Documenti/Dal-Governo/Allegato%202%20Ausili%20Monouso%202015_Filigrana.pdf (accessed 10 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
27. http://www.contenuti-web.com/continenza/fondazione-0000409.html (accessed 10 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
https://research.tufts-nemc.org/cear4/ SearchingtheCEARegistry (accessed 10 Jul 2016).,OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
http://www.istud.it/superabile/lesione.asp (accessed 10 Jul2016).,Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
42. http://www.who.int/choice/costs/CER_levels/en (accessed 10 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
"26), http://www.salute.gov.it/ imgs/C_17_pubblicazioni_2309_allegato.pdf (accessed 10 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
"Law n. 208, 28 December 2015, Stability Law —Legge di stabilità 2016, http://www.gazzettaufficiale.it/eli/id/2014/12/29/14G00203/sg(accessed 10 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
"Law n. 190, 23 December 2014, Stability Law —Legge di stabilità 2015, http://www.gazzettaufficiale.it/eli/id/2015/12/30/15G00222/sg(accessed 10 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
50. http://www.eunethta.eu (accessed 10 Jul 2016).51.,Non-OADS,/arxiv_data1/oa_pdf/9f/73/bmjopen-2016-012360.PMC5253566.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012670).,Non-OADS,/arxiv_data1/oa_pdf/34/61/bmjopen-2016-012670.PMC5253568.pdf
(cited 16 Aug 2015)http://sites.stat.psu.edu/~jls/mifaq.html#howto.,OADS,/arxiv_data1/oa_pdf/34/61/bmjopen-2016-012670.PMC5253568.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-015467).,Non-OADS,/arxiv_data1/oa_pdf/a3/cf/bmjopen-2016-015467.PMC5253569.pdf
http://www.fda.gov/downloads/Drugs/Guidances/ UCM193282.pdf[2].,Non-OADS,/arxiv_data1/oa_pdf/a3/cf/bmjopen-2016-015467.PMC5253569.pdf
http://www.rummlab.com.au/ (accessed 10 Oct 2014).32.,Non-OADS,/arxiv_data1/oa_pdf/a3/cf/bmjopen-2016-015467.PMC5253569.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012901).,Non-OADS,/arxiv_data1/oa_pdf/d4/3c/bmjopen-2016-012901.PMC5253570.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014612).,Non-OADS,/arxiv_data1/oa_pdf/7f/4b/bmjopen-2016-014612.PMC5253571.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/4b/bmjopen-2016-014612.PMC5253571.pdf
"Advanced Clinical Practice Framework for the West Midlands, 2015. https://hee.nhs.uk/sites/default/files/documents/ACP%20Framework%20for%20the%20WM.PDF (accessed 9 Jan 2017).",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/bmjopen-2016-014612.PMC5253571.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2017; 7:010172corr1.,Non-OADS,/arxiv_data1/oa_pdf/d4/83/bmjopen-2015-010172corr1.PMC5253572.pdf
Data sharing statement The data for Greece GATS 2013 are available from CDC (http://nccd.cdc.gov/GTSSData/Ancillary/DataReports.aspx?CAID=2).,OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
2009.http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf (accessed 12 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
http://apps.who.int/iris/bitstream/10665/44616/1/9789240687813_eng.pdf (accessed 12 Apr 2016).,OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
http://ec.europa.eu/agriculture/tobacco/index_en.htm (accessed 12 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
2011. http://www.who.int/fctc/reporting/party_reports/greece_annex1_the_greek_tobacco_epidemic_2011.pdf (accessed 12 Apr2016).,Non-OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
"Atlanta, GA: Centers for Disease Control and Prevention, 2010.http://www.who.int/tobacco/surveillance/en_tfi_gats_sampledesignmanual_v2_final_03nov2010.pdf (accessed 12 Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
"Atlanta, GA: Centers for Disease Control and Prevention, 2010. http://who.int/tobacco/surveillance/en_tfi_gats_sampleweights manual_v2_final_15dec2010.pdf (accessed 12 Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
"HCDCP, E-bulletin, 2014. http://www2.keelpno.gr/ blog/?p=5542&lang=en (accessed 12 Apr 2016).18.",Non-OADS,/arxiv_data1/oa_pdf/c4/34/bmjopen-2016-013150.PMC5253573.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013261).,Non-OADS,/arxiv_data1/oa_pdf/4c/53/bmjopen-2016-013261.PMC5253575.pdf
DOI: 3452762 https://figshare.com/articles/Usher_syndrome_study_sav/3452762.,Non-OADS,/arxiv_data1/oa_pdf/4c/53/bmjopen-2016-013261.PMC5253575.pdf
"http://www.birmingham.ac.uk/Documents/collegesocial-sciences/education/projects/final-report-on-life-and-change-with-usher.pdf, zuletztgeprüft am 2013;7:2015.",Non-OADS,/arxiv_data1/oa_pdf/4c/53/bmjopen-2016-013261.PMC5253575.pdf
https://www.rcophth.ac.uk/professional-resources/certificate-of-vision-impairment/ (accessed 14 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/4c/53/bmjopen-2016-013261.PMC5253575.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012294).,Non-OADS,/arxiv_data1/oa_pdf/7e/84/bmjopen-2016-012294.PMC5253577.pdf
"Australia: Commonwealth of Australia, 2011. http://www.comlaw.gov.au/Details/C2013C0019054.",Non-OADS,/arxiv_data1/oa_pdf/0b/c6/bmjopen-2016-014099.PMC5253579.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012377).,Non-OADS,/arxiv_data1/oa_pdf/f5/57/bmjopen-2016-012377.PMC5253580.pdf
"Klagenfurt:www.ssoar.info, 2014:144), 22by means of the QCAmap software (http://www.qcamap.org), using the methods according to Mayring (Mayring P .Qualitative content analysis: theoretical foundation, basic procedures and software solution.",OADS,/arxiv_data1/oa_pdf/f5/57/bmjopen-2016-012377.PMC5253580.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013637).,Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2016-013637.PMC5253582.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/a7/bmjqir.u211253.w4529.PMC5253583.pdf
2010. http://www.casp-uk.net/ 44.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/bmjopen-2016-012633.PMC5253584.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014267).,Non-OADS,/arxiv_data1/oa_pdf/df/c0/bmjopen-2016-014267.PMC5253585.pdf
2014. http://www.gmc-uk.org/SOMEP_2014_FINAL.pdf_58751753.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/32/bmjopen-2016-013656.PMC5253586.pdf
2013. http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013005305.,Non-OADS,/arxiv_data1/oa_pdf/b1/32/bmjopen-2016-013656.PMC5253586.pdf
"University of York, 2009. https://www.york.ac.uk/crd/SysRev/!SSL!/WebHelp/SysRev3.htm 1_3_UNDERTAKING_THE_REVIEW.htm 25.",Non-OADS,/arxiv_data1/oa_pdf/b1/32/bmjopen-2016-013656.PMC5253586.pdf
A National training survey 2012: key findings 2012. http://www.gmc-uk.org/National_training_survey_2012_key_findings_report.pdf_49280407.pdf 30.,Non-OADS,/arxiv_data1/oa_pdf/b1/32/bmjopen-2016-013656.PMC5253586.pdf
"GMC, 2009. http://www.gmc-uk.org/National_Training_Surveys_2008_09_20090929.pdf_30512348.pdf 33.",Non-OADS,/arxiv_data1/oa_pdf/b1/32/bmjopen-2016-013656.PMC5253586.pdf
National Training Survey —Key findings 2013. http://www.gmc-uk.org/National_training_survey_2013_key_findings_report_1013.pdf_56436856.pdf 34.,Non-OADS,/arxiv_data1/oa_pdf/b1/32/bmjopen-2016-013656.PMC5253586.pdf
2011. https://www.eoedeanery.nhs.uk/medical/page.php?page_id=1095 65.,Non-OADS,/arxiv_data1/oa_pdf/b1/32/bmjopen-2016-013656.PMC5253586.pdf
2011. http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8& ved=0CCIQFjAA&url=http%3A%2F%2Fwww.londondeanery.ac.uk%2Ffoundationschools%2Fconferences% 2Fconferences-new%2F2013%2F2-clare-inductionsurvey.,Non-OADS,/arxiv_data1/oa_pdf/b1/32/bmjopen-2016-013656.PMC5253586.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013629).,Non-OADS,/arxiv_data1/oa_pdf/e9/43/bmjopen-2016-013629.PMC5253588.pdf
Data are available from the Tromsø study for researchers who meet the criteria for access to confidential data (https://en.uit.no/prosjekter/prosjekt?p_document_id=80172).,OADS,/arxiv_data1/oa_pdf/e9/43/bmjopen-2016-013629.PMC5253588.pdf
2013. http://www.afhayes.com/ (accessed 02.06.2015).,Non-OADS,/arxiv_data1/oa_pdf/e9/43/bmjopen-2016-013629.PMC5253588.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011865).,Non-OADS,/arxiv_data1/oa_pdf/1d/a5/bmjopen-2016-011865.PMC5253590.pdf
2015. http://www.who.int/emergencies/mers-cov/en/ (accessed 17 Oct 2015).,OADS,/arxiv_data1/oa_pdf/1d/a5/bmjopen-2016-011865.PMC5253590.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/1d/a5/bmjopen-2016-011865.PMC5253590.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013389).,Non-OADS,/arxiv_data1/oa_pdf/a1/1e/bmjopen-2016-013389.PMC5253591.pdf
Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: PKM received financial support from The Lundbeck Foundation.,Non-OADS,/arxiv_data1/oa_pdf/a1/1e/bmjopen-2016-013389.PMC5253591.pdf
http://www.scts.org/_ userfiles/resources/5thBlueBook2003.pdf (accessed Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/a1/1e/bmjopen-2016-013389.PMC5253591.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013829).,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/bmjopen-2016-013829.PMC5253593.pdf
"Adelaide,Australia: Australia and New Zealand Dialysis and Trasnplant Registry, 2015. http://www.anzdata.org.au 4.",Non-OADS,/arxiv_data1/oa_pdf/e6/6f/bmjopen-2016-013829.PMC5253593.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013574).,Non-OADS,/arxiv_data1/oa_pdf/01/62/bmjopen-2016-013574.PMC5253594.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013635).,Non-OADS,/arxiv_data1/oa_pdf/fe/58/bmjopen-2016-013635.PMC5253595.pdf
http://www.seaco.asia 17.,Non-OADS,/arxiv_data1/oa_pdf/fe/58/bmjopen-2016-013635.PMC5253595.pdf
"http://www.alz.co.uk/1066/ Mohan D, et al.BMJ Open 2017; 7:e013635.",Non-OADS,/arxiv_data1/oa_pdf/fe/58/bmjopen-2016-013635.PMC5253595.pdf
Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare all authors had financial support from Advancing Partners and Communities/ US.,Non-OADS,/arxiv_data1/oa_pdf/d8/ce/bmjopen-2016-013888.PMC5253596.pdf
http://bettercarenetwork.org/sites/default/files/attachments/Someone%20that%20Matters.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/d8/ce/bmjopen-2016-013888.PMC5253596.pdf
"Phnom Penh and Calverton, MD 2015. http://dhsprogram.com/pubs/pdf/FR312/FR312.pdf 20.",Non-OADS,/arxiv_data1/oa_pdf/d8/ce/bmjopen-2016-013888.PMC5253596.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-014259).,Non-OADS,/arxiv_data1/oa_pdf/cb/c6/bmjopen-2016-014259.PMC5253597.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013960).,Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
"World Health Organization, 2015. http://www.who.int/chagas/epidemiology/en (accessed Dec2015).",Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
2012. http://apps.who.int/iris/bitstream/10665/70809/ 1/WHO_HTM_NTD_2012.1_eng.pdf (accessed May 2016).,OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
"London: Declaration on Neglected Tropical Diseases, 2012. http://www.who.int/neglected_diseases/London_Declaration_NTDs.pdf (accessed May 2016).",Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
http://www.transfusionguidelines.org.uk/dsg/bm/guidelines/so003-south-american-trypanosomiasis-risk (accessedDec 2015).,Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
"Ministerio de Sanidad y Consumo, 2005. http://boe.vlex.es/vid/minimas-hemodonacion-transfusion-17950316(accessed Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
"Bundesärztekammer, 2010. http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/RiliHaemotherapie2010.pdf(accessed Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
2014. http://chagas.info/ (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
2002. http://apps.who.int/iris/bitstream/10665/ 42443/1/WHO_TRS_905.pdf (accessed May 2016).,OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
"Ministerio de Sanidad y Política Social, 2009. http://www.msssi.gob.es/profesionales/saludPublica/ prevPromocion/promocion/migracion/docs/enfermenfermedad.pdf(accessed Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
2016. http://www.un.org/sustainabledevelopment/health/ (accessed May 2016).,Non-OADS,/arxiv_data1/oa_pdf/0b/20/bmjopen-2016-013960.PMC5253600.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013688).,Non-OADS,/arxiv_data1/oa_pdf/50/3f/bmjopen-2016-013688.PMC5253602.pdf
"The Cochrane Collaboration, 2013. http://srdta.cochrane.org/ 13.",OADS,/arxiv_data1/oa_pdf/50/3f/bmjopen-2016-013688.PMC5253602.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012816).,Non-OADS,/arxiv_data1/oa_pdf/98/b2/bmjopen-2016-012816.PMC5253603.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.86t23.,OADS,/arxiv_data1/oa_pdf/d2/e5/bmjopen-2016-011772.PMC5253604.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjresp-2016- 000168).,Non-OADS,/arxiv_data1/oa_pdf/b8/64/bmjresp-2016-000168.PMC5253607.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013492).,Non-OADS,/arxiv_data1/oa_pdf/86/21/bmjopen-2016-013492.PMC5253619.pdf
"https://audit.wa.gov.au/reports-and-publications/reports/information-systems-application-controls-audits/emergency-department-information-system-department-of-health/ Strobel NA, et al.BMJ Open 2017; 7:e013492.",OADS,/arxiv_data1/oa_pdf/86/21/bmjopen-2016-013492.PMC5253619.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013831).,Non-OADS,/arxiv_data1/oa_pdf/30/bd/bmjopen-2016-013831.PMC5253636.pdf
2013. http://www.mhlw.go.jp/stf/houdou/2r9852000002xple-att/2r9852000002xppb.pdf (accessed 14 Apr2016).,Non-OADS,/arxiv_data1/oa_pdf/30/bd/bmjopen-2016-013831.PMC5253636.pdf
2012. http://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/0000106403.pdf (accessed 14 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/30/bd/bmjopen-2016-013831.PMC5253636.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012813).,Non-OADS,/arxiv_data1/oa_pdf/cf/54/bmjopen-2016-012813.PMC5253642.pdf
2008. https://www.zotero.org/groups/ chagasepid8515/items/PHEQZ2HV (accessed 20 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/cf/54/bmjopen-2016-012813.PMC5253642.pdf
2005. http://blog.euromonitor.com/2005/03/china-changing- attitudes-to-pet-ownership-drive-pet-food-sales.html (accessed20 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/cf/54/bmjopen-2016-012813.PMC5253642.pdf
2012. http://www.censtatd.gov.hk/ (accessed13 Mar 2013).12.,Non-OADS,/arxiv_data1/oa_pdf/cf/54/bmjopen-2016-012813.PMC5253642.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/af/ircmj-18-09-36825.PMC5253700.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012591).,Non-OADS,/arxiv_data1/oa_pdf/af/9c/bmjopen-2016-012591.PMC5253713.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/af/9c/bmjopen-2016-012591.PMC5253713.pdf
"142 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/da/bmw157.PMC5253970.pdf
http://www.coresta.org/Recommended_Methods/CRM_74-update(July14).,OADS,/arxiv_data1/oa_pdf/f1/da/bmw157.PMC5253970.pdf
"http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Products/Guideline s/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf (accessed June, 2015).",OADS,/arxiv_data1/oa_pdf/f1/da/bmw157.PMC5253970.pdf
Availability and Implementation: Free access at http://www.rgenome.net/cas-analyzer/.,OADS,/arxiv_data1/oa_pdf/66/f0/btw561.PMC5254075.pdf
"286 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/f0/btw561.PMC5254075.pdf
"For the compressed files, we used a JavaScript library ‘pako’ (http://nodeca.github.io/pako/), which is slightly modified to support blocked gzip files.",OADS,/arxiv_data1/oa_pdf/66/f0/btw561.PMC5254075.pdf
"Ifusers upload paired-end sequencing data, Cas-Analyzer first mergespaired-end reads by the JavaScript port of Fastq-join, a part of ea-utils (https://code.google.com/archive/p/ea-utils/).",OADS,/arxiv_data1/oa_pdf/66/f0/btw561.PMC5254075.pdf
"306 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/5a/btw611.PMC5254078.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/fe/openhrt-2016-000474.PMC5255551.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/lupus-2016- 000184).,Non-OADS,/arxiv_data1/oa_pdf/f9/f6/lupus-2016-000184.PMC5255563.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/a8/ircmj-18-09-38871.PMC5255569.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2016-000395).,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/rmdopen-2016-000395.PMC5255890.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2016-000355).,Non-OADS,/arxiv_data1/oa_pdf/f7/6f/rmdopen-2016-000355.PMC5255891.pdf
"METHODS Scoring systemsKIMRISS BML scoring uses a HTML5 web-based inter- face (free for registered users, http://www.carearthritis.",OADS,/arxiv_data1/oa_pdf/f7/6f/rmdopen-2016-000355.PMC5255891.pdf
"Exercise 2: Scans were obtained from an open-label pilot study testing treatment ef ﬁcacy of adalimumab, a bio- logical anti-in ﬂammatory medication for knee OA (https://www.clinicaltrials.gov/ct2/show/NCT00686439).",Non-OADS,/arxiv_data1/oa_pdf/f7/6f/rmdopen-2016-000355.PMC5255891.pdf
Availabe  from: http://www.wpro.who.int/media-centre/fact- sheets/fs  20070529.,Non-OADS,/arxiv_data1/oa_pdf/ee/87/DRJ-13-494.PMC5256012.pdf
Availabe from: http://www.who.int/healthinfo/global_ burden_disease/GBD_report_2004update_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/87/DRJ-13-494.PMC5256012.pdf
Available from: http://www.mcc.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/a1/2b/DRJ-13-532.PMC5256018.pdf
Available from: http://www.dh.gov.uk/PublicationsandStatistics/ PublicationsPolicyandGuidance/fs/en.,Non-OADS,/arxiv_data1/oa_pdf/89/c5/DRJ-13-544.PMC5256020.pdf
Available from: http://www.who.int/ gho/ncd/risk_factors/physical_activity/en/.,OADS,/arxiv_data1/oa_pdf/89/c5/DRJ-13-544.PMC5256020.pdf
Available  from: http://www.whoindia.org/linkfiles/ncd_surveillance_ncd_ rf_surveillance_report.,OADS,/arxiv_data1/oa_pdf/89/c5/DRJ-13-544.PMC5256020.pdf
Available from: http://www.who.int/chp/steps/resources/GP AQ_Analysis_Guide.pdf.,OADS,/arxiv_data1/oa_pdf/89/c5/DRJ-13-544.PMC5256020.pdf
Available from: http://www.who.int/transplan-tation/gkt/statistics/en/.,OADS,/arxiv_data1/oa_pdf/39/63/AIM-24-322.PMC5256037.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/92/ircmj-18-09-40844.PMC5256038.pdf
Available from: https://www.latrobe.edu.au/arcshs/ downloads/arcshs-research-publications/national_hep_b_needs_ assesmt.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/92/ircmj-18-09-40844.PMC5256038.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/56/ircmj-18-09-38750.PMC5256040.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/43/asjsm-07-04-30199.PMC5256099.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/ec/ircmj-18-09-25490.PMC5256102.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ bjophthalmol-2016-309376).,OADS,/arxiv_data1/oa_pdf/b7/6a/bjophthalmol-2016-309376.PMC5256121.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Chang AE, Karnell LH, Menck HR.",Non-OADS,/arxiv_data1/oa_pdf/a4/bf/bjophthalmol-2016-309034.PMC5256122.pdf
"2015. http://melanomafocus.com/activities-2/um-guidelines-resources/ 41 Dummer R, Hauschild A, Guggenheim M, et al.",OADS,/arxiv_data1/oa_pdf/a4/bf/bjophthalmol-2016-309034.PMC5256122.pdf
"2014. http://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf 43 Carvajal RD, Sosman JA, Quevedo JF, et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/bf/bjophthalmol-2016-309034.PMC5256122.pdf
"Received 20 April 2015 Revised 20 June 2016Accepted 8 July 2016Published Online First 1 August 2016 ▸http://dx.doi.org/10.1136/ emermed-2016-206289 To cite: Abolfotouh MA, Al-Assiri MH, Alshahrani RT, et al.Emerg Med J 2017; 34:27–33.ABSTRACT Aim This study aimed to (i) assess the level of patient satisfaction and its association with differentsociodemographic and healthcare characteristics in anemergency care centre (ECC) in Saudi Arabia and (ii) toidentify the predictors of patients ’satisfaction.",Non-OADS,/arxiv_data1/oa_pdf/88/0f/emermed-2015-204954.PMC5256124.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/REFERENCES 1 Tasso K, Behar-Horenstein LS, Aumiller A, et al .",Non-OADS,/arxiv_data1/oa_pdf/88/0f/emermed-2015-204954.PMC5256124.pdf
"http://www.americanscience.org 5 Quintana JM, Gonzlez N, Bilbao A, et al.",Non-OADS,/arxiv_data1/oa_pdf/88/0f/emermed-2015-204954.PMC5256124.pdf
http://www.acep.,Non-OADS,/arxiv_data1/oa_pdf/88/0f/emermed-2015-204954.PMC5256124.pdf
"Data analysis and image processing W e used the SPM8 (Statistical Parametric Mappingsoftware, W ellcome Department of Imaging Neuroscience, London, UK; http://www.fil.ion.ucl.ac.",OADS,/arxiv_data1/oa_pdf/a5/5b/acupmed-2016-011071.PMC5256125.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Fomberstein K, Qadri S, Ramani R. Functional MRI and pain.",Non-OADS,/arxiv_data1/oa_pdf/a5/5b/acupmed-2016-011071.PMC5256125.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Erle DJ, Sheppard D. The cell biology of asthma.",Non-OADS,/arxiv_data1/oa_pdf/44/4a/acupmed-2015-010934.PMC5256126.pdf
Update 2013. http://www.worldallergy .org/definingthespecialty/white_book.php (accessed26 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/44/4a/acupmed-2015-010934.PMC5256126.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ 1Faculty of Sport, University of Ljubljana, Ljubljana, Slovenia;2Faculty of Mechanical Engineering, Technical University of Munich, Garching, Germany;3Department of Industrial Engineering, University of Padova, Padova, Italy;4Swedish Winter Sports Research Centre, Mid Sweden University, Östersund, Sweden;5School of Sport Sciences, UiT Arctic University of Norway, Tromsø, Norway Correspondence to Dr Matej Supej, Faculty of Sport, University of Ljubljana, Gortanova 22, Ljubljana 1000, Slovenia; matej.supej@fsp.uni-lj.si Br J Sports Med January 2017 Vol 51 No 1  1Editorials",Non-OADS,/arxiv_data1/oa_pdf/6e/28/bjsports-2016-096502.PMC5256127.pdf
Twitter: @DrDavid_Hughes Acknowledgements The authors wish to acknowledge the Collaborative Research Network for Advancing Exercise and Sports Science (https://bond.edu.au/researchers/research-strengths/university-research-centres/crn-advancing-exercise-sports-science)and Dr Silvia Manzanero for assistance with preparation of the manuscript.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Hayden EC.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
2012. https://ama.com.au/system/tdf/documents/Position_Statement_on_Genetic_Testing_2012.pdf?,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
2012. http://www.bases.org.uk/ write/Images/williams14-15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
2012. https://www.hgsa.org.au/documents/item/19.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
2015. https://www.nhmrc.gov.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
https://www.nhmrc.gov.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
"London, UK: Medical Research Council, 2001. https://www.mrc.ac.uk/publications/browse/human-tissue-and-biological- samples-for-use-in-research/.",Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
2010. https://www.legislation.gov.au/Details/F2010L01889 (accessed November 2016).,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
Available at: http://www.alrc.gov.au/publications/report-96.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bjsports-2016-096661.PMC5256128.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Elvik R. The non-linearity of risk and the promotion of environmentally sustainable transport.,Non-OADS,/arxiv_data1/oa_pdf/22/78/injuryprev-2016-041964.PMC5256166.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ injuryprev-2015-041922).,Non-OADS,/arxiv_data1/oa_pdf/2f/d4/injuryprev-2015-041922.PMC5256167.pdf
"All analyses were per- formed in the statistical package R (R Core T eam 2013, http://www.r-project.org, V .3.1.2).",OADS,/arxiv_data1/oa_pdf/2f/d4/injuryprev-2015-041922.PMC5256167.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Riggs E, Block K, Warr D, et al.",Non-OADS,/arxiv_data1/oa_pdf/2f/d4/injuryprev-2015-041922.PMC5256167.pdf
"Geneva: World Health Organisation, 2008. http://apps.who.int/iris/bitstream/10665/43943/1/9789241563703_eng.pdf (accessed 2 Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/2f/d4/injuryprev-2015-041922.PMC5256167.pdf
2009. http://www.who.int/patientsafety/implementation/apps/resources/de ﬁning_ partnerships-apps.pdf (accessed 2 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/2f/d4/injuryprev-2015-041922.PMC5256167.pdf
2011. http://www.vichealth.vic.gov.au/ Publications/VicHealth-General-Publications/Partnerships-Analysis-Tool.aspx (accessed 2 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/2f/d4/injuryprev-2015-041922.PMC5256167.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/1e/asjsm-07-04-32854.PMC5256168.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/30/asjsm-07-04-34832.PMC5256193.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ injuryprev-2015-041885).,Non-OADS,/arxiv_data1/oa_pdf/5d/b2/injuryprev-2015-041885.PMC5256231.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Adams PF, Kirzinger W, Martinez M. Summary health statistics for the US population: National Health Interview Survey, 2012.",Non-OADS,/arxiv_data1/oa_pdf/5d/b2/injuryprev-2015-041885.PMC5256231.pdf
http://www.bls.gov/iif/oshwc/cfoi/cfch0012.pdf 18 National Center for Health Statistics.,OADS,/arxiv_data1/oa_pdf/5d/b2/injuryprev-2015-041885.PMC5256231.pdf
"2015. http://www.bls.gov/tus/lexicons.htm 23 Hofferth SL, Flood SM, Sobek M. American Time Use Survey Data Extract System: Version 2.4[Machine-readable database] .",OADS,/arxiv_data1/oa_pdf/5d/b2/injuryprev-2015-041885.PMC5256231.pdf
2015. http://www.cdc.gov/nchs/nhis/quest_ data_related_1997_forward.htm 25 Lohr S. Sampling: design and analysis .,OADS,/arxiv_data1/oa_pdf/5d/b2/injuryprev-2015-041885.PMC5256231.pdf
"http://sites.stat.psu.edu/~dhunter/asymp/fall2006/lectures/ ANGELchpt05.pdf 29 Schenker N, Gentleman JF, Rose D, et al.",OADS,/arxiv_data1/oa_pdf/5d/b2/injuryprev-2015-041885.PMC5256231.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ References AoMRC (2015) www .aomrc.org.uk.,Non-OADS,/arxiv_data1/oa_pdf/77/ae/vetrec-2016-103862.PMC5256232.pdf
http://archive.ahrq.gov/downloads/pub/evidence/pdf/cme/cme.pdf.,OADS,/arxiv_data1/oa_pdf/77/ae/vetrec-2016-103862.PMC5256232.pdf
"Received 19 May 2015 Revised 11 July 2015 Accepted 17 July 2015 Published Online First 25 September 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-004480 To cite: Ogrinc G, Davies L, Goodman D, et al .BMJ Qual Saf2016; 25:986–992.ABSTRACT Since the publication of Standards for QUality Improvement Reporting Excellence (SQUIRE 1.0) guidelines in 2008, the science of the field hasadvanced considerably.",Non-OADS,/arxiv_data1/oa_pdf/8a/74/bmjqs-2015-004411.PMC5256233.pdf
It provides common ground to share these discoveries in the scholarly literature(http://www.squire-statement.org).,Non-OADS,/arxiv_data1/oa_pdf/8a/74/bmjqs-2015-004411.PMC5256233.pdf
"SQUIRE 2.0 Many publication guidelines, including CONSORT (randomised trials), STROBE (observational studies)and PRISMA (systematic reviews) focus on a particu- lar study methodology (http://www.equator-network.",Non-OADS,/arxiv_data1/oa_pdf/8a/74/bmjqs-2015-004411.PMC5256233.pdf
"The SQUIRE website (http://www.squire-statement.org) contains a number of resources in addition to the guidelines themselves,including interactive E&E pages and video commen- taries.",Non-OADS,/arxiv_data1/oa_pdf/8a/74/bmjqs-2015-004411.PMC5256233.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Davidoff F , Batalden P .",Non-OADS,/arxiv_data1/oa_pdf/8a/74/bmjqs-2015-004411.PMC5256233.pdf
2013. https://www.aamc.org/initiatives/cei/ te4q/ (accessed 21 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/8a/74/bmjqs-2015-004411.PMC5256233.pdf
"Correspondence to Dr Frank J Overdyk, Department of Anesthesiology, Hofstra North Shore-LIJ School of Medicine,Long Island Jewish Medical Center, 270 76th Avenue, New Hyde Park, NY 11040, USA; overdykf@icloud.com Received 23 March 2015 Revised 3 November 2015 Accepted 13 November 2015 Published Online First 11 December 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-005058 To cite: Overdyk FJ, Dowling O, Newman S, et al.",Non-OADS,/arxiv_data1/oa_pdf/1b/94/bmjqs-2015-004226.PMC5256234.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Hu YY , Arriaga AF , Roth EM, et al.",Non-OADS,/arxiv_data1/oa_pdf/1b/94/bmjqs-2015-004226.PMC5256234.pdf
"Correspondence to Dr Daisy Goodman, Department of Obstetrics and Gynecology, Dartmouth Hitchcock MedicalCenter, 1 Hospital drive, Lebanon, New Hampshire 03766, USA; daisy.j.goodman@hitchcock.org Received 10 June 2015 Revised 5 February 2016 Accepted 29 February 2016 Published Online First 27 April 2016 ▸http://dx.doi.org/10.1136/ bmjqs-2015-004411 To cite: Goodman D, Ogrinc G, Davies L, et al .BMJ Qual Saf 2016; 25:e7.ABSTRACT Since its publication in 2008, SQUIRE (Standards for Quality Improvement Reporting Excellence) has contributed to the completeness and transparency of reporting of quality improvementwork, providing guidance to authors and reviewers of reports on healthcare improvement work.",Non-OADS,/arxiv_data1/oa_pdf/8f/6f/bmjqs-2015-004480.PMC5256235.pdf
"Authors can explore the SQUIRE statement, this E&E and related documents indetail at http://www.squire-statement.org.",Non-OADS,/arxiv_data1/oa_pdf/8f/6f/bmjqs-2015-004480.PMC5256235.pdf
"The addition of a glossary of key terms, linked to SQUIRE and the E&E, and interactive electronic resources (http://www.squire-statement.org), providefurther opportunity to engage with SQUIRE 2.0 on a variety of levels.",Non-OADS,/arxiv_data1/oa_pdf/8f/6f/bmjqs-2015-004480.PMC5256235.pdf
"In 2015, healthcareimprovement-related MeSH terms include: Health Care Quality Access and Evaluation; Quality Assurance; Quality Improvement; Outcome andProcess Assessment (Healthcare); Quality Indicators, Health Care; T otal Quality Management; Safety Management (http://www.nlm.nih.gov/mesh/MBrowser.html).",OADS,/arxiv_data1/oa_pdf/8f/6f/bmjqs-2015-004480.PMC5256235.pdf
"Note that not all references are to peer-reviewed literature as someare to curricular materials in the website MedEd Portal (https://www.mededportal.org), and others are to online materials.The online supplementary appendix available with this report summarises key elements of each compo- nent which is another option to make details availableto readers.",Non-OADS,/arxiv_data1/oa_pdf/8f/6f/bmjqs-2015-004480.PMC5256235.pdf
"T o promote the spread and sus- tainability of SQUIRE 2.0, the Guidelines, this E&E and the accompanying glossary are accessible on theSQUIRE website (http://www.squire-statement.org).",Non-OADS,/arxiv_data1/oa_pdf/8f/6f/bmjqs-2015-004480.PMC5256235.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ogrinc G, Mooney SE, Estrada C, et al.",OADS,/arxiv_data1/oa_pdf/8f/6f/bmjqs-2015-004480.PMC5256235.pdf
"Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially , and license their derivative works on different terms, provided theoriginal work is properly cited and the use is non-commercial.See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 W achter RM, Flanders SA, Fee C, et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/77/bmjqs-2014-003924.PMC5256236.pdf
"Secondary Hospital Survey on Patient Safety Culture, 2010. http://www.ahrq.gov/professionals/quality-patient-safety/patientsafetyculture/hospital/ 10 Sorra JS, Dyer N. Multilevel psychometric properties of the AHRQ hospital survey on patient safety culture.",Non-OADS,/arxiv_data1/oa_pdf/fc/77/bmjqs-2014-003924.PMC5256236.pdf
"‘Bolam ’to ‘Montgomery ’is result of evolutionary change of medical practice towards ‘patient-centred care ’ Albert Lee Correspondence to Albert Lee, JC School of PublicHealth and Primary Care,The Chinese University of Hong Kong, 4th Floor, Lek Yuen Health Centre, Shatin,NT, Hong Kong;alee@cuhk.edu.hk Received 20 May 2016 Revised 4 July 2016 Accepted 12 July 2016Published Online First27 July 2016 ▸http://dx.doi.org/10.1136/ postgradmedj-2016-134368 To cite: Lee A. Postgrad Med J 2017; 93:46–50.ABSTRACT The Supreme Court judgement in ‘Montgomery v Lanarkshire Health Board ’has caused a change in the law concerning the duty of doctors on disclosure ofinformation to patients regarding risks.",Non-OADS,/arxiv_data1/oa_pdf/e1/ef/postgradmedj-2016-134236.PMC5256237.pdf
"AMC, 2010. http://www.amc.org.au/index.php/about/ good-medical-practice (last accessed 20 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/e1/ef/postgradmedj-2016-134236.PMC5256237.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Francis R. Independent Inquiry into care provided by Mid Staffordshire NHS Foundation T rust January 2005 –March 2009 .,Non-OADS,/arxiv_data1/oa_pdf/fe/7b/bmjqs-2015-004596.PMC5256238.pdf
"Sydney , NSW: University of T echnology Sydney, 2015. http://www.uts.edu.au/sites/default/files/fass-organizational-listening.pdf (accessed 9 Jul 2015).",Non-OADS,/arxiv_data1/oa_pdf/fe/7b/bmjqs-2015-004596.PMC5256238.pdf
2008. http://www.nrls.nhs.uk/resources/?entryid45=59833&p=13 (accessed 14 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/fe/7b/bmjqs-2015-004596.PMC5256238.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jramc-2015-000427).,Non-OADS,/arxiv_data1/oa_pdf/5c/c1/jramc-2015-000427.PMC5256239.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Bricknell M. Heat illness: a comparison between UK and Cyprus reports.,Non-OADS,/arxiv_data1/oa_pdf/5c/c1/jramc-2015-000427.PMC5256239.pdf
https://www.gov.uk/government/publications/number-of-service-personnel-who-have-been-medically-downgraded.,Non-OADS,/arxiv_data1/oa_pdf/5c/c1/jramc-2015-000427.PMC5256239.pdf
"32 Slater S. Olympics cycling: marginal gains underpin Team GB dominance, 8 August 2012. http://www.bbc.co.uk/sport/0/olympics/19174302 (accessed 26 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/5c/c1/jramc-2015-000427.PMC5256239.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Headquarters of the Surgeon General.,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
http://www.bbc.co.uk/news/ uk-wales-27765567 (accessed 13 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
http://natorto.cbw.pl/uploads/2004/7/MP-HFM-086-$$ALL.,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
https://www.gov.uk/government/ collections/uk-armed-forces-quarterly-manning-report-statistics-index (accessed 13Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
16 TSP7 —UK Reserve Forces and Cadets 1 April 2013. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ ﬁle/280401/2013.pdf (accessed 13 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
http://www.rta.nato.int/Pubs/RDP.asp?,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
http://www.metof ﬁce.gov.uk/public/weather/climate/gcqdsfz6w (accessed 13 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
http://www.theweek.co.,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
http://www.metof ﬁce.gov.uk/education/8789 (accessed 13 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
28 Annual 2013. http://www.metof ﬁce.gov.uk/climate/uk/summaries/2013/annual (accessed 13 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ ﬁle/33491/20121019IN06_ 12EmbeddingClimateResilinHSFU.pdf (accessed 13 Nov 2014).,OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
31 Global Strategic Trends out to 2045. https://www.gov.uk/government/uploads/ system/uploads/attachment_data/ ﬁle/348164/20140821_DCDC_GST_5_Web_ Secured.pdf (accessed 13 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/cb/fa/jramc-2014-000384.PMC5256240.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 201Impairment of Immunonutritional Status During Treatment  is a Factor Associated With Oncologic Outcomes in  Patients With Rectal Cancer Treated With Preoperative  Chemoradiotherapy In Ja Park Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2016;32(6):201-202 https://doi.org/10.3393/ac.2016.32.6.201 Studies regarding preoperative nutritional and immunologic sta - tus have increased.",Non-OADS,/arxiv_data1/oa_pdf/84/9d/ac-32-201.PMC5256245.pdf
"Department of Colon and Rectal Surgery, University of College of Medicine  and Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505,  Korea Tel: +82-2-3010-3937, Fax: +82-2-474-9027 E-mail: ipark@amc.seoul.kr © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/9d/ac-32-201.PMC5256245.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 205Intestinal Perforation: A Surgeon’s Nightmare Enlightened  by Scientific Research Byung Soh Min Departments of Surgery, Y onsei University College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2016;32(6):205 https://doi.org/10.3393/ac.2016.32.6.205 Intestinal perforation is a surgeon’s nightmare that every colorectal  surgeon has encountered once in a while, or at least a few times,  during his or her career.",Non-OADS,/arxiv_data1/oa_pdf/7e/b1/ac-32-205.PMC5256246.pdf
"Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-2100, Fax: +82-2-313-8289 E-mail: bsmin@yuhs.ac.kr © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/b1/ac-32-205.PMC5256246.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 215Obstructive Left Colon Cancer Should Be Managed by  Using a Subtotal Colectomy Instead of Colonic Stenting Chung Ki Min, Hyung Ook Kim, Donghyoun Lee, Kyung Uk Jung, Sung Ryol Lee, Hungdai Kim,   Ho-Kyung Chun Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, KoreaOriginal Article Ann Coloproctol 2016;32(6):215-220 https://doi.org/10.3393/ac.2016.32.6.215 Purpose:  This study compared a subtotal colectomy to self-expandable metallic stent (SEMS) insertion as a bridge to sur - gery for patients with left colon-cancer obstruction.",Non-OADS,/arxiv_data1/oa_pdf/16/1a/ac-32-215.PMC5256247.pdf
"© 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/1a/ac-32-215.PMC5256247.pdf
"Chang-Nam Kim Department of Surgery, Eulji University School of Medicine, Daejeon, KoreaEditorial Ann Coloproctol 2016;32(6):206-207 https://doi.org/10.3393/ac.2016.32.6.206 A colonic diverticulum represents a sac-like protrusion of the co - lonic wall while diverticulosis is defined as the presence of diver - ticula.",Non-OADS,/arxiv_data1/oa_pdf/e3/eb/ac-32-206.PMC5256248.pdf
"Department of Surgery, Eulji University Hospital, Eulji University School of  Medicine, 95 Dunsanseo-ro, Seo-gu, Daejeon 35233, Korea Tel: +82-42-259-1335, Fax: +82-42-259-1335 E-mail: kimcn@eulji.ac.kr  © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/eb/ac-32-206.PMC5256248.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 208Prognostic Impact of Immunonutritional Status Changes  During Preoperative Chemoradiation in Patients With  Rectal Cancer Y ong Joon Lee, Woo Ram Kim1, Jeonghee Han, Y oon Dae Han, Min Soo Cho, Hyuk Hur, Kang Y oung Lee,   Nam Kyu Kim, Byung Soh Min Department of Surgery, Severance Hospital, Y onsei University College of Medicine, Seoul; 1Department of Surgery, CHA Bundang Medical  Center, CHA University, Seongnam, KoreaOriginal Article Ann Coloproctol 2016;32(6):208-214 https://doi.org/10.3393/ac.2016.32.6.208 Purpose:  Previous studies have demonstrated the prognostic impact of the prognostic nutritional index (PNI), a proposed  indicator of immunonutritional statuses of surgical patients, on patients with various gastrointestinal cancers.",Non-OADS,/arxiv_data1/oa_pdf/9c/af/ac-32-208.PMC5256249.pdf
"Department of Surgery, Severance Hospital, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-2100, Fax: +82-2-313-8289, E-mail: bsmin@yuhs.ac © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/af/ac-32-208.PMC5256249.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 221Predictors of Morbidity and Mortality After Surgery for  Intestinal Perforation Rumi Shin, Sang Mok Lee, Beonghoon Sohn, Dong Woon Lee1, Inho Song1, Y oung Jun Chai,   Hae Won Lee, Hye Seong Ahn, In Mok Jung, Jung Kee Chung, Seung Chul Heo Department of Surgery, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul; 1Department of Surgery,  Seoul National University College of Medicine, Seoul, KoreaOriginal Article Ann Coloproctol 2016;32(6):221-227 https://doi.org/10.3393/ac.2016.32.6.221 Purpose:  An intestinal perforation is a rare condition, but has a high mortality rate, even after immediate surgical inter - vention.",Non-OADS,/arxiv_data1/oa_pdf/7c/8f/ac-32-221.PMC5256250.pdf
"Department of Surgery, Seoul Metropolitan Government-Seoul National  University Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu,  Seoul 07061, Korea  Tel: +82-2-870-2273, Fax: +82-2-870-3866, E-mail: heosc3@brmh.org  © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/8f/ac-32-221.PMC5256250.pdf
http://doi.org/10.1177/0148607115625638.,Non-OADS,/arxiv_data1/oa_pdf/7c/8f/ac-32-221.PMC5256250.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 239Colonic Perforation Secondary to Idiopathic Intramural  Hemorrhage  Takashi Sakamoto, Akira Saito1, Alan Kawarai Lefor2, Tadao Kubota Departments of Surgery and 1Pathology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu; 2Department of Surgery, Jichi Medical  University, Shimotsuke, JapanCase Report Ann Coloproctol 2016;32(6):239-242 https://doi.org/10.3393/ac.2016.32.6.239 Intramural colonic hemorrhage is rare and often secondary to trauma or anticoagulation therapy.",Non-OADS,/arxiv_data1/oa_pdf/7d/60/ac-32-239.PMC5256251.pdf
"Department of Surgery, Tokyo Bay Urayasu Ichikawa Medical Center,   3-4-32, Todaijima, Urayasu, Chiba, 279-0001, Japan Tel: +81-47-351-3101, Fax: +81-47-352-6237 E-mail: takac93@gmail.com © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/60/ac-32-239.PMC5256251.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 228Management of Colonic Diverticulitis Tailored to Location  and Severity: Comparison of the Right and the Left Colon Byeoung Hoon Chung, Gi Won Ha, Min Ro Lee, Jong Hun Kim Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, KoreaOriginal Article Ann Coloproctol 2016;32(6):228-233 https://doi.org/10.3393/ac.2016.32.6.228 Purpose:  This study assessed optimal management of colonic diverticulitis as functions of disease location and severity  and factors associated with complicated diverticulitis.",Non-OADS,/arxiv_data1/oa_pdf/d4/84/ac-32-228.PMC5256252.pdf
"Research Institute of Clinical Medicine, Chonbuk National University  Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju 54896, Korea Tel: +82-63-250-1570, Fax: +82-63-271-6197, E-mail: gsminro@jbnu.ac.kr © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/84/ac-32-228.PMC5256252.pdf
http://doi.org/10.1111/ans.13028.,Non-OADS,/arxiv_data1/oa_pdf/d4/84/ac-32-228.PMC5256252.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 234Pneumoretroperitoneum, Pneumomediastinum,  Subcutaneous Emphysema After a Rectal Endoscopic  Mucosal Resection Hee Cheul Jung, Hyun Jin Kim, Sung Bok Ji, Jun Hyeong Cho, Ji Hye Kwak, Chang Min Lee, Wan Soo Kim,  Jin Ju Kim, Jae Min Lee, Sang Su Lee Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, KoreaCase Report Ann Coloproctol 2016;32(6):234-238 https://doi.org/10.3393/ac.2016.32.6.234 An endoscopic mucosal resection (EMR) is an effective and safe therapeutic technique for treating a patient with a later - ally-spreading tumor (LST).",Non-OADS,/arxiv_data1/oa_pdf/79/25/ac-32-234.PMC5256253.pdf
"Department of Internal Medicine, Gyeongsang National University School of  Medicine, 15 Jinju-daero 816beon-gil, Jinju 52727, Korea Tel: +82-55-755-8721, Fax: +82-55-755-9078,  E-mail: hee-cheul@hanmail.net © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/25/ac-32-234.PMC5256253.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 203Comparison of a Subtotal Colectomy With Self-Expandable  Metallic Stent in the Management of Patients With  Obstructive Left Colon Cancer Byung Chun Kim Department of Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2016;32(6):203-204 https://doi.org/10.3393/ac.2016.32.6.203 Colorectal obstruction caused by colorectal cancer has been re - ported to occur in 7%–29% of all patients with colorectal cancers  [1, 2], with left-sided colonic obstruction being more common  than right-sided colonic obstruction [3].",Non-OADS,/arxiv_data1/oa_pdf/35/41/ac-32-203.PMC5256254.pdf
"Department of Surgery, Kangnam Sacred Heart Hospital, Hallym University  College of Medicine, 1 Singil-ro, Yeongdeungpo-gu, Seoul 07441, Korea Tel: +82-2-829-5130, Fax: +82-2-849-4469,  E-mail: bckimgs@hallym.or.kr © 2016 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/41/ac-32-203.PMC5256254.pdf
"1: 34-43 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.34 | Original Article |  “I’m healthy, I don ’t have pain ”- health screening  participation and its association with chronic pain in a  low socioeconomic status Singaporean population  Singhealth Internal Medicine, Singapore General Hospital, *Yong Loo Lin School of Medicine, National University of Singapore,  National University Health System, †National Psychiatry Residency Program, National Healthcare Group,  ‡Department of Anaesthesia, Ng Teng Fong General Hospital, JurongHealth, §Saw Swee Hock School of Public Health,  National University of Singapore, National University Health System, Singapore Liang En Wee, David Sin*, Wen Qi Cher*, Zong Chen Li*, Tammy Ts ang†, Sabina Shibli‡, and Gerald Koh§ Background:  We sought to determine the association between chronic pain and participating in routine health  screening in a low socioeconomic-status (SES) rental-flat community in Singapore.",Non-OADS,/arxiv_data1/oa_pdf/7d/1e/kjpain-30-34.PMC5256257.pdf
Available at  http://www.singstat.gov.sg/statistics/visualising-data/charts/ home-ownership-rate-of-resident-households.,OADS,/arxiv_data1/oa_pdf/7d/1e/kjpain-30-34.PMC5256257.pdf
Available at http://www.hdb.gov.sg/cs/  infoweb/residential/renting-a-flat/renting-from-hdb/parentho od-provisional-housing-schem e-pphs/rents-and-deposits.,Non-OADS,/arxiv_data1/oa_pdf/7d/1e/kjpain-30-34.PMC5256257.pdf
Available at  http://www.nas.gov.sg/archivesonline/data/pdfdoc/20150223002/hh_income_press_release.pdf.,OADS,/arxiv_data1/oa_pdf/7d/1e/kjpain-30-34.PMC5256257.pdf
"1: 3-17 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.3 | Review Article | Effects of applying nerve blocks to prevent postherpetic  neuralgia in patients with acute herpes zoster:  a systematic review and meta-analysis 1Department of Preventive Medicine, College of Medicine, Korea University,  2Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  3Department of Anesthesiology and Pain Medicine, Kangwon National University Hospital, Chuncheon, Korea Hyun Jung Kim1,* ,  H y e o n g  S i k  A h n1,*, Jae Young Lee2, Seong Soo Choi2,  Yu Seon Cheong3, Koo Kwon2, Syn Hae Yoon2, and Jeong Gill Leem2  Background:  Postherpetic neuralgia (PHN) is a common and painful complication of acute herpes zoster.",Non-OADS,/arxiv_data1/oa_pdf/37/e0/kjpain-30-3.PMC5256258.pdf
"1: 59-61 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.59 |C a s e  R e p o r t| Fluoroscopy-guided intra-articular steroid injection for  sternoclavicular joint arthritis secondary to limited  cutaneous systemic sclerosis: a case report Department of Algology, Kayseri Training and Research Hospital,  *Division of Algology, Department of Physical Medicine and Rehabilitation, Erciyes University, School of Medicine,  †Department of Physical Medicine and Rehabilitation, Kayseri Training and Research Hospital,  ‡Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Erciyes University, School of Medicine,  Kayseri, Turkey Savas Sencan, Emel G üler*, Isa C üce†, and Kemal Erol‡ We report a case of fluoroscopy-guided intraarticular st eroid injection for sternoclavicular joint (SCJ) arthritis  caused by limited cutaneous systemic sclerosis (SSc).",Non-OADS,/arxiv_data1/oa_pdf/17/d2/kjpain-30-59.PMC5256259.pdf
"1: 51-58 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.51 | Original Article |  Usefulness of four commonly used neuropathic pain  screening questionnaires in patients with chronic  low back pain: a cross-sectional study Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, SAS Nagar (Mohali),  *Department of Anesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research,  Chandigarh, India Kapil Gudala, Babita Ghai*, and Dipika Bansal Background:  Recently symptoms-based screening questionnaires have gained attention for screening for a  neuropathic pain component (NePC) in various chronic pain conditions.",Non-OADS,/arxiv_data1/oa_pdf/60/90/kjpain-30-51.PMC5256260.pdf
"1: 66-70 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.66 | Brief Report | A brief report on a technical description of  ultrasound-guided lumbar sympathetic block  1Department of Anesthesiology and Pain Medicine, Seoul National University Hospital,  Seoul National University College of Medicine, Seoul,  2Department of Anesthesiology and Pain Medicine, National Police Hospital, Seoul, Korea 3Department of Anesthesiology and Pain Medicine, Apollo Speciality Hospitals, OMR, Chennai, India Jee Youn Moon1, Jae Kyu Choi1, Ji Yeon Shin2, Sung Won Chon2, and Sushmitha Dev1,3 The lumbar sympathetic ganglion block (LSGB) is widely used for diagnosing and treating sympathetically  maintained pain disorders.",Non-OADS,/arxiv_data1/oa_pdf/69/c0/kjpain-30-66.PMC5256261.pdf
"1: 44-50 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.44 | Original Article |  Lumbar herniated disc: spontaneous regression  Department of Neurosurgery, Kahramanmaras Sutcu Imam University Medical Faculty, Kahramanmaras, T urkey Idiris Altun and Kas ım Zafer Y üksel Background:  Low back pain is a frequent condition that resu lts in substantial disability and causes admission  of patients to neurosurgery clinics.",Non-OADS,/arxiv_data1/oa_pdf/09/68/kjpain-30-44.PMC5256262.pdf
"1: 71-72 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.71 | Letters to Editor | Repetitive transcranial magnetic stimulation: a potential  therapeutic modality for chronic low back pain Department of Neurosurgery, Orthopedics Research Center, Mazandaran University of Medical Sciences,  *Department of Anesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari,  †Student Research Committee, Department of Medical-Surgical Nursing, School of Nursing and Midwifery,  Mashhad University of Medical Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/c4/5b/kjpain-30-71.PMC5256263.pdf
"1: 18-33 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.18 | Review Article | Guidelines for prescribing opioids for  chronic non-cancer pain in Korea Department of Anesthesiology and Pain Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University  of Korea, Seoul, *Department of Anesthesiology and Pain Medicine, Samsung Medical Center, School of Medicine,  Sungkyunkwan University, Seoul, †Department of Anesthesiology and Pain Medicine, Chonbuk National University Hospital,  School of Medicine, Chonbuk National University, Jeonju, ‡Department of Anesthesiology and Pain Medicine, Pusan National  University Yangsan Hospital, School of Medicine, Pusan National University, Yangsan, §Department of Anesthesiology and Pain  Medicine, Kyungpook National University Medical Center, School of Medicine, Kyungpook National University, Daegu,  ∥Department of Anesthesiology and Pain Medicine, Kimchan Hospital, Suwon, ¶Department of Anesthesiology and Pain  Medicine, Soonchunhyang University Cheonan Hospital, College of Medicine, Soonchunhyang Univertisy, Cheonan,  **Department of Anesthesiology and Pain Medicine, Keimyung University Dongsan Medical Center, School of Medicine,  Keimyung University, Daegu, ††Department of Anesthesiology and Pain Medicine, Seoul St. Mary’s Hospital, College of Medicine,  T h e  C a t h o l i c  U n i v e r s i t y  o f  K o r e a ,  S e o u l ,  K o r e a Eung Don Kim, Jin Young Lee*, Ji Seon Son†, Gyeong Jo Byeon‡, Jin Seok Yeo§, Do Wan Kim∥,  Sie Hyeon Yoo¶, Ji Hee Hong**, and Hue Jung Park††; Opioids Research Group in the Korean Pain Society As the treatment of chronic non-cancer pain gradually increases, clinicians have more opportunities to  encounter opioid prescription.",Non-OADS,/arxiv_data1/oa_pdf/48/28/kjpain-30-18.PMC5256264.pdf
"Various Assessment Tools to Measure Pain Intensity and Functional Status [1] Roland Morris Disability Questionnaire www.chirogeek.com/001_Roland-Morris-Questionnaire.htm Pain, Enjoyment and General Activity (PEG)www.ncbi.nlm.nih.gov/pmc/articles/PMC2686775 Graded Chronic Pain Scale (Washington State Guidelines) www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdfBrief Pain Inventory medicine.iupui.edu/RHEU/Physicians/bpisf.pdf Physical Functional Ability Questionnairewww.cdc.gov/nchs/data/nhanes/nhanes_09_10/pfq_f.pdf Bieri Pain Scale www.healthcare.uiowa.edu/igec/tools/pain/faces.pdfPain Management Resource Directory (includes assessment tools) www.compassionandsupport.org/index.php/for_professionals/pain_management AUDIT Alcohol Consumption Questionswww.ewashtenaw.org/government/departments/wcho/ch_auditc.pdf CRAFFT Adolescent Substance Abuse Screening T ool www.childrenshospital.org/views/february09/images/CRAFFT .pdfPatient Health Questionnaire-2 for Depression Assessment www.cqaimh.org/pdf/tool_phq2.pdf Sample Pain Treatment Agreementshttp://hrsa.dshs.wa.gov/pharmacy/ChronicPainAgreement.pdf www.painmed.org/library/sample_agreements/controlled-substances-agrmt110803.pdf www.dopl.utah.gov/licensing/forms/OpioidGuidlines_summary.pdfprescription of opioids in Korea.",Non-OADS,/arxiv_data1/oa_pdf/48/28/kjpain-30-18.PMC5256264.pdf
Available at  http://nationalpaincentre.mcmaster.ca/opioid/.,Non-OADS,/arxiv_data1/oa_pdf/48/28/kjpain-30-18.PMC5256264.pdf
"1: 62-65 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.62 |C a s e  R e p o r t| Psoas compartment block for treatment of motor weakness  and pain following herpes zoster Department of Anesthesiology and Pain Medicine, Kyungpook National University Hospital,  *School of Dentistry, Kyungpook National University, Daegu, Korea Sae Young Kim, Dong Gyeong Kim, Yong Min Park, and Young Hoon J eon* Reactivation of the latent varicella zoster virus in the sensory ganglion causes herpes zoster (HZ).",Non-OADS,/arxiv_data1/oa_pdf/83/ae/kjpain-30-62.PMC5256265.pdf
"1: 73 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.73 | Erratum | Erratum: correction of author name, rearrangement of  author list, and adding foot note Woo Seog Sim Department of Anesthesiology and Pain Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ec/fc/kjpain-30-73.PMC5256266.pdf
"2: 96-102, https://doi.org/10.3344/kjp.2016.29.2.96 ”,  author name of “Hyung Woo Lim ” should be corrected as “Hyeong Woo Im ” and the arrangement of author list should  be as follows:  Hyeong Woo Im, Ji Won Choi, Jin Y oung Lee, Won Il Lee, Eun Kyun g Lee, Choo Hoon Chang*, Jae Y oung Y ang, and  Woo Seog Sim Furthermore, foot note should be added as follows:  This article w as based on the master ’s d egree thesis of Dr. Hy eong W oo Im.",Non-OADS,/arxiv_data1/oa_pdf/ec/fc/kjpain-30-73.PMC5256266.pdf
1: 1-2 pISSN 2005-9159  eISSN 2093-0569https://doi.org/10.3344/kjp.2017.30.1.1 |E d i t o r i a l| Guidelines for prescribing opioids for chronic non-cancer  pain in Korea: can you overcome “opiophobia ”?,Non-OADS,/arxiv_data1/oa_pdf/8d/17/kjpain-30-1.PMC5256267.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/jech- 2015-206745).,Non-OADS,/arxiv_data1/oa_pdf/f0/4d/jech-2015-206745.PMC5256268.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Pihlstrom BL, Michalowicz BS, Johnson NW.",Non-OADS,/arxiv_data1/oa_pdf/f0/4d/jech-2015-206745.PMC5256268.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/81/asjsm-07-04-35000.PMC5256271.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/fd/asjsm-07-04-35024.PMC5256272.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/tobaccocontrol-2015-052804).,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/tobaccocontrol-2015-052804.PMC5256309.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 International Agency for Research on Cancer.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/tobaccocontrol-2015-052804.PMC5256309.pdf
"Tokyo, 2014. http://www.mhlw.go.jp/toukei/list/20- 21.html (accessed 1 Nov 2015) (in Japanese) 13 Ministry of Health, Labour and Welfare.",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/tobaccocontrol-2015-052804.PMC5256309.pdf
"Tokyo, 2014. http://www.mhlw.go.jp/toukei/list/29-6.html (accessed 1 Nov 2015) (in Japanese) 14 Oshio T. The association between involvement in family caregiving and mental health among middle-aged adults in Japan.",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/tobaccocontrol-2015-052804.PMC5256309.pdf
"Tokyo, 2005. http://www.mhlw.go.jp/bunya/kenkou/eiyou-chosa2-01/index.",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/tobaccocontrol-2015-052804.PMC5256309.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Bauld L, Angus K, de Andrade M. E-cigarette uptake and marketing A report commissioned by Public Health England.",Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
https://www.gov.uk/government/uploads/ system/uploads/attachment_data/ ﬁle/311491/Ecigarette_uptake_and_marketing.pdf (accessed 7 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
http://www.mhra.gov.uk/home/groups/comms-ic/documents/ websiteresources/con297583.pdf (accessed 11 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
http://www.derbyshire.gov.uk/images/sfy31_tcm44 –247854.pdf (accessed 12 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
https://www.shef ﬁeld.gov.uk/dms/scc/management/corporate-communications/ documents/business-industry/trading-standards/Electronic_Cigarettes_Guidance.pdf (accessed 12 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
http://www.google.co.,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
http://www3.hants.,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
"http://www.ti.ubc.ca 13 Okamoto M, Kita T, Okuda H, et al.",Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
http://www.inchem.org/documents/pims/chemical/nicotine.,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
http://ecita.org.uk/sites/ default/ ﬁles/u41/bibra%20EU_Classi ﬁcation_of_nicotine_mixtures_acute_oral_and_ dermal_toxicity.pdf (accessed 25 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
"http://echa.europa.eu/documents/10162/56df129c-42d3 –4533-a828-e5d26a58bc63 (accessed 20 Apr 2015).19 Cameron JM, Howell DN, White JR, et al.",Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
2015. http://www.ncsct.co.uk/usr/pub/NCSCT_midwifery_brie ﬁng.,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
http://www.cdc.gov/mmwr/pdf/wk/mm6313.pdf (accessed 26 Mar 2015).,OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
"28 NPIS National Poisons Information Service (2014) Report 2013/14, http://www.npis.",Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
http://www.nytimes.com/aponline/2015/04/13/us/ ap-us-toddler-nicotine-death.html?_r=0 (accessed 19 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/de/11/tobaccocontrol-2015-052683.PMC5256311.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ tobaccocontrol-2015-052771).,Non-OADS,/arxiv_data1/oa_pdf/28/3c/tobaccocontrol-2015-052771.PMC5256312.pdf
Data sharing statement Eurobarometer datasets are publicly available online at http://zacat.gesis.org.,OADS,/arxiv_data1/oa_pdf/28/3c/tobaccocontrol-2015-052771.PMC5256312.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/28/3c/tobaccocontrol-2015-052771.PMC5256312.pdf
http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf (accessed 25thSep 2015).,Non-OADS,/arxiv_data1/oa_pdf/28/3c/tobaccocontrol-2015-052771.PMC5256312.pdf
http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf(accessed 25 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/28/3c/tobaccocontrol-2015-052771.PMC5256312.pdf
"Exposure to secondhand smoke incars and homes, and e-cigarette use among 10 –11 year old children in Wales: CHETS Wales 2. http://gov.wales/docs/caecd/research/2014/141203-exposure- secondhand-smoke-cars-ecigarette-use-among-10 –11-year-olds-chets-2-main-en.pdf (accessed 25 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/28/3c/tobaccocontrol-2015-052771.PMC5256312.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1082 -1091 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/42/41/arm-40-1082.PMC5256313.pdf
"Tel: +82-31-380-3860, Fax: +82-31-380-3864, E-mail: ohnsh@hallym.ac.kr ORCID: Soyeon Jang  (http://orcid.org/ 0000-0002-1124-2457 ); Kwang-Ik Jung  (http://orcid.org/ 0000-0003-1998-1921 ); Woo-Kyoung Yoo  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/42/41/arm-40-1082.PMC5256313.pdf
org/ 0000-0002-1273-0647 ); Myung Hun Jung  (http://orcid.org/ 0000-0003-2393-3930 ); Suk Hoon Ohn  (http://orcid.org/ 0000-0002-1139-1946 ).,Non-OADS,/arxiv_data1/oa_pdf/42/41/arm-40-1082.PMC5256313.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/41/arm-40-1082.PMC5256313.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1024 -1032 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/75/a9/arm-40-1024.PMC5256314.pdf
"Tel: +82-63-859- 1610, Fax: +82-63-843-1385, E-mail: helmaine@naver.com ORCID: Seung Hwa Rhie  (http://orcid.org/ 0000-0003-0663-8331 ); Jiwon Choi  (http://orcid.org/ 0000-0002-5339-4854 ); Se Jeong Jeon  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/75/a9/arm-40-1024.PMC5256314.pdf
org/ 0000-0002-1134-2757 ); Sung Don Kang  (http://orcid.org/ 0000-0002-3965-1674 ); Min Cheol Joo  (http://orcid.org/ 0000-0003-2778-4194 ); Min Su  Kim  (http://orcid.org/ 0000-0001-9954-1445 ).,Non-OADS,/arxiv_data1/oa_pdf/75/a9/arm-40-1024.PMC5256314.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/a9/arm-40-1024.PMC5256314.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):998-1009 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/ea/36/arm-40-998.PMC5256315.pdf
"Tel: +82-32-621-5057, Fax: +82-32-621-5070, E-mail: khd1516@naver.com ORCID: Hyun Seok  (http://orcid.org/ 0000-0001-7266-6045 ); Seung Yeol Lee  (http://orcid.org/ 0000-0003-1571-9408 ); Jihoon Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/ea/36/arm-40-998.PMC5256315.pdf
org/ 0000-0001-6843-3724 ); Jungho Yeo  (http://orcid.org/ 0000-0002-8583-2943 ); Hyungdong Kang  (http://orcid.org/ 0000-0001-8599-4822 ).,Non-OADS,/arxiv_data1/oa_pdf/ea/36/arm-40-998.PMC5256315.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/36/arm-40-998.PMC5256315.pdf
Annals of Rehabilitation MedicineImages in This Issue Ann Rehabil Med 2016 ;40(6):1149 -1150 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/92/5d/arm-40-1149.PMC5256316.pdf
"Tel: + 82-53-620-4098, Fax: + 82-53-620-3278, E-mail: yousung1008@hanmail.net ORCID: SungHo Jang  (http://orcid.org/ 0000-0001-6383-5505 ); YouSung Seo  (http://orcid.org/ 0000-0002-7480-3071 ).",Non-OADS,/arxiv_data1/oa_pdf/92/5d/arm-40-1149.PMC5256316.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/5d/arm-40-1149.PMC5256316.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1040 -1047 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/52/21/arm-40-1040.PMC5256317.pdf
"Tel:  +82-43-269-6227, Fax: +82-43-269-6228, E-mail: hippocrates@hanmail.net ORCID: Kyoung Moo Lee  (http://orcid.org/ 0000-0002-3191-8848 ); Hyo-Jong Kim  (http://orcid.org/ 0000-0001-8460-2698 ).",Non-OADS,/arxiv_data1/oa_pdf/52/21/arm-40-1040.PMC5256317.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/21/arm-40-1040.PMC5256317.pdf
Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016 ;40(6):1124 -1128 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/2b/2a/arm-40-1124.PMC5256318.pdf
"Tel: +82-2-2210-  3136, Fax: +82-2-2210-3133, E-mail: btjrbj@gmail.com ORCID: Pyong-Hwa Seol  (http://orcid.org/0000-0001-8778-8184); Kangwook Ha  (http://orcid.org/0000-0002-0216-0871); Yun Hee Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/2b/2a/arm-40-1124.PMC5256318.pdf
org/0000-0003-1629-9310); Hojun Kwak  (http://orcid.org/0000-0001-7667-8051); Seung-Wan Park  (http://orcid.org/0000-0002-5996-3544); Byungju  Ryu  (http://orcid.org/0000-0003-0109-9885).,Non-OADS,/arxiv_data1/oa_pdf/2b/2a/arm-40-1124.PMC5256318.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/2a/arm-40-1124.PMC5256318.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1114 -1123 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/84/e1/arm-40-1114.PMC5256319.pdf
"Tel: +82-2-950-1134, Fax: +82-2-935-3076, E-mail: goodsangjae@naver.com ORCID: Chul Kim  (http://orcid.org/ 0000-0001-8223-2945 ); Hee Eun Choi  (http://orcid.org/ 0000-0002-8753-929X ); Kihoon Lee  (http://orcid.org/ 0000- 0001-7445-832X ); Youngjoo Kim  (http://orcid.org/ 0000-0001-9379-656X ); Sang Jae Lee  (http://orcid.org/ 0000-0001-9499-3979 ).",Non-OADS,/arxiv_data1/oa_pdf/84/e1/arm-40-1114.PMC5256319.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/e1/arm-40-1114.PMC5256319.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1010 -1017 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/62/cb/arm-40-1010.PMC5256320.pdf
"Tel: +82-33-258-9205,  Fax: +82-33-258-2146, E-mail: stewardofgod@gmail.com ORCID: Gowun Kim  (http://orcid.org/ 0000-0002-5694-8111 ); David Min  (http://orcid.org/ 0000-0002-0956-019X ); Eun-ok Lee  (http://orcid.org/ 0000- 0002-2480-9184 ); Eun Kyoung Kang  (http://orcid.org/ 0000-0001-5315-1361 ).",Non-OADS,/arxiv_data1/oa_pdf/62/cb/arm-40-1010.PMC5256320.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/cb/arm-40-1010.PMC5256320.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):972-980 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/ab/06/arm-40-972.PMC5256321.pdf
"Tel: +82-63-250-1795, Fax: +82-63-254-4145, E-mail: mhko@jbnu.ac.kr ORCID: Jin-Young Chun  (http://orcid.org/ 0000-0002-3971-1366 ); Jeong-Hwan Seo  (http://orcid.org/ 0000-0002-6915-6674 ); Sung-Hee Park  (http:// orcid.org/ 0000-0002-4743-2551 ); Yu Hui Won  (http://orcid.org/ 0000-0003-2007-9652 ); Gi-Wook Kim  (http://orcid.org/ 0000-0002-1628-8382 ); Sungjun  Moon  (http://orcid.org/ 0000-0002-1995-8353 ); Myoung-Hwan Ko  (http://orcid.org/ 0000-0002-0566-3677 ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/arm-40-972.PMC5256321.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/06/arm-40-972.PMC5256321.pdf
Numerous screening tests have been proposed  and are currently being used for surveillance of develop -Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1108 -1113 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/30/2f/arm-40-1108.PMC5256322.pdf
"Tel: +82-31-900-0970, Fax: +82-31-900-0028, E-mail: snoopyhara@hanmail.net ORCID: Seong Woo Kim  (http://orcid.org/ 0000-0002-1548-8147 ); Jiyong Kim  (http://orcid.org/ 0000-0003-4693-8400 ); Sangyoon Lee  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/30/2f/arm-40-1108.PMC5256322.pdf
org/ 0000-0001-5943-8881 ); Ha Ra Jeon  (http://orcid.org/ 0000-0002-4234-8086 ).,Non-OADS,/arxiv_data1/oa_pdf/30/2f/arm-40-1108.PMC5256322.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/2f/arm-40-1108.PMC5256322.pdf
It occurs frequently in patients with post-stroke hemiple -Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):961-971 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/09/4a/arm-40-961.PMC5256323.pdf
"Tel: +82-51- 240-5690, Fax: +82-51-254-8511, E-mail: fallilwy@naver.com ORCID: Kyeong Woo Lee  (http://orcid.org/ 0000-0001-8785-5535 ); Sang Beom Kim  (http://orcid.org/ 0000-0002-5622-5933 ); Jong Hwa Lee  (http:// orcid.org/ 0000-0003-2489-358X ); Sook Joung Lee  (http://orcid.org/ 0000-0002-6894-445X ); Seung Wan Yoo  (http://orcid.org/ 0000-0003-4955-6969 ).",Non-OADS,/arxiv_data1/oa_pdf/09/4a/arm-40-961.PMC5256323.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/4a/arm-40-961.PMC5256323.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1092 -1099 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/39/57/arm-40-1092.PMC5256324.pdf
"Tel: +82-2-901-1915, Fax: +82-2-901-1920, E-mail: leejungah@korea.kr ORCID: Jung Ah Lee  (http://orcid.org/ 0000-0002-5837-3008 ); Hyun Choi  (http://orcid.org/ 0000-0003-3210-8561 ); Dong-A Kim  (http://orcid.org/ 0000- 0001-7048-0650 ); Bum-Suk Lee  (http://orcid.org/ 0000-0002-0506-0403 ); Jaejin Lee  (http://orcid.org/ 0000-0003-0856-5578 ); Jae Hyuk Bae  (http:// orcid.org/ 0000-0001-7710-5538 ); Mun Hee Lim  (http://orcid.org/ 0000-0002-0319-7422 ); Jin-Ju Kim  (http://orcid.org/ 0000-0002-3075-4191 ).",Non-OADS,/arxiv_data1/oa_pdf/39/57/arm-40-1092.PMC5256324.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/57/arm-40-1092.PMC5256324.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1071 -1081 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/b8/fd/arm-40-1071.PMC5256325.pdf
"Tel: +82-31-787-7739, Fax: +82-31-787-4051, E-mail: jseok337@snu.ac.kr ORCID: Yun Suk Jung  (http://orcid.org/ 0000-0001-6683-9499 ); Jee Hyun Suh  (http://orcid.org/ 0000-0002-9789-0235 ); Ha Young Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/b8/fd/arm-40-1071.PMC5256325.pdf
org/ 0000-0002-4220-527X ); Kyunghoon Min  (http://orcid.org/ 0000-0003-3357-9795 ); Yoongul Oh  (http://orcid.org/ 0000-0003-4324-9765 ); Donghwi  Park  (http://orcid.org/ 0000-0002-7724-4682 ); Ju Seok Ryu  (http://orcid.org/ 0000-0003-3299-3038 ).,Non-OADS,/arxiv_data1/oa_pdf/b8/fd/arm-40-1071.PMC5256325.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/fd/arm-40-1071.PMC5256325.pdf
AI impairs the body’s  ability to respond to stress during trauma and critical Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1033 -1039 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/19/03/arm-40-1033.PMC5256326.pdf
"Tel: +82-42-338-2460, Fax: +82-42-338-2461, E-mail: sso224@cnuh.co.kr ORCID: Soo Ho Park  (http://orcid.org/ 0000-0002-1815-5196 ); Kang Hee Cho  (http://orcid.org/ 0000-0002-6592-3370 ).",Non-OADS,/arxiv_data1/oa_pdf/19/03/arm-40-1033.PMC5256326.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/03/arm-40-1033.PMC5256326.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):989-997 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/32/ff/arm-40-989.PMC5256327.pdf
"Tel: +39-3346262362, Fax: +39- 53228704, E-mail: s.straudi@ospfe.it ORCID: Sofia Straudi  (http://orcid.org/ 0000-0002-2061-9922 ); Carlotta Martinuzzi  (http://orcid.org/ 0000-0001-6587-7098 ); Andrea Baroni  (http:// orcid.org/ 0000-0002-8681-3090 ); Maria Grazia Benedetti  (http://orcid.org/ 0000-0002-2623-8506 ); Calogero Foti  (http://orcid.org/ 0000-0003-2246- 348X ); Amira Sabbagh Charabati  (http://orcid.org/ 0000-0003-2249-2838 ); Claudia Pavarelli  (http://orcid.org/ 0000-0002-0997-8051 ); Nino Basaglia   (http://orcid.org/ 0000-0001-6726-0315 ).",Non-OADS,/arxiv_data1/oa_pdf/32/ff/arm-40-989.PMC5256327.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/ff/arm-40-989.PMC5256327.pdf
The FH is the most common site of lesion Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1057 -1063 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/db/1d/arm-40-1057.PMC5256328.pdf
"Tel: +82-2-3779-1257, Fax: +82-2-3779-2075, E-mail: gstinfog@catholic.ac.kr ORCID: Ji Yeon Kim  (http://orcid.org/ 0000-0002-6517-9596 ); Seojin Song  (http://orcid.org/ 0000-0002-7956-1075 ); Hye Jung Park  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/db/1d/arm-40-1057.PMC5256328.pdf
org/ 0000-0002-6731-4376 ); Won Ihl Rhee  (http://orcid.org/ 0000-0002-4111-9978 ); Sun Jae Won  (http://orcid.org/ 0000-0002-9057-3747 ).,Non-OADS,/arxiv_data1/oa_pdf/db/1d/arm-40-1057.PMC5256328.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/1d/arm-40-1057.PMC5256328.pdf
Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016 ;40(6):1129 -1134 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/62/94/arm-40-1129.PMC5256329.pdf
"Tel: +82-32-280-5207, Fax: +82-32-280-5040, E-mail: dhjangmd@naver.com ORCID: Ja young Oh  (http://orcid.org/ 0000-0002-0230-7677 ); Hyunjung Do  (http://orcid.org/ 0000-0001-7972-2548 ); Seungok Lee  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/62/94/arm-40-1129.PMC5256329.pdf
org/ 0000-0003-4538-8427 ); Ja-Hyun Jang  (http://orcid.org/ 0000-0003-0516-4947 ); Eunhae Cho  (http://orcid.org/ 0000-0003-3056-0001 ); Dae-Hyun  Jang  (http://orcid.org/ 0000-0001-8293-084X ).,Non-OADS,/arxiv_data1/oa_pdf/62/94/arm-40-1129.PMC5256329.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/94/arm-40-1129.PMC5256329.pdf
"Catheter localization in the ureter is a rare complica - tion; in fact, only 17 cases of an indwelling urethral or Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016 ;40(6):1140 -1143 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.",Non-OADS,/arxiv_data1/oa_pdf/3d/85/arm-40-1140.PMC5256330.pdf
"Tel: +82-55-750-8252, Fax: +82- 55-750-8255, E-mail: hsshin@gnu.ac.kr ORCID: Hyejung Choi  (http://orcid.org/ 0000-0003-1572-432X ); Chang Han Lee  (http://orcid.org/ 0000-0001-8351-5226 ); Heesuk Shin  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/3d/85/arm-40-1140.PMC5256330.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/85/arm-40-1140.PMC5256330.pdf
"If the pharyngeal swallow has not  been initiated as the liquid passes the tongue base, there Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1018 -1023 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.",Non-OADS,/arxiv_data1/oa_pdf/95/69/arm-40-1018.PMC5256331.pdf
"Tel: +82- 31-961-7465, Fax: +82-31-961-7488, E-mail: skjoct09@gmail.com ORCID: Jin-Woo Park  (http://orcid.org/ 0000-0003-4989-2575 ); Gyu-Jeong Sim  (http://orcid.org/ 0000-0003-4083-4934 ); Dong-Chan Yang  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/95/69/arm-40-1018.PMC5256331.pdf
org/ 0000-0001-7733-4066 ); Kyoung-Hwan Lee  (http://orcid.org/ 0000-0002-8720-3315 ); Jihea Chang  (http://orcid.org/ 0000-0003-0115-0492 ); Kiyeun  Nam  (http://orcid.org/ 0000-0001-6932-6541 ); Ho-Jun Lee  (http://orcid.org/ 0000-0002-1997-2593 ); Bum Sun Kwon  (http://orcid.org/ 0000-0001-7755- 435X ).,Non-OADS,/arxiv_data1/oa_pdf/95/69/arm-40-1018.PMC5256331.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/69/arm-40-1018.PMC5256331.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1048 -1056 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/70/e5/arm-40-1048.PMC5256332.pdf
"Tel: +82-42-338-2460, Fax: +82-42-338-2461, E-mail: mksohn@cnuh.co.kr ORCID: Hyewon Lee  (http://orcid.org/ 0000-0003-3105-4071 ); Sungju Jee  (http://orcid.org/ 0000-0002-9400-9609 ); Soo Ho Park  (http://orcid.org/ 0000- 0002-1815-5196 ); Seung-Chan Ahn  (http://orcid.org/ 0000-0003-2295-6233 ); Juneho Im  (http://orcid.org/ 0000-0002-2296-7832 ); Min Kyun Sohn   (http://orcid.org/ 0000-0002-2548-545X ).",Non-OADS,/arxiv_data1/oa_pdf/70/e5/arm-40-1048.PMC5256332.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/e5/arm-40-1048.PMC5256332.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):981-988 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/arm-40-981.PMC5256333.pdf
"Tel: +82- 51-990-6261, Fax: +82-51-241-2019, E-mail: ghichan@hotmail.com ORCID: Hui Dong Kim  (http://orcid.org/ 0000-0002-4932-5282 ); Saehyun Kim  (http://orcid.org/ 0000-0002-3151-7227 ); Dong Kyu Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/arm-40-981.PMC5256333.pdf
org/ 0000-0002-9484-6562 ); Ho Joong Jeong  (http://orcid.org/ 0000-0002-0607-2799 ); Young-Joo Sim  (http://orcid.org/ 0000-0002-0640-8766 ); Ghi  Chan Kim  (http://orcid.org/ 0000-0002-4954-3175 ).,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/arm-40-981.PMC5256333.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/arm-40-981.PMC5256333.pdf
Annals of Rehabilitation MedicineErratum Ann Rehabil Med 2016 ;40(6):1151 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/15/7d/arm-40-1151.PMC5256334.pdf
"Jin-Hong Kim (http://orcid.org/0000-0003-1871-8400) After the publication of this work [2], we noticed that the fourth author’s name ‘Dong-Joo Kim’ was incorrectly listed  as ‘Dong-Ju Kim’ .",Non-OADS,/arxiv_data1/oa_pdf/15/7d/arm-40-1151.PMC5256334.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/7d/arm-40-1151.PMC5256334.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1064 -1070 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/34/da/arm-40-1064.PMC5256335.pdf
"Tel: +82-2-2290-9349, Fax: +82-2-2282-0772, E-mail: dumitru1@hanyang.ac.kr ORCID: Seunghwi Jo  (http://orcid.org/ 0000-0002-5575-8914 ); Si-Bog Park  (http://orcid.org/ 0000-0001-8910-2262 ); Mi Jung Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/34/da/arm-40-1064.PMC5256335.pdf
org/ 0000-0003-2920-9900 ); Taikon Kim  (http://orcid.org/ 0000-0002-7961-0439 ); Kyeong Il Park  (http://orcid.org/ 0000-0001-8226-2044 ); Junhyun  Sung  (http://orcid.org/ 0000-0002-7913-1614 ); Un Jin Park  (http://orcid.org/ 0000-0002-2199-6287 ); Yee-Suk Kim  (http://orcid.org/ 0000-0003-4956- 0693 ); Byeong Jik Kang  (http://orcid.org/ 0000-0001-5197-4452 ); Kyu Hoon Lee  (http://orcid.org/ 0000-0001-7372-5676 ).,Non-OADS,/arxiv_data1/oa_pdf/34/da/arm-40-1064.PMC5256335.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/da/arm-40-1064.PMC5256335.pdf
"For the first time, Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016 ;40(6):1135 -1139 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.",Non-OADS,/arxiv_data1/oa_pdf/04/81/arm-40-1135.PMC5256336.pdf
"Tel:  +82-2-970-8315, Fax: +82-2-979-8268, E-mail: md52516@hanmail.net ORCID: Chan Ho Lee (http://orcid.org/0000-0002-5129-6652); Su Jung Shim (http//orcid.org/0000-0002-2364-6651); Hyun Jung Kim (http//orcid.",Non-OADS,/arxiv_data1/oa_pdf/04/81/arm-40-1135.PMC5256336.pdf
org/0000-0002-2198-5668); Hyuna Yang (http//orcid.org/0000-0002-2265-4166); Youn Joo Kang (http://orcid.org/0000-0002-9938-5435).,Non-OADS,/arxiv_data1/oa_pdf/04/81/arm-40-1135.PMC5256336.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/81/arm-40-1135.PMC5256336.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016 ;40(6):1100 -1107 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/0b/70/arm-40-1100.PMC5256337.pdf
"Tel: +82-42-338- 2423, Fax: +82-42-338-2461, E-mail: drjeesungju@cnuh.co.kr ORCID: Sehi Kweon  (http://orcid.org/ 0000-0002-8745-9927 ); Bon seok Koo  (http://orcid.org/ 0000-0003-3238-8719 ); Sungju Jee  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/0b/70/arm-40-1100.PMC5256337.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/70/arm-40-1100.PMC5256337.pdf
Annals of Rehabilitation MedicineCorrigendum Ann Rehabil Med 2016 ;40(6):1152 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/37/b0/arm-40-1152.PMC5256338.pdf
"1152 Correction: Physiological Responses   During the Lower Body Positive   Pressure Supported Treadmill Test Tae Sik Bang, MD1, Woo Hyuk Choi, MD2, Sang Hun Kim, MD2, Je-Sang Lee, MD2,   Soo-Yeon Kim, MD, PhD1, Myung Jun Shin, MD, PhD1, Yong Beom Shin, MD, PhD2,3 1Department of Rehabilitation Medicine, Pusan National University Yangsan Hospital, Pusan National University School of  Medicine, Yangsan; 2Department of Rehabilitation Medicine, Pusan National University Hospital, Pusan National University  School of Medicine, Busan; 3Biomedical Research Institute, Pusan National University Hospital, Busan, Korea https://doi.org/10.5535/arm.2016.40.5.851  Ann Rehabil Med 2016;40(5):851-861 To the Editor, We found an error of funding acknowledgment in this article.",Non-OADS,/arxiv_data1/oa_pdf/37/b0/arm-40-1152.PMC5256338.pdf
"Tel: +82-51–240–7485, Fax: +82-51–247–7485, E-mail: yi0314@gmail.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/b0/arm-40-1152.PMC5256338.pdf
The Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016 ;40(6):1144 -1148 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2016.40.6.,Non-OADS,/arxiv_data1/oa_pdf/c6/77/arm-40-1144.PMC5256339.pdf
"Tel: +82-51- 890-6295, Fax: +82-51-891-1430, E-mail: rehabit@inje.ac.kr  ORCID: Hyun Woo Bae  (http://orcid.org/ 0000-0002-6445-3362 ); Hyundong Kim  (http://orcid.org/ 0000-0002-7984-7065 ); Sung won Choi  (http:// orcid.org/ 0000-0002-2043-4565 ); Nami Han  (http://orcid.org/ 0000-0003-3651-9755 ); Mi Ja Eom  (http://orcid.org/ 0000-0002-3652-045X ).",Non-OADS,/arxiv_data1/oa_pdf/c6/77/arm-40-1144.PMC5256339.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/77/arm-40-1144.PMC5256339.pdf
Available from: https://dailymed.nlm.nih.gov/dai - lymed/drugInfo.cfm?setid=3495a71a-cc04-4776-851f- f185956f32af.,Non-OADS,/arxiv_data1/oa_pdf/c6/77/arm-40-1144.PMC5256339.pdf
"Keywords: Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fever; Infection Address for correspondence: Chul-Gyu Yoo, M.D., Ph.D. Division of Pulmonary and Critical Care Medicine, Department of  Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, KoreaPhone: 82-2-2072-2210, Fax: 82-2-762-9662E-mail: cgyoo@snu.ac.krReceived: Aug. 2, 2016Revised: Sep. 12, 2016Accepted: Oct. 4, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttps://doi.org/10.4046/trd.2017.80.1.45ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:45-51 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/0f/c1/trd-80-45.PMC5256340.pdf
"Fever following EBUS-TBNA https://doi.org/10.4046/trd.2017.80.1.45  47 www.e-trd.org TBNA was performed with the patient under moderate seda- tion using fentanyl and midazolam, as well as local anesthesia using lidocaine.",Non-OADS,/arxiv_data1/oa_pdf/0f/c1/trd-80-45.PMC5256340.pdf
"Fever following EBUS-TBNA https://doi.org/10.4046/trd.2017.80.1.45  49 www.e-trd.org ing diabetes mellitus underwent EBUS-TBNA for diagnosis of  mediastinal lymphadenopathy, but no specific diagnosis was obtained.",Non-OADS,/arxiv_data1/oa_pdf/0f/c1/trd-80-45.PMC5256340.pdf
"Fever following EBUS-TBNA https://doi.org/10.4046/trd.2017.80.1.45  51 www.e-trd.org Kawanami T, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/c1/trd-80-45.PMC5256340.pdf
"15, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttps://doi.org/10.4046/trd.2017.80.1.60ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:60-68",Non-OADS,/arxiv_data1/oa_pdf/2e/c4/trd-80-60.PMC5256341.pdf
Mometasone inhibits mucin and TNF-α in NCI-H292 cells https://doi.org/10.4046/trd.2017.80.1.60  61 www.e-trd.org interleukin-1 β up-regulated MUC2 and MUC5AC synthesis  in human airway epithelial cells (NCI-H292)8.,Non-OADS,/arxiv_data1/oa_pdf/2e/c4/trd-80-60.PMC5256341.pdf
Mometasone inhibits mucin and TNF-α in NCI-H292 cells https://doi.org/10.4046/trd.2017.80.1.60  63 www.e-trd.org 8.,Non-OADS,/arxiv_data1/oa_pdf/2e/c4/trd-80-60.PMC5256341.pdf
Mometasone inhibits mucin and TNF-α in NCI-H292 cells https://doi.org/10.4046/trd.2017.80.1.60  65 www.e-trd.org 5.,Non-OADS,/arxiv_data1/oa_pdf/2e/c4/trd-80-60.PMC5256341.pdf
Mometasone inhibits mucin and TNF-α in NCI-H292 cells https://doi.org/10.4046/trd.2017.80.1.60  67 www.e-trd.org son of the efficacy and safety of mometasone furoate to other  inhaled steroids for asthma: a meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/2e/c4/trd-80-60.PMC5256341.pdf
"29, 2016, Revised: Aug. 30, 2016, Accepted: Sep. 1, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttps://doi.org/10.4046/trd.2017.80.1.35ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:35-44 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e4/85/trd-80-35.PMC5256342.pdf
"Loculated tuberculous pleural effusion https://doi.org/10.4046/trd.2017.80.1.35  37 www.e-trd.org TB treatment; (4) lymphocytic exudates from the first or sub- sequent thoracentesis, high ADA levels (>40 U/L) in pleural fluid, negative cytological results, and effusions that resolved in response to anti-TB treatment 1,16.",Non-OADS,/arxiv_data1/oa_pdf/e4/85/trd-80-35.PMC5256342.pdf
Loculated tuberculous pleural effusion https://doi.org/10.4046/trd.2017.80.1.35  39 www.e-trd.org 3.,Non-OADS,/arxiv_data1/oa_pdf/e4/85/trd-80-35.PMC5256342.pdf
Loculated tuberculous pleural effusion https://doi.org/10.4046/trd.2017.80.1.35  41 www.e-trd.org Table 4.,Non-OADS,/arxiv_data1/oa_pdf/e4/85/trd-80-35.PMC5256342.pdf
"Loculated tuberculous pleural effusion https://doi.org/10.4046/trd.2017.80.1.35  43 www.e-trd.org Soolingen D, et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/85/trd-80-35.PMC5256342.pdf
"29, 2016Revised: Sep. 9, 2016Accepted: Oct. 24, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttps://doi.org/10.4046/trd.2017.80.1.27ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:27-34 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/cb/48/trd-80-27.PMC5256343.pdf
"Smear and culture conversion in induced sputum samples https://doi.org/10.4046/trd.2017.80.1.27  29 www.e-trd.org above 1% in Löwenstein-Jensen medium, using the propor - tional method.",Non-OADS,/arxiv_data1/oa_pdf/cb/48/trd-80-27.PMC5256343.pdf
Smear and culture conversion in induced sputum samples https://doi.org/10.4046/trd.2017.80.1.27  31 www.e-trd.org (8%) was culture-positive for MTB in LM and none of the 13  patients tested culture-positive in SM.,Non-OADS,/arxiv_data1/oa_pdf/cb/48/trd-80-27.PMC5256343.pdf
"Smear and culture conversion in induced sputum samples https://doi.org/10.4046/trd.2017.80.1.27  33 www.e-trd.org tice in clinical settings; therefore, our serial IS specimen based  results may not be generalizable.",Non-OADS,/arxiv_data1/oa_pdf/cb/48/trd-80-27.PMC5256343.pdf
"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 06351, KoreaPhone: 82-2-3410-3429, Fax: 82-2-3410-3849, E-mail: wjkoh@skku.eduReceived: Dec.  17, 2016, Revised: Dec.  19, 2016, Accepted: Dec.  20, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).EDITORIALhttps://doi.org/10.4046/trd.2017.80.1.90ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:90-92 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.Table 1.",Non-OADS,/arxiv_data1/oa_pdf/39/58/trd-80-90.PMC5256344.pdf
"Progression of tuberculosis pleurisy https://doi.org/10.4046/trd.2017.80.1.90  91 www.e-trd.org Traditionally, tuberculous pleurisy is indicated by predomi- nant lymphocytosis in the pleural fluid and a low yield of effu- sion culture due to the paucibacillary nature of TB4.",Non-OADS,/arxiv_data1/oa_pdf/39/58/trd-80-90.PMC5256344.pdf
Available from: http://cdc.go.kr/CDC/cms/content/mo- bile/45/67545_view.html.,Non-OADS,/arxiv_data1/oa_pdf/39/58/trd-80-90.PMC5256344.pdf
"22, 2016Accepted: Nov. 4, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttps://doi.org/10.4046/trd.2017.80.1.83ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:83-89 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/a8/e6/trd-80-83.PMC5256345.pdf
Autophagy and apoptosis https://doi.org/10.4046/trd.2017.80.1.83  85 www.e-trd.org sema was quantified by the measurement of the mean linear  intercept (MLI)16.,OADS,/arxiv_data1/oa_pdf/a8/e6/trd-80-83.PMC5256345.pdf
"Autophagy and apoptosis https://doi.org/10.4046/trd.2017.80.1.83  87 www.e-trd.org with the respective siRNA treatments (Figure 5A, C).",Non-OADS,/arxiv_data1/oa_pdf/a8/e6/trd-80-83.PMC5256345.pdf
Autophagy and apoptosis https://doi.org/10.4046/trd.2017.80.1.83  89 www.e-trd.org impaired macroautophagy.,Non-OADS,/arxiv_data1/oa_pdf/a8/e6/trd-80-83.PMC5256345.pdf
"95Copyright © 2017 The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.Clinical Practice Guideline of Acute Respiratory Distress Syndrome Tuberc Respir Dis 2016;79:214-233, https://doi.org/10.4046/trd.2016.79.4.214 The manuscript had been published in the Korean Journal of Critical Care Medicine (Korean J Crit Care Med 2016;31:76-100)  and we have republished it after the permission of secondary publication (Tuberc Respir Dis 2016;79:214-233) from the Korean Society of Critical Care Medicine and The Korean Academy of Tuberculosis and Respiratory Diseases.",Non-OADS,/arxiv_data1/oa_pdf/8f/23/trd-80-95.PMC5256346.pdf
And Jae Wha Cho should be written as Jae Hwa Cho in Acknowledgments sections.The authors apologize for any inconvenience that this may have caused.ERRATUMhttps://doi.org/10.4046/trd.2017.80.1.95 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:95,Non-OADS,/arxiv_data1/oa_pdf/8f/23/trd-80-95.PMC5256346.pdf
"Department of Internal Medicine, Kyungpook National University School of Medicine, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Korea Phone: 82-53-420-5537, Fax: 82-53-426-2046, E-mail: kimch@knu.ac.krAddress for co-correspondence: Jaehee Lee, M.D.Department of Internal Medicine, Kyungpook National University School of Medicine, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, KoreaPhone: 82-53-420-5536, Fax: 82-53-426-2046, E-mail: jaelee@knu.ac.krReceived: Aug. 8, 2016, Revised: Sep. 25, 2016, Accepted: Oct. 28, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttps://doi.org/10.4046/trd.2017.80.1.77ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:77-82 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/52/a1/trd-80-77.PMC5256347.pdf
ADA2 and MTB-specific antigens https://doi.org/10.4046/trd.2017.80.1.77  79 www.e-trd.org 4.,Non-OADS,/arxiv_data1/oa_pdf/52/a1/trd-80-77.PMC5256347.pdf
ADA2 and MTB-specific antigens https://doi.org/10.4046/trd.2017.80.1.77  81 www.e-trd.org IFN-γ addition (Figure 1F).,Non-OADS,/arxiv_data1/oa_pdf/52/a1/trd-80-77.PMC5256347.pdf
"21, 2016Accepted: Sep. 19, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttps://doi.org/10.4046/trd.2017.80.1.69ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:69-76 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/48/1e/trd-80-69.PMC5256348.pdf
"HRQL, depression, and anxiety in tuberculosis https://doi.org/10.4046/trd.2017.80.1.69  71 www.e-trd.org viously validated in Brazil21, was used to record symptoms of  anxiety and depression.",OADS,/arxiv_data1/oa_pdf/48/1e/trd-80-69.PMC5256348.pdf
"HRQL, depression, and anxiety in tuberculosis https://doi.org/10.4046/trd.2017.80.1.69  73 www.e-trd.org cantly associated with depression in persons with a TB diag- nosis, like personal, socio-demographic (age and financial sta-tus), environmental, and clinical (persistent cough) 28.",Non-OADS,/arxiv_data1/oa_pdf/48/1e/trd-80-69.PMC5256348.pdf
"HRQL, depression, and anxiety in tuberculosis https://doi.org/10.4046/trd.2017.80.1.69  75 www.e-trd.org impact of smoking on many aspects of TB, such as TB infec - tion, TB disease, and mortality32,33.",Non-OADS,/arxiv_data1/oa_pdf/48/1e/trd-80-69.PMC5256348.pdf
Available from:  http://www.saude.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/48/1e/trd-80-69.PMC5256348.pdf
Available from: http://www.who.int.,Non-OADS,/arxiv_data1/oa_pdf/48/1e/trd-80-69.PMC5256348.pdf
"Room 8446, St. Paul’s Hospital, Vancouver, BC, V6Z 1Y6, Canada Phone: 1-604-806-8346, Fax: 1-604-806-9274E-mail: don.sin@hli.ubc.caReceived: Aug. 31, 2016Revised: Sep. 5, 2016Accepted: Oct. 22, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW https://doi.org/10.4046/trd.2017.80.1.11ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:11-20 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/76/d8/trd-80-11.PMC5256349.pdf
"Asthma-COPD overlap syndrome: what we know and what we don’t https://doi.org/10.4046/trd.2017.80.1.11  13 www.e-trd.org consensus on what threshold value should be used to guide  therapy13,16,17.",Non-OADS,/arxiv_data1/oa_pdf/76/d8/trd-80-11.PMC5256349.pdf
"Asthma-COPD overlap syndrome: what we know and what we don’t https://doi.org/10.4046/trd.2017.80.1.11  15 www.e-trd.org responsiveness, which is as noted earlier one of the hallmark  findings in asthma, also increases the risk of incident COPD by 4-fold, independent of other factors including smoking and aging 42.",Non-OADS,/arxiv_data1/oa_pdf/76/d8/trd-80-11.PMC5256349.pdf
"Asthma-COPD overlap syndrome: what we know and what we don’t https://doi.org/10.4046/trd.2017.80.1.11  17 www.e-trd.org Treatment of ACOS As noted previously, there have been no large scale thera- peutic trials on patients with ACOS.",Non-OADS,/arxiv_data1/oa_pdf/76/d8/trd-80-11.PMC5256349.pdf
Available from: http://stats.oecd.org/index.aspx?DataSetCode=RPOP#.,OADS,/arxiv_data1/oa_pdf/76/d8/trd-80-11.PMC5256349.pdf
Available from: http://ginasthma.org/asthma-copd-and-asthma-copd-overlap-syndrome-acos/.,Non-OADS,/arxiv_data1/oa_pdf/76/d8/trd-80-11.PMC5256349.pdf
Asthma-COPD overlap syndrome: what we know and what we don’t https://doi.org/10.4046/trd.2017.80.1.11  19 www.e-trd.org characteristics of three clinical phenotypes of chronic ob- structive pulmonary disease (COPD).,Non-OADS,/arxiv_data1/oa_pdf/76/d8/trd-80-11.PMC5256349.pdf
"Division of Pulmonary and Critical Care Medicine, Asan Medical Center,  University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaPhone: 82-2-3010-5783, Fax: 82-2-3010-6968E-mail: heathcliff6800@hanmail.netReceived: Dec. 11, 2015Revised: Feb. 23, 2016Accepted: Nov. 14, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW https://doi.org/10.4046/trd.2017.80.1.21ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:21-26 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/61/c8/trd-80-21.PMC5256350.pdf
Administrative control in health care settings https://doi.org/10.4046/trd.2017.80.1.21  23 www.e-trd.org 2.,Non-OADS,/arxiv_data1/oa_pdf/61/c8/trd-80-21.PMC5256350.pdf
Administrative control in health care settings https://doi.org/10.4046/trd.2017.80.1.21  25 www.e-trd.org assay (QFT-GIT) and T-SPOT.,Non-OADS,/arxiv_data1/oa_pdf/61/c8/trd-80-21.PMC5256350.pdf
Available from: http://www.cdc.gov/tb/education/corecurr/pdf/corecurr_all.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/c8/trd-80-21.PMC5256350.pdf
Available from: http://www.who.int/ publications/guidelines/en/.,Non-OADS,/arxiv_data1/oa_pdf/61/c8/trd-80-21.PMC5256350.pdf
Available from: http://www.lungkorea.org/image/mail/file_110217.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/c8/trd-80-21.PMC5256350.pdf
"Department of Pulmonary and Critical Care Medicine, Asan Medical  Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaPhone: 82-2-3010-3136, Fax: 82-2-3010-6968E-mail: ymoh55@amc.seoul.krReceived: Dec.  20, 2016 Revised: Dec.  22, 2016 Accepted: Dec.  23, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).EDITORIALhttps://doi.org/10.4046/trd.2017.80.1.93ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:93-94 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/6b/d2/trd-80-93.PMC5256351.pdf
Available from: http://goldcopd.org/gold-2017-global-strate-gy-diagnosis-management-prevention-copd/.,Non-OADS,/arxiv_data1/oa_pdf/6b/d2/trd-80-93.PMC5256351.pdf
"5, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW https://doi.org/10.4046/trd.2017.80.1.1ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:1-10 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8f/f5/trd-80-1.PMC5256352.pdf
"Lung regeneration therapy for COPD https://doi.org/10.4046/trd.2017.80.1.1  3 www.e-trd.org and molecular mechanisms of re-alveolization, the lung be- gan to attract considerable attention as an emerging target of regenerative therapy.",Non-OADS,/arxiv_data1/oa_pdf/8f/f5/trd-80-1.PMC5256352.pdf
Clinical Trials of Cell Therapies   in COPD Subjects According to ClinicalTrials.gov (https://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/8f/f5/trd-80-1.PMC5256352.pdf
"gov) and the EU Clinical Trials Register (https://www.clini-caltrialsregister.eu), only four early-phase clinical trials of cell therapy in patients with COPD have been completed; seven trials are ongoing and one has an unknown status ( Tables 2, 3 ).",Non-OADS,/arxiv_data1/oa_pdf/8f/f5/trd-80-1.PMC5256352.pdf
Lung regeneration therapy for COPD https://doi.org/10.4046/trd.2017.80.1.1  5 www.e-trd.org neic BM-MSCs (Prochymal) or vehicle control.,Non-OADS,/arxiv_data1/oa_pdf/8f/f5/trd-80-1.PMC5256352.pdf
Lung regeneration therapy for COPD https://doi.org/10.4046/trd.2017.80.1.1  7 www.e-trd.org retinoids was carried out in the early 2000s32.,Non-OADS,/arxiv_data1/oa_pdf/8f/f5/trd-80-1.PMC5256352.pdf
Available from: http://www.goldcopd.org/up-loads/users/files/GOLD_Report_2015_Sept2.pdf.,OADS,/arxiv_data1/oa_pdf/8f/f5/trd-80-1.PMC5256352.pdf
Lung regeneration therapy for COPD https://doi.org/10.4046/trd.2017.80.1.1  9 www.e-trd.org Physiol 2013;305:L542-54.,Non-OADS,/arxiv_data1/oa_pdf/8f/f5/trd-80-1.PMC5256352.pdf
"22, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttps://doi.org/10.4046/trd.2017.80.1.52ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2017;80:52-59 Copyright © 2017The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/21/c1/trd-80-52.PMC5256353.pdf
Indacaterol safety and effectiveness in Korean COPD patients https://doi.org/10.4046/trd.2017.80.1.52  53 www.e-trd.org Introduction Chronic obstructive pulmonary disease (COPD) is a pro - gressive lung disease characterized by persistent airflow  limitation which is associated with an enhanced chronic inflammatory response to noxious particles or gases 1.,Non-OADS,/arxiv_data1/oa_pdf/21/c1/trd-80-52.PMC5256353.pdf
"Indacaterol safety and effectiveness in Korean COPD patients https://doi.org/10.4046/trd.2017.80.1.52  55 www.e-trd.org taken with regard to the study drug, and treatment for AEs.",Non-OADS,/arxiv_data1/oa_pdf/21/c1/trd-80-52.PMC5256353.pdf
"Indacaterol safety and effectiveness in Korean COPD patients https://doi.org/10.4046/trd.2017.80.1.52  57 www.e-trd.org 3.45; p=0.01), and concomitant therapies used (RR, 7.91;  p=0.003) were the factors that affects the incidence rate of AEs (Table 4).4.",Non-OADS,/arxiv_data1/oa_pdf/21/c1/trd-80-52.PMC5256353.pdf
Indacaterol safety and effectiveness in Korean COPD patients https://doi.org/10.4046/trd.2017.80.1.52  59 www.e-trd.org References 1.,Non-OADS,/arxiv_data1/oa_pdf/21/c1/trd-80-52.PMC5256353.pdf
Available from: http://www.goldcopd.org.,OADS,/arxiv_data1/oa_pdf/21/c1/trd-80-52.PMC5256353.pdf
"8 This plant has bioactive components  such as gallic, eleagic acid, isoquercetin, leucocianidolum,  Received: September 3, 2016  Revised: October 30, 2016  Accepted: November 9, 2016 Address for Correspondence: Nasibeh Roozbeh, Mother and Child Welfare Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IranTel: +98-76-3335-0445, Fax: +98-76-3335-1355, E-mail: nasibe62@yahoo.comEditorialpISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.129 Journal of Menopausal Medicine 2016;22:129-130  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Acacia Nilotica: New Plant for Help in Pelvic Organ  Prolapse Nasibeh Roozbeh, Leili Darvish Mother and Child Welfare Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran",Non-OADS,/arxiv_data1/oa_pdf/d3/b6/jmm-22-129.PMC5256354.pdf
"Journal of Menopausal Medicine 2016;22:129-130 130 https://doi.org/10.61 18/jmm.2016.22.3.129 J MM Kaempferol 3, 7-diglucoside, glucopyranoside, rutin,  derivatives of (+)-catechin-5-gallate, apigenin-6, 8-bis- C-glucopyranoside, m-catechol and their derivatives.",Non-OADS,/arxiv_data1/oa_pdf/d3/b6/jmm-22-129.PMC5256354.pdf
Available from: http://www.freepatentsonline.com/20160022755.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/b6/jmm-22-129.PMC5256354.pdf
"7~10  GnRH-a related hypoestrogenism frequently causes  climacteric-like symptoms, such as vasomotor symptoms  and overall severe bone loss.11,12 Several drugs have been  associated with GnRH-a to reduce these side effects and to  Received: August 2, 2016  Revised: August 22, 2016  Accepted: September 19, 2016 Address for Correspondence: Hyuk Jung, Department of Obstetrics and Gynecology, Chosun University School of Medicine, 365 Pilmun-daero, Dong-gu, Gwangju 61453, KoreaTel: +82-62-220-3091, Fax: +82-62-232-2310, E-mail: bimilo@hanmail.netOriginal ArticlepISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.174 Journal of Menopausal Medicine 2016;22:174-179  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Raloxifene Administration in Women Treated with Long  Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density Young Hwa Cho1, Mi Jung Um2, Suk Jin Kim2, Soo Ah Kim2,3, Hyuk Jung2,3 1Department of Obstetrics and Gynecology, Cheomdan Hospital, 2Department of Obstetrics and Gynecology, Chosun University Hospital,  3Department of Obstetrics and Gynecology, Chosun University School of Medicine, Gwangju, Korea Objectives: To evaluate the efficacy of raloxifene in preventing bone loss associated with long term gonadotropin-releasing  hormone agonist (GnRH-a) administration.",Non-OADS,/arxiv_data1/oa_pdf/6f/7e/jmm-22-174.PMC5256355.pdf
"Raloxifene Administration with GnRH-a for Endometriosis https://doi.org/10.61 18/jmm.2016.22.3.174 allow prolonged treatment.11~18  Raloxifene hydrochloride is a synthetic non-steroidal  drug derived from benzothiophene and afferent to selective  estrogen receptor modulators (SERMs), a group of compounds that interact with estrogen receptors eliciting tissue-specific responses.",Non-OADS,/arxiv_data1/oa_pdf/6f/7e/jmm-22-174.PMC5256355.pdf
Journal of Menopausal Medicine 2016;22:174-179 176 https://doi.org/10.61 18/jmm.2016.22.3.174 J MM Results 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/7e/jmm-22-174.PMC5256355.pdf
"Raloxifene Administration with GnRH-a for Endometriosis https://doi.org/10.61 18/jmm.2016.22.3.174 In addition, raloxifene reduces the risk of vertebral  fractures in postmenopausal osteoporotic women with  or without preexisting fractures by about 40% versus a  placebo,22,33~35 thereby improving quality of life.36  In women treated with GnRH-a, the positive effect of  raloxifene on bone metabolism was also confirmed by the lack of significant change in biochemical parameters of bone formation and reabsorption.",Non-OADS,/arxiv_data1/oa_pdf/6f/7e/jmm-22-174.PMC5256355.pdf
Journal of Menopausal Medicine 2016;22:174-179 178 https://doi.org/10.61 18/jmm.2016.22.3.174 J MM 7.,Non-OADS,/arxiv_data1/oa_pdf/6f/7e/jmm-22-174.PMC5256355.pdf
Raloxifene Administration with GnRH-a for Endometriosis https://doi.org/10.61 18/jmm.2016.22.3.174 32.,Non-OADS,/arxiv_data1/oa_pdf/6f/7e/jmm-22-174.PMC5256355.pdf
"Corrected author’ s list and affiliation  Ikjin Chang, Kyung Jin Hwang, Ho Jin Choi, Ho Sun Chang, Hyo Jin Yoon, Eung Seok Lee, Sun Young Choi Department of Obstetrics and Gynecology, Grace Women’ s Hospital, Goyang, Korea Address for Correspondence: Ikjin Chang, Department of Obstetrics and Gynecology, Grace Women’s Hospital, 1073 Jungang-ro,  Ilsandong-gu, Goyang 10447, KoreaTel: +82-31-901-4000, Fax: +82-31-907-1717, E-mail: ikjinzzang@naver.comErratumpISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.189 Journal of Menopausal Medicine 2016;22:189  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Erratum to: HIFU: Effects and Clinical Effectiveness of  Non-surgical Therapy for Uterine Fibroids Ikjin Chang, Kyung Jin Hwang, Ho Jin Choi, Ho Sun Chang, Hyo Jin Yoon, Eung Seok Lee, Sun Young Choi Department of Obstetrics and Gynecology, Grace Women’s Hospital, Goyang, Korea",Non-OADS,/arxiv_data1/oa_pdf/c8/13/jmm-22-189.PMC5256356.pdf
"During initial 6 months of lactation  Received: July 18, 2016  Revised: August 29, 2016  Accepted: October 5, 2016 Address for Correspondence: Nalini Sharma, Department of Obstetrics and Gynaecology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Mawdiangdiang, Shillong, Meghalaya 793018, IndiaTel: +91-0364-253-8234, Fax: +91-0364-253-8025, E-mail: alinisharma100@rediffmail.comOriginal ArticlepISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.161 Journal of Menopausal Medicine 2016;22:161-166  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Effect of Multiparity and Prolonged Lactation on Bone  Mineral Density Nalini Sharma1, Tanie Natung2, Rituparna Barooah3, Santa Singh Ahanthem1 1Department of Obstetrics and Gynaecology, 2Department of Ophthalmology, 3Department of Physiology, North Eastern Indira Gandhi  Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India Objectives: This study was done to determine the effect of multiparity and prolonged lactation on bone mineral density (BMD).",Non-OADS,/arxiv_data1/oa_pdf/e7/36/jmm-22-161.PMC5256357.pdf
Journal of Menopausal Medicine 2016;22:161-166 162 https://doi.org/10.61 18/jmm.2016.22.3.161 J MM there is 5% to 6% decrease in BMD which resolves in next  6 months period.,Non-OADS,/arxiv_data1/oa_pdf/e7/36/jmm-22-161.PMC5256357.pdf
Multiparity and Prolonged Lactation on BMD https://doi.org/10.61 18/jmm.2016.22.3.161 Discussion We observed negative and statistically significant correlation between parity and BMD.,Non-OADS,/arxiv_data1/oa_pdf/e7/36/jmm-22-161.PMC5256357.pdf
"Journal of Menopausal Medicine 2016;22:161-166 164 https://doi.org/10.61 18/jmm.2016.22.3.161 J MM age, BMI, and menopausal years.",Non-OADS,/arxiv_data1/oa_pdf/e7/36/jmm-22-161.PMC5256357.pdf
Multiparity and Prolonged Lactation on BMD https://doi.org/10.61 18/jmm.2016.22.3.161 factor for future osteoporosis.,Non-OADS,/arxiv_data1/oa_pdf/e7/36/jmm-22-161.PMC5256357.pdf
Journal of Menopausal Medicine 2016;22:161-166 166 https://doi.org/10.61 18/jmm.2016.22.3.161 J MM nourished Bangladeshi women.,Non-OADS,/arxiv_data1/oa_pdf/e7/36/jmm-22-161.PMC5256357.pdf
"Recently, as a non-invasive method, high intensity  Received: June 9, 2016  Revised: July 27, 2016  Accepted: July 28, 2016 Address for Correspondence: Kyu-Sup Lee, Department of Obstetrics & Gynecology, Pusan National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea Tel: +82-55-360-2580, Fax: +82-55-360-2160, E-mail: kuslee@pusan.ac.kr Original ArticlepISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.139 Journal of Menopausal Medicine 2016;22:139-145  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Expulsion of Fibroids to the Endometrial Cavity after  Magnetic Resonance Imaging-guided High Intensity Focused Ultrasound Surgery (MRgFUS) Treatment of Intramural Uterine Fibroids Jae-Hyeok Jeong1, Gil Pyo Hong1, Yu-Ri Kim1, Da Gyo Hong1, Jae-Eun Ha1, Jung In Yeom1,   Eun-Jeong Kim1, Hyung-Il Kim1, Kyu-Sup Lee2 1Department of Obstetrics & Gynecology, Hwa Myung Il Sin Christian Hospital, 2Department of Obstetrics & Gynecology, Pusan National  University School of Medicine, Busan, Korea Objectives: This report seeks to introduce some cases of the patients who received magnetic resonance imaging (MRI)-guided  high intensity focused ultrasound (HIFU) surgery (MRgFUS)-based intramural uterine fibroids treatment where the post-MRgFUS  intramural uterine fibroids decreased in its volume and protruded towards the endometrial cavity to be expelled by hysteroscopy.",Non-OADS,/arxiv_data1/oa_pdf/22/58/jmm-22-139.PMC5256358.pdf
Journal of Menopausal Medicine 2016;22:139-145 140 https://doi.org/10.61 18/jmm.2016.22.3.139 J MM focused ultrasound (HIFU) was introduced and utilized  in many different ways.,Non-OADS,/arxiv_data1/oa_pdf/22/58/jmm-22-139.PMC5256358.pdf
Hysteroscopic Myomectomy after MRI-guided HIFU https://doi.org/10.61 18/jmm.2016.22.3.139 with normal saline or filling in the rectum with glycerin  or through other diverse techniques in order not to expose  intestine to HIFU for intestine damage prevention.,Non-OADS,/arxiv_data1/oa_pdf/22/58/jmm-22-139.PMC5256358.pdf
"Journal of Menopausal Medicine 2016;22:139-145 142 https://doi.org/10.61 18/jmm.2016.22.3.139 J MM locations in all patients were intramural uterine but on at  least day 5 or up to day 73 after the HIFU treatment, their  fibroids were observed to protrude toward the endometrial  cavity in the ultrasound exam or MRI scan.",Non-OADS,/arxiv_data1/oa_pdf/22/58/jmm-22-139.PMC5256358.pdf
Hysteroscopic Myomectomy after MRI-guided HIFU https://doi.org/10.61 18/jmm.2016.22.3.139 fibroids.,Non-OADS,/arxiv_data1/oa_pdf/22/58/jmm-22-139.PMC5256358.pdf
"Journal of Menopausal Medicine 2016;22:139-145 144 https://doi.org/10.61 18/jmm.2016.22.3.139 J MM receiving HIFU treatment for 6 months; then reported 33%  reduction in their fibroid volumes, indicating a significant  correlation with P value 0.037 between the NPV ration right  after the operation and fibroid volume reduction.",Non-OADS,/arxiv_data1/oa_pdf/22/58/jmm-22-139.PMC5256358.pdf
Hysteroscopic Myomectomy after MRI-guided HIFU https://doi.org/10.61 18/jmm.2016.22.3.139 HIFU treatment for benign and malignant solid tumor.,Non-OADS,/arxiv_data1/oa_pdf/22/58/jmm-22-139.PMC5256358.pdf
"Furthermore, reanalysis of RCT showed that starting MHT closer to menopause tended to reduce the risk of CVD  Received: June 23, 2016  Revised: July 19, 2016  Accepted: August 16, 2016 Address for Correspondence: Seok Kyo Seo, Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: +82-2-2228-2230, Fax: +82-2-313-8357, E-mail: tudeolseo@yuhs.acBo Hyon Yun and Seung Joo Chon contributed equally to this work and should be considered co-first authors.Original ArticlepISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.167 Journal of Menopausal Medicine 2016;22:167-173  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Decreased Renal Function Is a Risk Factor for Subclinical  Coronary Atherosclerosis in Korean Postmenopausal Women Bo Hyon Yun1,2, Seung Joo Chon3, Si Hyun Cho2,4, Young Sik Choi1,2, Byung Seok Lee1,2, Seok Kyo Seo1,2 1Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, 2Institute of Women’s Life Medical  Science, Yonsei University College of Medicine, Seoul, 3Department of Obstetrics and Gynecology, Gil Hospital, Gachon University College of  Medicine, Incheon, 4Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul,  Korea Objectives:  Decreased renal function is associated with increased cardiovascular risk.",Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jmm-22-167.PMC5256359.pdf
"Journal of Menopausal Medicine 2016;22:167-173 168 https://doi.org/10.61 18/jmm.2016.22.3.167 J MM compared with starting MHT distant from menopause,  which suggests determining start point of MHT could be  important.6 However, when the endothelium is involved  with atherosclerosis already, it is too late for estrogen to exert a beneficial effect.",Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jmm-22-167.PMC5256359.pdf
"Decreased Renal Function and Atherosclerosis https://doi.org/10.61 18/jmm.2016.22.3.167 4. baPWV measurement PWV was measured using the automatic waveform  analyzer (BP-203RPE; Colin Co., Komaki, Japan) in accordance with a previously described method.",OADS,/arxiv_data1/oa_pdf/e9/cd/jmm-22-167.PMC5256359.pdf
"Journal of Menopausal Medicine 2016;22:167-173 170 https://doi.org/10.61 18/jmm.2016.22.3.167 J MM Univariate regression analysis revealed that the eGFR  was significantly positively associated with BMI (β   = 0.444, P < 0.001) and E2 (β  = 0.130, P = 0.040), and  negatively associated with FSH (β  = -0.194, P = 0.002),  HDL-cholesterol (β  = -0.146, P = 0.021) and baPWV (β   = -0.337, P < 0.001) (Table 2 ).",Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jmm-22-167.PMC5256359.pdf
Decreased Renal Function and Atherosclerosis https://doi.org/10.61 18/jmm.2016.22.3.167 function and risk of coronary atherosclerosis in healthy  postmenopausal women.,Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jmm-22-167.PMC5256359.pdf
Journal of Menopausal Medicine 2016;22:167-173 172 https://doi.org/10.61 18/jmm.2016.22.3.167 J MM affect on cardiovascular system.,Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jmm-22-167.PMC5256359.pdf
Decreased Renal Function and Atherosclerosis https://doi.org/10.61 18/jmm.2016.22.3.167 in postmenopausal women with hysterectomy: the Women's  Health Initiative randomized controlled trial.,Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jmm-22-167.PMC5256359.pdf
"The patient did not have any hyperpigmentation or nodules in  Received: March 16, 2016  Revised: May 2, 2016  Accepted: May 12, 2016 Address for Correspondence: Yeon Jean Cho, Department of Obstetrics and Gynecology, Dong-A University College of Medicine, 26 Daesingongwon-ro, Seo-gu, Busan 49201, KoreaTel: +82-51-240-5090, Fax: +82-52-244-9553, E-mail: jeanjane@naver.comCase ReportpISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.180 Journal of Menopausal Medicine 2016;22:180-183  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Superficial Angiomyxoma of the Vulva in a Postmenopausal  Woman: A Case Report and Review of Literature  Seung Hyun Lee1, Yeon Jean Cho1, Myoungseok Han1, Jong Woon Bae1, Jung-Woo Park1, So Ra Oh1,  Sujin Kim2 Departments of 1Obstetrics and Gynecology, 2Pathology, Dong-A University College of Medicine, Busan, Korea  Superficial angiomyxomas (SAMs) are rare benign cutaneous tumors that involve the subcutaneous layer.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/jmm-22-180.PMC5256360.pdf
Case of SAM of the Vulva in Postmenopausal Woman https://doi.org/10.61 18/jmm.2016.22.3.180 other areas of the skin or any significant medical history  of hypertension or dyslipidemia.,Non-OADS,/arxiv_data1/oa_pdf/0d/61/jmm-22-180.PMC5256360.pdf
"Journal of Menopausal Medicine 2016;22:180-183 182 https://doi.org/10.61 18/jmm.2016.22.3.180 J MM cyst, which was the preoperative diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/jmm-22-180.PMC5256360.pdf
Case of SAM of the Vulva in Postmenopausal Woman https://doi.org/10.61 18/jmm.2016.22.3.180 reported.,Non-OADS,/arxiv_data1/oa_pdf/0d/61/jmm-22-180.PMC5256360.pdf
"3,4 According to the World  Health Organization (WHO), menopause is the actual  Received: July 9, 2016  Revised: August 6, 2016  Accepted: August 16, 2016 Address for Correspondence: Mohammad Heidari, Department of Nursing, School of Nursing and Midwifery, Shahrekord University of Medical Sciences, Ayatollah Kashani Blvd, Shahrekord 8815713471, IranTel: +98-91-3185-0128, Fax: +98-38-1333-5652, E-mail: heidari@skums.ac.irOriginal ArticlepISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.154 Journal of Menopausal Medicine 2016;22:154-160  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Quality of Life in Postmenopausal Female Members and  Non-members of the Elderly Support Association Mina Shirvani, Mohammad Heidari Department of Nursing, School of Nursing and Midwifery, Shahrekord University of Medical Sciences, Shahrekord, Iran Objectives: The purpose of this study was to evaluate the quality of life (QOL) in postmenopausal members and non-members of  the elderly support association in Borujen city, Iran.",Non-OADS,/arxiv_data1/oa_pdf/3f/39/jmm-22-154.PMC5256361.pdf
Quality of Life of Postmenopausal in Elderly https://doi.org/10.61 18/jmm.2016.22.3.154 cessation of menstruation for at least 12 months due to loss  of ovarian follicular activity.,Non-OADS,/arxiv_data1/oa_pdf/3f/39/jmm-22-154.PMC5256361.pdf
"Journal of Menopausal Medicine 2016;22:154-160 156 https://doi.org/10.61 18/jmm.2016.22.3.154 J MM general health, vitality, social functioning, emotional role,  psychological health, and one statement on change in health  status.16,17 To respond to questions from the 5 point Likert scale,  ranging from excellent to poor, was used.",Non-OADS,/arxiv_data1/oa_pdf/3f/39/jmm-22-154.PMC5256361.pdf
"Quality of Life of Postmenopausal in Elderly https://doi.org/10.61 18/jmm.2016.22.3.154 the minimum range of the standard reliability coefficients,  ranging from 0.77 to 0.9.18 Therefore, to determine the  internal consistency and reliability of the questionnaire, the  Cronbach's alpha coefficient was used (r = 0.83).",Non-OADS,/arxiv_data1/oa_pdf/3f/39/jmm-22-154.PMC5256361.pdf
Journal of Menopausal Medicine 2016;22:154-160 158 https://doi.org/10.61 18/jmm.2016.22.3.154 J MM Discussion The results showed that the mean age of menopause  was 57.7 years.,Non-OADS,/arxiv_data1/oa_pdf/3f/39/jmm-22-154.PMC5256361.pdf
Quality of Life of Postmenopausal in Elderly https://doi.org/10.61 18/jmm.2016.22.3.154 References 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/39/jmm-22-154.PMC5256361.pdf
Journal of Menopausal Medicine 2016;22:154-160 160 https://doi.org/10.61 18/jmm.2016.22.3.154 J MM older adults.,Non-OADS,/arxiv_data1/oa_pdf/3f/39/jmm-22-154.PMC5256361.pdf
"4,5  Further, concerns regarding sexually transmitted diseases,  Received: May 30, 2016  Revised: August 12, 2016  Accepted: August 26, 2016 Address for Correspondence: K ıymet Handan Kelek çi, Department of Dermatology, İzmir Atat ürk Training and Research Hospital,  Gazeteci Hasan Tahsin Cad., Karaba ğlar, İzmir 35965, Turkey Tel: +90-23-2244-4444, Fax: +90-23-2244-4444, E-mail: drhandankelekci@yahoo.comOriginal ArticlepISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.131 Journal of Menopausal Medicine 2016;22:131-138  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).The Impact of Inflammatory and Infectious Diseases of  Vulvar on Quality of Life  Kıymet Handan Kelekçi, Selçuk Özyurt, Bülent Özkan, Şemsettin Karaca, Ali Karakuzu, İlgül Bilgin Department of Dermatology, İzmir Atatürk Training and Research Hospital, İzmir Katip Çelebi University, İzmir, Turkey Objectives: This study aimed to evaluate the effects of vulvar dermatoses (VD) and vulvar infections (VE) on anxiety, depression  scores, general, and dermatological quality of life (QOL) of women.",Non-OADS,/arxiv_data1/oa_pdf/c5/71/jmm-22-131.PMC5256362.pdf
"Journal of Menopausal Medicine 2016;22:131-138 132 https://doi.org/10.61 18/jmm.2016.22.3.131 J MM intimacy of sexual contact, fear of malignancy, together  with intense feelings of isolation, shame, anxiety, or  depression can delay the diagnosis and thus may cause  disease progression.1,2,6 Current treatments for many vulvar  disorders, including pruritus and/or pain and irritation  are generally symptomatic.",Non-OADS,/arxiv_data1/oa_pdf/c5/71/jmm-22-131.PMC5256362.pdf
Quality of Life of Vulvar Disease https://doi.org/10.61 18/jmm.2016.22.3.131 be at risk.,Non-OADS,/arxiv_data1/oa_pdf/c5/71/jmm-22-131.PMC5256362.pdf
"Journal of Menopausal Medicine 2016;22:131-138 134 https://doi.org/10.61 18/jmm.2016.22.3.131 J MM in 27.3%, and severe in 45.4% patients.",Non-OADS,/arxiv_data1/oa_pdf/c5/71/jmm-22-131.PMC5256362.pdf
"Quality of Life of Vulvar Disease https://doi.org/10.61 18/jmm.2016.22.3.131 HAM-A and HAM-D subscales, in the VD groups 33.3% (n  = 20) and 50% (n = 30) of patients presented higher than  the anxiety and depression cutoff scores, respectively.",Non-OADS,/arxiv_data1/oa_pdf/c5/71/jmm-22-131.PMC5256362.pdf
Journal of Menopausal Medicine 2016;22:131-138 136 https://doi.org/10.61 18/jmm.2016.22.3.131 J MM was a significant difference between the anxiety scores of  patients with VE compared with that of the control group as  well as those with VD based on the HAM-A scale.,Non-OADS,/arxiv_data1/oa_pdf/c5/71/jmm-22-131.PMC5256362.pdf
Quality of Life of Vulvar Disease https://doi.org/10.61 18/jmm.2016.22.3.131 The limitations of this study were evaluated data to  be gathered at only one point in time.,Non-OADS,/arxiv_data1/oa_pdf/c5/71/jmm-22-131.PMC5256362.pdf
Journal of Menopausal Medicine 2016;22:131-138 138 https://doi.org/10.61 18/jmm.2016.22.3.131 J MM and its correlation with clinical profiles.,Non-OADS,/arxiv_data1/oa_pdf/c5/71/jmm-22-131.PMC5256362.pdf
"Her  Received: October 28, 2016  Revised: November 14, 2016  Accepted: November 16, 2016 Address for Correspondence: Yong Jin Na, Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, KoreaTel: +82-55-360-2581, Fax: +82-55-360-2160, E-mail: yjna@pusan.ac.krCase ReportpISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.184 Journal of Menopausal Medicine 2016;22:184-187  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Non-puerperal Uterine Inversion Presented with  Hypovolemic Shock Yong Jung Song, Juseok Yang, Hyun Sil Yun, Sun Kyung Lee, Hwi Gon Kim, Dong Hyung Lee,   Ook Hwan Choi, Yong Jin Na Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine,  Yangsan, Korea We report a non-puerperal uterine inversion with nulliparous women caused by huge pedunculated submucosal fibroid.",Non-OADS,/arxiv_data1/oa_pdf/14/c4/jmm-22-184.PMC5256363.pdf
Non-puerperal Uterine Inversion https://doi.org/10.61 18/jmm.2016.22.3.184 laboratory findings revealed hemoglobin of 3 g/dL with  leucocytosis.,Non-OADS,/arxiv_data1/oa_pdf/14/c4/jmm-22-184.PMC5256363.pdf
"Journal of Menopausal Medicine 2016;22:184-187 186 https://doi.org/10.61 18/jmm.2016.22.3.184 J MM puerperal women.2,3 Pulling power from intrauterine masses  such as fibroids, sarcomas and carcinomas might cause  fundal inversion chronically.",Non-OADS,/arxiv_data1/oa_pdf/14/c4/jmm-22-184.PMC5256363.pdf
Non-puerperal Uterine Inversion https://doi.org/10.61 18/jmm.2016.22.3.184 2.,Non-OADS,/arxiv_data1/oa_pdf/14/c4/jmm-22-184.PMC5256363.pdf
"Corrected author’ s list and affiliation Seung Do Choi, M.D., Ph.D.1, Ahmed Fadiel, M.S., Ph.D.2, Frederick Naftolin, M.D., Ph.D.2   1Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan,  Korea, 2Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA Address for Correspondence: Seung Do Choi, Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang  University Cheonan Hospital, 8 2Gil Soonchunhyang, Cheonan 31151, KoreaTel: +82-41-570-2154, Fax: +82-41-571-7887, E-mail: sdchoi@schmc.ac.krErratumpISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.188 Journal of Menopausal Medicine 2016;22:188  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Erratum to: Ezrin Is an Essential Marker for Metastasis of  Gynecologic Cancer Seung Do Choi, M.D., Ph.D.1, Ahmed Fadiel, M.S., Ph.D.2, Frederick Naftolin, M.D., Ph.D.2 1Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea,  2Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA",Non-OADS,/arxiv_data1/oa_pdf/a8/62/jmm-22-188.PMC5256364.pdf
"Recent studies described a micellar estradiol  Received: June 23, 2016  Revised: August 5, 2016  Accepted: August 16, 2016 Address for Correspondence: Fatemeh Abdi, Student Research Committee, Nursing and Midwifery Faculty, Shahid Beheshti University of Medical Sciences, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran 1983963113, IranTel: +98-21-8865-5366, Fax: +98-21-8820-2521, E-mail: abdi@sbmu.ac.irEditorialpISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.127 Journal of Menopausal Medicine 2016;22:127-128  J MM Copyright © 2016 by The Korean Society of Meno pause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Nanomedicine Approaches for Treatment of Menopausal  Symptoms Fatemeh Abdi1, Fahimeh Ramezani Tehrani2, Hamid Mobedi3, Mahrokh Dolatian4, Nariman Mosaffa5 1Student Research Committee, Nursing and Midwifery Faculty, Shahid Beheshti University of Medical Sciences, 2Reproductive Endocrinology  Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, 3Biomaterials Department, Iran  Polymer and Petrochemical Institute, 4Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti  University of Medical Sciences, 5Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran,  Iran",Non-OADS,/arxiv_data1/oa_pdf/28/9b/jmm-22-127.PMC5256365.pdf
"Journal of Menopausal Medicine 2016;22:127-128 128 https://doi.org/10.61 18/jmm.2016.22.3.127 J MM formulation, which constitutes an alternative transdermal  delivery system not requiring the permeation enhancers  or temporary skin digestion, both of which increase the  possibility of irritation which can occur with other skin delivery systems.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/jmm-22-127.PMC5256365.pdf
"On top of that, missing thyroid dysfunction in postmenopausal women would more increase  Received: June 23, 2016  Revised: August 8, 2016  Accepted: August 16, 2016 Address for Correspondence: Seok Kyo Seo, Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: +82-2-2228-2230, Fax: +82-2-313-8357, E-mail: tudeolseo@yuhs.acOriginal ArticlepISSN: 2288-6478, eISSN: 2288-6761 https://doi.org/10.6118/jmm.2016.22.3.146 Journal of Menopausal Medicine 2016;22:146-153  J MM Copyright © 2016 by The Korean Society of Meno  p ause This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/).Serum Thyroid Stimulating Hormone Levels Are Associated  with the Presence of Coronary Atherosclerosis in Healthy Postmenopausal Women Seung Joo Chon1, Jin Young Heo2,3, Bo Hyon Yun2,3, Yeon Soo Jung4, Seok Kyo Seo2,3 1Department of Obstetrics and Gynecology, Gil Hospital, Gachon University College of Medicine, Incheon, 2Department of Obstetrics and  Gynecology, Severance Hospital, Yonsei University College of Medicine, 3Institute of Women’s Life Medical Science, Yonsei University College  of Medicine, Seoul, 4Department of Obstetrics and Gynecology, Wonju Severance Christian Hospital, Yonsei University Wonju College of  Medicine, Wonju, Korea Objectives: Menopause is a natural aging process causing estrogen deficiency, accelerating atherogenic processes including  dyslipidemia.",Non-OADS,/arxiv_data1/oa_pdf/6b/a4/jmm-22-146.PMC5256366.pdf
"TSH, Atherosclerosis in Postmenopausal Woman https://doi.org/10.61 18/jmm.2016.22.3.146 the risk of CVD.",Non-OADS,/arxiv_data1/oa_pdf/6b/a4/jmm-22-146.PMC5256366.pdf
Journal of Menopausal Medicine 2016;22:146-153 148 https://doi.org/10.61 18/jmm.2016.22.3.146 J MM Results Baseline characteristics of the subjects are displayed on  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/a4/jmm-22-146.PMC5256366.pdf
"TSH, Atherosclerosis in Postmenopausal Woman https://doi.org/10.61 18/jmm.2016.22.3.146 analysis was conducted.",Non-OADS,/arxiv_data1/oa_pdf/6b/a4/jmm-22-146.PMC5256366.pdf
"Journal of Menopausal Medicine 2016;22:146-153 150 https://doi.org/10.61 18/jmm.2016.22.3.146 J MM in premenopausal and postmenopausal women has been  elucidated to the actions of estrogens on cardiovascular  system, particularly on vascular endothelium.",Non-OADS,/arxiv_data1/oa_pdf/6b/a4/jmm-22-146.PMC5256366.pdf
"TSH, Atherosclerosis in Postmenopausal Woman https://doi.org/10.61 18/jmm.2016.22.3.146 hypothyroidism was found to be a strong risk factor for  atherosclerosis and myocardial infarction in postmenopausal  women.31 It is clear that abnormal thyroid function is a risk for  CVD, but whether thyroid function within the reference range would also be associated with cardiovascular risk has  to be evaluated.",Non-OADS,/arxiv_data1/oa_pdf/6b/a4/jmm-22-146.PMC5256366.pdf
Journal of Menopausal Medicine 2016;22:146-153 152 https://doi.org/10.61 18/jmm.2016.22.3.146 J MM products on five women's diseases.,Non-OADS,/arxiv_data1/oa_pdf/6b/a4/jmm-22-146.PMC5256366.pdf
"TSH, Atherosclerosis in Postmenopausal Woman https://doi.org/10.61 18/jmm.2016.22.3.146 risk factor for atherosclerosis and myocardial infarction  in elderly women: the Rotterdam Study.",Non-OADS,/arxiv_data1/oa_pdf/6b/a4/jmm-22-146.PMC5256366.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/tobaccocontrol-2015-052737).,Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
"20 CORE PROVISIONS OF THE MODEL TOBACCO WASTE ACT AND BARRIERS TO IMPLEMENTATION The Product Stewardship Institute (PSI) is a US-based non-pro ﬁt organisation (http://www.productstewardship.us/) that workswith a variety of governmental, private sector and non-pro ﬁt partners to implement some of the 89 EPR/PS-based state lawscurrently operative in 33 states.",Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Novotny TE, Slaughter E. Tobacco product waste: an environmental approach to reduce tobacco consumption.",Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
http://boss.blogs.nytimes.com/2012/04/30/ cutting-our- ﬁrst-dealwith-big-obacco/?_php=true&_type=blogs&_r=0.,Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
http://act.oceanconservancy.org/pdf/Marine_Debris_2011_Report_OC.pdf.,OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
"http://lup.lub.lu.se/luur/download?func=downloadFile&recordOId=19692& ﬁleOId=1002025 20 Zhang X, Cowling DW, Tang Hao Z.",Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
"http://productstewardship.net/PDFs/Joint_PS_Framework_Principles.pdf 22 Product Policy Institute, Product Stewardship Institute, and California Product Stewardship Council.",OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
"http://calpsc.org/mobius/ cpsc-content/uploads/2015/02/UPSTREAM-PSI-CPSC_PS-EPR-Principles_ FINALwEndorsers.pdf 116 Curtis C, et al.Tob Control 2017; 26:113 –117.",Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
http://www.deq.state.or.us/lq/sw/ prodstewardship/OregonPaintCareUpdateLocalGovts.pdf 24 Product Stewardship Institute.,Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
http://www.paintcare.org/wp-content/uploads/docs/ or-report-psi-evaluation-2013.pdf 25 Coalition for Fire-Safe Cigarettes.,Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
http://www.nfpa.org/safety-information/ for-consumers/causes/smoking/coalition-for- ﬁre-safe-cigarettes/model-legislation26 Freiberg M. (Don ’t) See more butts: preemption and local regulation of cigarette litter.,Non-OADS,/arxiv_data1/oa_pdf/bf/76/tobaccocontrol-2015-052737.PMC5256370.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/cc/1a/tobaccocontrol-2015-052487.PMC5256373.pdf
Behavioral Risk Factor Surveillance System: Prevalence and Trends Data 2013. http://apps.nccd.cdc.gov/brfss/ 22 Shiffman S. Light and intermittenet smokers: background and perspective.,OADS,/arxiv_data1/oa_pdf/cc/1a/tobaccocontrol-2015-052487.PMC5256373.pdf
http://www.cdph.ca.gov/ programs/tobacco/Pages/CTCPEvaluationResources.aspx 28 U.S. Census Bureau.,OADS,/arxiv_data1/oa_pdf/cc/1a/tobaccocontrol-2015-052487.PMC5256373.pdf
"Secondary Introduction to NAICS 2014. https://www.census.gov/eos/www/naics/index.html 29 Carlos HA, Shi X, Sargent J, et al.",OADS,/arxiv_data1/oa_pdf/cc/1a/tobaccocontrol-2015-052487.PMC5256373.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ sextrans-2015-052354).,Non-OADS,/arxiv_data1/oa_pdf/23/08/sextrans-2015-052354.PMC5256375.pdf
"1Department of Infectious Disease Epidemiology, ImperialCollege London, London, UK 2Division of Infectious Diseases, Department of Medicine, St Michael ’s Hospital, University of Toronto,Toronto, Canada Correspondence to Dr Michael Pickles, Department of Infectious DiseaseEpidemiology, St Mary ’s Campus, Norfolk Place, Imperial College, London W2 1PG, UK;m.pickles@imperial.ac.uk Received 26 August 2015 Revised 12 May 2016 Accepted 22 May 2016Published Online First17 August 2016 ▸http://dx.doi.org/10.1136/ sextrans-2016-052640 ▸http://dx.doi.org/10.1136/ sextrans-2016-052651 To cite: Ramachandran S, Mishra S, Condie N, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/08/sextrans-2015-052354.PMC5256375.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/23/08/sextrans-2015-052354.PMC5256375.pdf
"http://apps.who.int/gho/data/node.main.619?lang=en 2 Cohen MS, Chen YQ, McCauley M, et al.",OADS,/arxiv_data1/oa_pdf/23/08/sextrans-2015-052354.PMC5256375.pdf
"https://unstats.un.org/unsd/methods/m49/m49regin.htm 16 Napper LE, Fisher DG, Reynolds GL, et al.",OADS,/arxiv_data1/oa_pdf/23/08/sextrans-2015-052354.PMC5256375.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ To cite Semchenko EA, Seib KL.",Non-OADS,/arxiv_data1/oa_pdf/37/52/sextrans-2015-052378.PMC5256376.pdf
"2012. http://www.who.int/ reproductivehealth/publications/rtis/9789241503501/ en/ 3 Aledort JE, Hook EW III, Weinstein MC, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/52/sextrans-2015-052378.PMC5256376.pdf
"2015. http://www.who.int/ mediacentre/factsheets/fs110/en/ 8 Jerse AE, Bash MC, Russell MW.",Non-OADS,/arxiv_data1/oa_pdf/37/52/sextrans-2015-052378.PMC5256376.pdf
"Secondary Antibiotic Resistance Threatsin the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ ar-threats-2013-508.pdf 10 Hobbs MM, Sparling PF, Cohen MS, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/52/sextrans-2015-052378.PMC5256376.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References 1.Betran AP , Torloni MR, Zhang J, et al.",Non-OADS,/arxiv_data1/oa_pdf/26/40/ebmed-2016-110393.PMC5256379.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Marie Curie Cancer Care.,Non-OADS,/arxiv_data1/oa_pdf/06/86/bmjspcare-2014-000794.PMC5256384.pdf
2013. http://media.wix.com/ugd/dded87_951541699e9edc71ce66c9bac4734c69.pdf 19 NVivo qualitative data analysis software.,Non-OADS,/arxiv_data1/oa_pdf/06/86/bmjspcare-2014-000794.PMC5256384.pdf
"Department of Health, 2010. http://www.goldstandardsframework.org.uk/home 44 Grande G, Ewing G. Death at home unlikely if informal carers prefer otherwise: implications for policy .",Non-OADS,/arxiv_data1/oa_pdf/06/86/bmjspcare-2014-000794.PMC5256384.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Waddell N, Pajic M, Patch AM, et al.",Non-OADS,/arxiv_data1/oa_pdf/b1/61/gutjnl-2016-312539.PMC5256386.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2016-312078).,OADS,/arxiv_data1/oa_pdf/76/01/gutjnl-2016-312078.PMC5256390.pdf
"Correspondence to Dr Marina Pasca di Magliano, PhD, Department of Surgery and Department of Cell andDevelopmental Biology,University of Michigan Medical School, 1500 E Medical Center Drive, Cancer Center 4304,Ann Arbor, MI 48109-5936,USA; marinapa@umich.edu Received 15 April 2016 Revised 26 May 2016Accepted 10 June 2016Published Online First 8 July 2016 ▸http://dx.doi.org/10.1136/ gutjnl-2016-312427 To cite: Zhang Y, Velez- Delgado A, Mathew E, et al.",Non-OADS,/arxiv_data1/oa_pdf/76/01/gutjnl-2016-312078.PMC5256390.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Hingorani SR, Petricoin EF, Maitra A, et al.",Non-OADS,/arxiv_data1/oa_pdf/76/01/gutjnl-2016-312078.PMC5256390.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2015-310874).,OADS,/arxiv_data1/oa_pdf/44/21/gutjnl-2015-310874.PMC5256391.pdf
"Correspondence to Professor T H J Florin, UQ Department of Medicine, Mater Adult Hospital, South Brisbane,QLD 4101, Australia;t.ﬂorin@uq.edu.au Received 9 October 2015 Revised 13 June 2016Accepted 15 June 2016Published Online First 13 July 2016 ▸http://dx.doi.org/10.1136/ gutjnl-2016-312450 To cite: Oancea I, Movva R, Das I, et al.Gut 2017; 66:59–69.ABSTRACT Objective Mercaptopurine (MP) and pro-drug azathioprine are ‘ﬁrst-line ’oral therapies for maintaining remission in IBD.",Non-OADS,/arxiv_data1/oa_pdf/44/21/gutjnl-2015-310874.PMC5256391.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 World Health Organization (WHO).,Non-OADS,/arxiv_data1/oa_pdf/10/ec/heartjnl-2016-309983.PMC5256393.pdf
2011. http://www.who.int/nmh/publications/ncd_report_chapter1.pdf?ua=1 (accessed Jan 2015).,OADS,/arxiv_data1/oa_pdf/10/ec/heartjnl-2016-309983.PMC5256393.pdf
2007. http://www.who.int/ cardiovascular_diseases/guidelines/Full%20text.pdf (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/10/ec/heartjnl-2016-309983.PMC5256393.pdf
http://www.aihw.gov.au/publication-detail/?id=10737418409 (accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/10/ec/heartjnl-2016-309983.PMC5256393.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Schneider SM, Pouget I, Staccini P ,et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/flgastro-2016-100736.PMC5256397.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Roush SW, Murphy TV, Vaccine-Preventable Disease Table Working G. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in theUnited States.",Non-OADS,/arxiv_data1/oa_pdf/55/08/medethics-2015-103327.PMC5256398.pdf
"http://dx.doi.org/ 10.1017/CBO9780511862670.009 15 Verweij M, Dawson A.",Non-OADS,/arxiv_data1/oa_pdf/55/08/medethics-2015-103327.PMC5256398.pdf
There has been extensive discussion of placebo controls and ethics of research in medicine.451 92 1 –23The principle adopted by the W orld Medical Association is “in general it is ethically unacceptable to conduct placebo controlled trialsif a proven therapy is available for the condition underinvestigation ”(http://www.wma.net/en/40news/20archives/2001/ 2001_01/).,Non-OADS,/arxiv_data1/oa_pdf/b8/1b/medethics-2015-103333.PMC5256399.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ Figure 2 Bland-Altman plots showing predicted versus actual weight for each weight estimation method.,Non-OADS,/arxiv_data1/oa_pdf/4e/4d/archdischild-2016-310917.PMC5256403.pdf
"2004 (updated 12 January 2004; cited 28 June 2016).https://www-users.york.ac.uk/~mb55/meas/sizemeth.htm 28 Young KD, Korotzer NC.",OADS,/arxiv_data1/oa_pdf/4e/4d/archdischild-2016-310917.PMC5256403.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/bjophthalmol-2015-308166).,Non-OADS,/arxiv_data1/oa_pdf/5f/31/bjophthalmol-2015-308166.PMC5256408.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1 Wong WL, Su X, Li X, et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/31/bjophthalmol-2015-308166.PMC5256408.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/vr.103744).,Non-OADS,/arxiv_data1/oa_pdf/9a/05/vetrec-2016-103744.PMC5256409.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References ARTEAGA, A., DHAND, N. K., MCCANN, T ., KNOTTENBEL T , C. M., TEBB, A. J., EV ANS, H., ECKERSALL, P .",Non-OADS,/arxiv_data1/oa_pdf/9a/05/vetrec-2016-103744.PMC5256409.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/bjophthalmol-2015-307595).,Non-OADS,/arxiv_data1/oa_pdf/02/92/bjophthalmol-2015-307595.PMC5256412.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Kim YJ, Sung KR, Lee KS, et al.",Non-OADS,/arxiv_data1/oa_pdf/02/92/bjophthalmol-2015-307595.PMC5256412.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/bjophthalmol-2016-309190).,Non-OADS,/arxiv_data1/oa_pdf/45/1a/bjophthalmol-2016-309190.PMC5256413.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Rogers S, McIntosh RL, Cheung N, et al .",Non-OADS,/arxiv_data1/oa_pdf/45/1a/bjophthalmol-2016-309190.PMC5256413.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References ALBREC ht, h. (2013) t he situation of complementary medicine in Germany .",Non-OADS,/arxiv_data1/oa_pdf/5a/f5/vetrec-2016-103779.PMC5256414.pdf
http://midanmarketing.com/consumers-case/antibiotics-and-growth-hormones/.,Non-OADS,/arxiv_data1/oa_pdf/5a/f5/vetrec-2016-103779.PMC5256414.pdf
"Accessed n ovember 15, 2016 MintEL GROUP (2015) Consumers market report research: packaged red meat – US –  February , 2015. http://store.mintel.com/packaged-red-meat-us-february-2015.",Non-OADS,/arxiv_data1/oa_pdf/5a/f5/vetrec-2016-103779.PMC5256414.pdf
http://fas.org/sgp/crs/misc/R41983.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/f5/vetrec-2016-103779.PMC5256414.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ludvigsson JF, Lef ﬂer DA, Bai JC, et al.",OADS,/arxiv_data1/oa_pdf/8f/6e/archdischild-2015-310122.PMC5256417.pdf
"J Allergy and Asthma 2015;2. http://www.hoajonline.com/ journals/pdf/2054-9873-2-2.pdf 18 Odén A, Kanis JA, McCloskey EV, et al.",Non-OADS,/arxiv_data1/oa_pdf/8f/6e/archdischild-2015-310122.PMC5256417.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 AMA President Robert Wah proudly claims his ’Star Trek ’roots.,Non-OADS,/arxiv_data1/oa_pdf/6c/b8/medhum-2016-010902.PMC5256418.pdf
"Modern Healthcare , 21 Jun 2014. http://www.modernhealthcare.com/article/20140621/MAGAZINE/ 306219956 (accessed 15 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/6c/b8/medhum-2016-010902.PMC5256418.pdf
"Eugene Smith ’s Landmark Portrait: ‘Country Doctor ’.Time ,1F e b 2012. http://time.com/3456085/w-eugene-smiths-landmark-photo-essay-country-doctor/ (accessed 15 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/6c/b8/medhum-2016-010902.PMC5256418.pdf
"Absolute GDM values were extracted from absolute paleointensity databases: Geomagia50.v3 (http://geomagia.gfz-potsdam.de, December 2015) [ Brown et al.",OADS,/arxiv_data1/oa_pdf/bd/b9/JGRB-121-7716.PMC5256419.pdf
", 2015a, 2015b] and PINT2015-05 (http://earth.liv.ac.uk/pint/, December 2015) [ Biggin et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/b9/JGRB-121-7716.PMC5256419.pdf
Available from: http://www.elso.org/resources/Guidelines.aspx.,Non-OADS,/arxiv_data1/oa_pdf/1c/f1/AMS2-4-079.PMC5256425.pdf
Movie stimuli Color natural movies were drawn from the Apple QuickTime HD gallery (http://www.apple.com/quicktime/guide/hd/ ) and YouTube (http://www.,Non-OADS,/arxiv_data1/oa_pdf/f8/ad/i1534-7362-17-1-11.PMC5256465.pdf
Software A computer package implementing our algorithm is available at: https://github.com/basvanopheusden/ BMD.,Non-OADS,/arxiv_data1/oa_pdf/a9/1f/i1534-7362-17-1-13.PMC5256468.pdf
"Retrieved from http://www.cs.unc.edu/~welch/media/pdf/ kalman_intro.pdfJournal of Vision (2017) 17(1):13, 1–23 Mihali, van Opheusden, & Ma 18",Non-OADS,/arxiv_data1/oa_pdf/a9/1f/i1534-7362-17-1-13.PMC5256468.pdf
"Retrieved 22 December 2016 from http://www.oxfordscholarship.com/view/10.1093/acprof:oso/9780199764167.001.0001/acprof-9780199764167-chapter-030 Jochen, L., Ralf, E., & Kliegl, R. (2008).",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/i1534-7362-17-1-8.PMC5256469.pdf
http://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/i1534-7362-17-1-8.PMC5256469.pdf
"Retrieved from http://www.eurofound.europa.eu/publications/htmlfiles/ef0862.htm Van Der Vegt, G. S., & Bunderson, J. S. (2005).",Non-OADS,/arxiv_data1/oa_pdf/06/5f/10.1177_1046496416667816.PMC5256475.pdf
Reprints and permissions:   http://www.sagepub.co.uk/  journalsPermissions.nav 1830 http://msj.sagepub.comMULTIPLE SCLEROSIS MSJJOURNAL Introduction Peripartum depression is the most frequent form of maternal morbidity in pregnancy and affects 15%–20% of mothers in the first year following delivery; 10% of fathers are also affected.,Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
"N Razaz, H Tremlett et al.http://msj.sagepub.com 1831We, therefore, carried out a study to examine the tim- ing of parental depression, specifically peripartum depression, and its potential association with psychi-atric disorders among children exposed to parental MS since birth.",Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
"Multiple Sclerosis Journal 22(14) 1832 http://msj.sagepub.comuntil the first diagnosis of a psychiatric disorder, emi- gration from British Columbia or the study end date, which was 31 December 2011.",Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
"N Razaz, H Tremlett et al.http://msj.sagepub.com 1833The adjusted Cox model showed that children with  parental MS had a 34% higher rate of psychiatric disorders compared with children without parental MS (adjusted HR: 1.34; 95% CI 1.03–1.74; Table 5, model 2).",OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
"Multiple Sclerosis Journal 22(14) 1834 http://msj.sagepub.comdisorders in children were also observed among boys,  children whose parents had subsequent depression or anxiety and those who were not married.",Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
"N Razaz, H Tremlett et al.http://msj.sagepub.com 1835MS and even when detected is often inadequately  managed.31 Maternal depression is particularly con- cerning because it is often a risk factor for a poor quality of life, paternal depression and adverse emo-tional, intellectual and cognitive development in chil-dren.",Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
Multiple Sclerosis Journal 22(14) 1836 http://msj.sagepub.comTable 3.,Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
"N Razaz, H Tremlett et al.http://msj.sagepub.com 1837depression is not uncommon among fathers and has a  12-month postpartum prevalence of 4%–10%.2 An  elevated risk of depression in those with MS compared with those without MS has also been observed in other studies; rates of depression among women with MS are 59% higher than among women without MS, while among men, rates of depression are 93% higher in those with MS compared with those without MS. 34  The higher risk of peripartum depression in men with MS could be triggered by their new role as fathers, which may require them to confront their physical or cognitive impairments and ability to address their fam-ily’s emotional and financial needs.",Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
Multiple Sclerosis Journal 22(14) 1838 http://msj.sagepub.comchild mental health suggest that the rates of psychiat- ric disorders among children of depressed parents are two to five times above normal and that the risk asso-ciated with maternal depressive symptoms may be comparable with that of paternal depressive symp-toms.,Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
"N Razaz, H Tremlett et al.http://msj.sagepub.com 1839 2.",Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
"Statistics Canada: Annual income estimates for census families and individuals (T1 Family File), Statistics  Canada, http://www23.statcan.gc.ca/imdb/p2SV.pl?Fu nction=getSurvey&;SDDS=4105&lang=en&db=IMDB&dbg=f&adm=8&dis=2 (accessed 4 July 2015).",OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
Multiple Sclerosis Journal 22(14) 1840 http://msj.sagepub.com 29.,Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
Visit SAGE journals online  http://msj.sagepub.com  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/1b/05/10.1177_1352458516631037.PMC5256476.pdf
http://www.random.org 6.,Non-OADS,/arxiv_data1/oa_pdf/93/d3/10.1177_0271678X16629485.PMC5256485.pdf
http://www.wma.net/en/30publications/10policies/b3/ 7.,Non-OADS,/arxiv_data1/oa_pdf/93/d3/10.1177_0271678X16629485.PMC5256485.pdf
"R package version 0.92-5,http://CRAN.R-project.org/package=robustbase (2014accessed 17 June 2015).454 Journal of Cerebral Blood Flow & Metabolism 37(2)",Non-OADS,/arxiv_data1/oa_pdf/93/d3/10.1177_0271678X16629485.PMC5256485.pdf
"R package version 3.5, http://CRAN.R-project.org/package ¼DTK (2015; accessed22 June 2013).",Non-OADS,/arxiv_data1/oa_pdf/93/d3/10.1177_0271678X16629485.PMC5256485.pdf
http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/ LicensedProductsBLAs/FractionatedPlasmaProducts Copyright 2017 BMJ Publishing Group.,Non-OADS,/arxiv_data1/oa_pdf/df/1f/bcr-2016-218044.PMC5256494.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Chen YS, Chao A, Yu HY, et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/be/bcr-2016-012806.PMC5256511.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 James PA, Oparil S, Carter BL, et al .",Non-OADS,/arxiv_data1/oa_pdf/2c/d7/bcr-2016-218388.PMC5256569.pdf
"), GeneReviews® [Internet], University of Washington, Seattle, Seattle (WA), 1993-2016 (Available from) http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/b8/06/main.PMC5256666.pdf
"Sinda Zarrouk-Mahjoub University of Tunis El Manar, Genomics Platform, Pasteur Institute of Tunis, Tunisia 12 January 2017Molecular Genetics and Metabolism Reports 10 (2017) 83 http://dx.doi.org/10.1016/j.ymgmr.2017.01.007 2214-4269/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b8/06/main.PMC5256666.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/06/main.PMC5256666.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Socioeconomic factorsSmokingPrimary carePopulation studiesSweden 1.,Non-OADS,/arxiv_data1/oa_pdf/be/40/main.PMC5256667.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.12.016 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/40/main.PMC5256667.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/40/main.PMC5256667.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/be/40/main.PMC5256667.pdf
"of Health and Human Services, Centers for Disease Control and Prevention, Na-tional Center for Chronic Disease Prevention and Health Promotion, Of ﬁce on Smoking and Health, Washington, DC (Available at http://www.cdc.gov/tobacco/ data_statistics/sgr/sgr_2004/chapters.htm .",Non-OADS,/arxiv_data1/oa_pdf/be/40/main.PMC5256667.pdf
(Available at http://www.scb.se .,Non-OADS,/arxiv_data1/oa_pdf/be/40/main.PMC5256667.pdf
"World Health Organization, Geneva, Switzerland (Available at http://www.who.int/ fctc/en .",Non-OADS,/arxiv_data1/oa_pdf/be/40/main.PMC5256667.pdf
"This method does not involve http://dx.doi.org/10.1016/j.redox.2017.01.009 Received 3 January 2017; Received in revised form 6 January 2017; Accepted 11 January 2017⁎Corresponding author at: Department of Physiology and Biophysics, State University of New York at Bu ﬀalo, 124 Sherman Hall, Bu ﬀalo, NY 14214, USA.",Non-OADS,/arxiv_data1/oa_pdf/59/6f/main.PMC5256671.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/6f/main.PMC5256671.pdf
This  is  an  open access article under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/73/main.PMC5256673.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.001 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/73/main.PMC5256673.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/15/main.PMC5256675.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.01.005 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/15/main.PMC5256675.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 98 e103,Non-OADS,/arxiv_data1/oa_pdf/8c/15/main.PMC5256675.pdf
Allelic proﬁles and ST were analysed according to the PubMLST Website ( http://pubmlst.org/achromobacter/ ).,OADS,/arxiv_data1/oa_pdf/8c/15/main.PMC5256675.pdf
http://www.bacterio.net/achromobacter.html (Accessed 10 January 2017).,Non-OADS,/arxiv_data1/oa_pdf/8c/15/main.PMC5256675.pdf
"[14] CSLI, Performance Standards for Antimicrobial Susceptibility Testing; Twenty- fourth Informational Supplement, CLSI Document M100 eS24, Clinical and Standards Laboratory Institute, Wayne, PA, 2014. http://shop.clsi.org/site/ Sample_pdf/M100S25_sample.pdf (Accessed 20 October 2016).",Non-OADS,/arxiv_data1/oa_pdf/8c/15/main.PMC5256675.pdf
http://cftr2.org/mutation/general/F508del/Y1092X (Accessed 07 October 2016).,Non-OADS,/arxiv_data1/oa_pdf/8c/15/main.PMC5256675.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/05/main.PMC5256676.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.01.016 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7e/05/main.PMC5256676.pdf
"33 (2009) 277 e316, http://dx.doi.org/10.1177/0148607109335234 .",Non-OADS,/arxiv_data1/oa_pdf/7e/05/main.PMC5256676.pdf
"Care 17 (1) (2013) S7, http://dx.doi.org/10.1186/cc11505 .",Non-OADS,/arxiv_data1/oa_pdf/7e/05/main.PMC5256676.pdf
"2012 (2012) 136937, http://dx.doi.org/ 10.1155/2012/136937 .",Non-OADS,/arxiv_data1/oa_pdf/7e/05/main.PMC5256676.pdf
"Esophagus 23 (2010) 106 e111, http://dx.doi.org/ 10.1111/j.1442-2050.2009.01007.x .",Non-OADS,/arxiv_data1/oa_pdf/7e/05/main.PMC5256676.pdf
"53 (2014) 61 e71, http://dx.doi.org/10.1007/s00394-013-0498-6 .",Non-OADS,/arxiv_data1/oa_pdf/7e/05/main.PMC5256676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/e2/main.PMC5256677.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.01.004 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/82/e2/main.PMC5256677.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 104 e106,Non-OADS,/arxiv_data1/oa_pdf/82/e2/main.PMC5256677.pdf
"Rep. 2 (12) (2011) 95, http://dx.doi.org/10.1258/ shorts.2011.011080 .",Non-OADS,/arxiv_data1/oa_pdf/82/e2/main.PMC5256677.pdf
3; http://xoofee.com/2012/12/curvesnap/).,Non-OADS,/arxiv_data1/oa_pdf/9a/50/i1552-5783-58-1-204.PMC5256680.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.007,Non-OADS,/arxiv_data1/oa_pdf/a9/0d/main.PMC5257022.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,3 2 –33 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a9/0d/main.PMC5257022.pdf
http://dx.doi.org/10.1016/j.redox.2016.10.005 Received 3 October 2016Accepted 11 October 2016Redox Biology 11 (2017) 620–621 Available online 13 October 2016 2213-2317/ © 2016 Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/71/8c/main.PMC5257023.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/71/8c/main.PMC5257023.pdf
E-mail address: p.sachdev@unsw.edu.au http://dx.doi.org/10.1016/j.dadm.2016.10.006 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/29/2d/main.PMC5257024.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/2d/main.PMC5257024.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/29/2d/main.PMC5257024.pdf
Website A website that contains a description of STROKOG and summaries of the member studies has been established (https://cheba.unsw.edu.au/group/strokog ).,Non-OADS,/arxiv_data1/oa_pdf/29/2d/main.PMC5257024.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.10.006 .RESEARCH IN CONTEXT 1.,OADS,/arxiv_data1/oa_pdf/29/2d/main.PMC5257024.pdf
Alzheimers Dement 2016; http://dx.doi.org/10.1016/j.jalz.2016.06.004 [Epub ahead of print].,OADS,/arxiv_data1/oa_pdf/29/2d/main.PMC5257024.pdf
Available at: http://www.thelancet.com/ campaigns/efﬁciency/statement .,Non-OADS,/arxiv_data1/oa_pdf/29/2d/main.PMC5257024.pdf
Avail- able at: http://methods.cochrane.org/ipdma/ .,OADS,/arxiv_data1/oa_pdf/29/2d/main.PMC5257024.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.018,Non-OADS,/arxiv_data1/oa_pdf/ed/98/main.PMC5257025.pdf
The MALDI-TOF MS spectrum of ‘Ndongobacter massiliensis ’strain Marseille-P3170Tis available online ( http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/ed/98/main.PMC5257025.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,3 4 –36 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ed/98/main.PMC5257025.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,3 4 –36 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ed/98/main.PMC5257025.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/14/main.PMC5257028.pdf
E-mail address: shimada.hitoshi@qst.go.jp http://dx.doi.org/10.1016/j.dadm.2016.12.009 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/14/main.PMC5257028.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/14/main.PMC5257028.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.12.009 .,OADS,/arxiv_data1/oa_pdf/8a/14/main.PMC5257028.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6a/a4/main.PMC5257031.pdf
E-mail address: vemuri.prashanthi@mayo.edu http://dx.doi.org/10.1016/j.dadm.2016.12.010 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/a4/main.PMC5257031.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/a4/main.PMC5257031.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.12.010 .P.,OADS,/arxiv_data1/oa_pdf/6a/a4/main.PMC5257031.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chronic kidney diseaseHemodialysisOxidative stressBiomarkerProtein-bound di-tyrosineCreatinine 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.12.004 2214-6474/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"72 (3) (2007) 247 –259, http://dx.doi.org/10.1038/sj.ki.5002343 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"[5] United States Renal Data System, Annual Data Report: Atlas of Chronic Kidney Dis- ease & End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD,2013, 2013 ( http://www.ajkd.org/issue/S0272-6386(13)X0014-9 ).",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"16 (2) (2005) 529–538, http://dx.doi.org/10.1681/ASN.2004080656 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"20 (3) (2015) 259 –272, http://dx.doi.org/10.1007/s10741-014-9460-9 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"62 (5) (2002) 1524 –1538, http://dx.doi.org/10.1046/j.1523-1755.2002.00600.x .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"1) (2009) S49 –S55, http://dx.doi.org/10.2215/CJN.02720409 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"47 (5) (2013) 346 –356, http://dx.doi.org/10.3109/10715762.2013.779373 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"4 (2002) 935 –944, http://dx.doi.org/10.1089/ 152308602762197470 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"3) (2010) s113 –s119, http://dx.doi.org/10.2450/2010.018S .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"27 (11) (2012) 4010 – 4021, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"25 (1) (2012)120–126, http://dx.doi.org/10.5301/JN.2011.8432 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"London, Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease, Circulation 106 (17) (2002) 2212 –2217, http://dx.doi.org/10.1161/01.CIR.0000035250.66458.67 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"3 (2) (2008) 505 –521, http://dx.doi.org/10.2215/CJN.03670807 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"58 (6) (2000) 2571 –2578, http://dx.doi.org/10.1046/j.1523-1755.2000.00443.x .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"63 (1) (2003) 353 –359, http://dx.doi.org/10.1046/j.1523-1755.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Acta 366 (1 –2) (2006) 137 –145, http://dx.doi.org/10.1016/j.cca.2005.09.028 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"89 (2015) 443 –451, http://dx.doi.org/ 10.1016/j.freeradbiomed.2015.08.022 .",OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"43 (10) (2009) 1008 –1018, http://dx.doi.org/10.1080/10715760903165003 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"54 (4) (2013) 409 –413, http://dx.doi.org/ 10.3233/CH-131739 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Acta 1689 (2) (2004) 91 –102, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Acta 393 (2) (2008) 114 –118, http://dx.doi.org/10.1016/j.cca.",OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Acta 413 (9 –10) (2012) 901 –906, http://dx.doi.org/10.1016/j.cca.2012.01.038 .",OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"45 (1) (2005) 39 –47,http://dx.doi.org/10.1053/j.ajkd.2004.09.011 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"64 (1) (2003) 82 –91,http://dx.doi.org/10.1046/j.1523-1755.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"10 (10) (2008) 1699 –1712, http://dx.doi.org/10.1089/ars.2007.1999 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"26 (5) (2006) 1156 –1162, http://dx.doi.org/10.1161/01.ATV.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"104 (6) (2009) 750 –757, http://dx.doi.org/10.1161/CIRCRESAHA.108.193169 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"21 (6) (2006) 1555 –1563, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"45 (10) (2011) 1115 –1123, http://dx.doi.org/10.3109/10715762.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Acta 1850 (1) (2015) 1 –12,http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"20 (6) (2005) 1134 –1139, http://dx.doi.org/10.1093/ndt/gfh764 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"25 (6) (2015) 494 –503, http://dx.doi.org/10.1053/j.jrn.2015.06.003 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"17 (11) (2012) 1515 –1527, http://dx.doi.org/10.1089/ars.2012.4702 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"23 (5) (2010) 498 –509, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"5 (10) (2008) 621 –635, http://dx.doi.org/10.1038/ncpcardio1322 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"17 (6) (2004) 438 –448, http://dx.doi.org/10.1111/j.0894-0959.2004.17604.x .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"10 (2) (2006) 389 –406, http://dx.doi.org/10.1111/j.1582-4934.2006.tb00407.x .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"113 (1) (2013) 596–698, http://dx.doi.org/10.1021/cr300073p .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"10 (3) (2008) 445 –473, http://dx.doi.org/10.1089/ars.2007.1716 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"13 (9B) (2009) 3131 –3140, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"39 (5) (2002) 1040 –1046, http://dx.doi.org/ 10.1053/ajkd.2002.32787 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"1019 (2016) 178 –190, http://dx.doi.org/10.1016/j.jchromb.2015.11.052 .",OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"46 (10) (2009) 1411 –1419, http://dx.doi.org/10.1016/j.freeradbiomed.2009.02.024 .",OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"26 (1) (2007) 108 –120, http://dx.doi.org/10.1002/mas.20109 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Yang, Impairments of the biological properties of serum albumin in patients on haemodialysis, Nephrology (Carlton) 12 (1) (2007) 18 –24, http://dx.doi.org/10.1111/j.1440-1797.2006.00745.x .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"1 (2013) 83, http://dx.doi.org/10.1186/2051-5960-1-83 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"69 (3) (2015) 309 – 313, http://dx.doi.org/10.1038/ejcn.2014.261 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"48 (1) (2006) 59 –68, http://dx.doi.org/10.1053/j.ajkd.2006.03.047 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"34 (1) (2011) 12 –19,http://dx.doi.org/10.1159/000321508 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Davies, Tyrosine oxidation products: analysis and biolog- ical relevance, Amino Acids 25 (3 –4) (2003) 227 –232, http://dx.doi.org/10.1007/ s00726-003-0013-0 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"34 (4) (1999) 694 –701, http://dx.doi.org/10.1016/ S0272-6386(99)70395-1 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"68 (4) (2005) 1766 –1776, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"7 (9) (2012) 1446 –1453, http://dx.doi.org/10.2215/CJN.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Moosa, Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive re-view and meta-analysis, Nutrition 26 (1) (2010) 10 –32,http://dx.doi.org/10.1016/ j.nut.2009.07.009 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"58 (3) (2011) 418 –428, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Care 40 (1) (2014) 14 –22,http://dx.doi.org/10.1111/jorc.12048 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"19 (2) (2009) 127–135, http://dx.doi.org/10.1053/j.jrn.2008.08.003 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"21 (2) (2010) 223 –230, http://dx.doi.org/10.1681/ ASN.2009020213 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"42 (2) (2003) 286 –294, http://dx.doi.org/10.1016/S0272-6386(03)00653-X .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"14 (2) (2010) 226 –232, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"6 (10) (2011) 2452 –2461, http://dx.doi.org/10.2215/CJN.00710111 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"7 (3) (2011) 166–176, http://dx.doi.org/10.1038/nrneph.2011.2 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"16 (1) (2012) 68 –74,http://dx.doi.org/10.1111/j.1744-9987.2011.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"50 (6) (2004) lii–lvii,http://dx.doi.org/10.1097/01.MAT.0000147958.87989.EB .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"39 (1 –3) (2015) 84 –92, http://dx.doi.org/10.1159/000368940 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Ikizler, J. Himmelfarb, Effect of renal transplantation on biomarkers of in ﬂammation and oxidative stress in end-stage renal disease patients, Transplantation 79 (8) (2005) 914 –919, http://dx.doi.org/10.1097/01.TP.0000157773.96534.29 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"116 (4) (2010) c294 –c299, http://dx.doi.org/10.1159/000318792 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"J. Nephrol.28 (3) (2008) 397 –404, http://dx.doi.org/10.1159/000112413 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"41 (6) (2008) 381–386, http://dx.doi.org/10.1016/j.clinbiochem.2007.12.011 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Sarcopenia Muscle 4 (4) (2013) 247 –257, http://dx.doi.org/10.1007/s13539-013- 0115-9 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"Pract.115 (1) (2010) c82 –c89, http://dx.doi.org/10.1159/000294281 .",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
"26 (3) (2013) 556 –563, http://dx.doi.org/10.5301/jn.5000195 .63 G. Colombo et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/eb/main.PMC5257032.pdf
This  is  an  open  access  article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/2e/main.PMC5257178.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.013 2210-2612/© 2017  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/4c/2e/main.PMC5257178.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"In  cases  of  intestinal  perforation,  the  stent should  be  immediately  removed;  otherwise  it  may  lead  to  peritoni- tis  and  potential  formation  of  intra-abdominal  or  retroperitoneal http://dx.doi.org/10.1016/j.ijscr.2017.01.016 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"62  (5) (2005) 512–515,  http://dx.doi.org/10.1016/j.cursur.2005.03.011 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"57  (1)  (2003) 136–138, http://dx.doi.org/10.1067/mge.2003.37 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"17  (11)  (2003)  1803–1807,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"Svendsen,  Proximal  displacement  of  biliary  stent  with distal  perforation  and  impaction  in  the  pancreas,  Endoscopy  33  (2)  (2001) 195,  http://dx.doi.org/10.1055/s-2001-11920 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"Heffron, Biliary  strictures  in liver transplant  recipients:  treatment  with  metal stents, Radiology  199  (2)  (1996)  339–346,  http://dx.doi.org/10.1148/ radiology.199.2.8668775 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"57  (1)  (2003)  124–126,  http://dx.doi.org/10.1067/mge.2003.71 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"Imaging  32 (3)  (2007)  317–319, http://dx.doi.org/10.1007/s00261-006-9067-2 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"15  (9)  (2001)  1043,  http://dx.doi.org/10.1007/s004640041008 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"Case  Rep.  2014  (12) (2014), http://dx.doi.org/10.1093/jscr/rju134 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"148 (5) (2011) e397–399,  http://dx.doi.org/10.1016/j.jviscsurg.2011.09.011 .",OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"(2014), http://dx.doi.org/10.1111/ans.12796 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"Assal,  Migrated  biliary  stent  causing  perforation  of sigmoid  colon and  pelvic  abscess,  BMJ  Case  Rep.  2015  (2015),  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"2)  (2006)  E96,  http://dx.doi.org/ 10.1055/s-2006-944621 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"47  (6)  (1998)  543–544,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
"Rosseland, Gut perforation  caused  by  biliary  endoprosthesis,  Endoscopy  32  (1)  (2000) 87–89,  http://dx.doi.org/10.1055/s-2000-87 .",Non-OADS,/arxiv_data1/oa_pdf/e7/0a/main.PMC5257179.pdf
http://dx.doi.org/10.1016/j.idcr.2016.12.005 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5257180.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  7  (2017)  47 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5257180.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC5257181.pdf
His  blood  tests  began  showing  an  improve- http://dx.doi.org/10.1016/j.ijscr.2017.01.004 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC5257181.pdf
"12  (7)  (2012)  1663–1664,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC5257181.pdf
"232  (4)  (2000)  515–529,  http://dx.doi.org/10.1097/00000658- 200010000-00007 .",Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC5257181.pdf
"4  (2)  (2008) 159–164, http://dx.doi.org/10.1016/j.soard.2007.12.009 .",Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC5257181.pdf
"33  (7–8)  (2001)  3416,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC5257181.pdf
"22  (1)  (2012)  119–123,  http://dx.doi.org/ 10.1007/s11695-011-0448-4 .",Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC5257181.pdf
"Despite the almost homo- genous appearance on the histological level, the liver lobules/acini http://dx.doi.org/10.1016/j.redox.2017.01.012 Received 22 December 2016; Received in revised form 12 January 2017; Accepted 13 January 2017E-mail address: Thomas.Kietzmann@oulu.",Non-OADS,/arxiv_data1/oa_pdf/56/78/main.PMC5257182.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/56/78/main.PMC5257182.pdf
http://dx.doi.org/10.7554/eLife.13308.,Non-OADS,/arxiv_data1/oa_pdf/56/78/main.PMC5257182.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/b3/main.PMC5257183.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.017 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/b3/main.PMC5257183.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/76/main.PMC5257184.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.019 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/94/76/main.PMC5257184.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/b3/main.PMC5257185.pdf
"According  to  the  Ki-67  labeling index  and  the  2010  WHO  classiﬁcation,  the  histologic  classiﬁcation http://dx.doi.org/10.1016/j.ijscr.2017.01.012 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/88/b3/main.PMC5257185.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: The Great East Japan Earthquake The Fukushima Health Management SurveyEvacueePolycythemiaLifestyle-related disease 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/main.PMC5257186.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.01.003 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/main.PMC5257186.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/main.PMC5257186.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/main.PMC5257186.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ImmunizationPatient educationVaccination historyPatient empowerment Mobile health Electronic health records 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
"URL's: http://www.vi-vi.org ,http://info@vi-vi.org (B. Rath).",Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.01.002 2211-3355/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.4161/hv.26010 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.9745/GHSP-D-13-00115 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1080/21645515.2015.1009807 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1080/21645515.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1093/pubmed/fdw032 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
February 10]; Avail- able from http://immunize.ca/en/app.aspx .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1097/ GRF.0b013e3182988a3b .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1371/journal.pone.0092500 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1586/14760584.2014.897618 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
47:1 –8.http://dx.doi.org/10.1016/j.amepre.2014.02.009 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.2008.01.011 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
BMC Public Health 15:836. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1371/journal.pmed.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1197/jamia.M2556 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1080/21645515.2015.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1002/pds.3401 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.pec.2007.11.006 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.amepre.2014.10.023 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.amjmed.2008.05.005 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.amepre.2015.04.029 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1097/INF.0000000000000802 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.2011.01.065 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
EBioMedicine http://dx.doi.org/ 10.1016/j.ebiom.2016.08.042 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
40:67 –76.http://dx.doi.org/10.5993/AJHB.40.1.8 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.2196/resprot.5045 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
5):7 –11.http://dx.doi.org/ 10.1111/1469-0691.12453 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
28:3 –5.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1007/s11845-013-0919-9 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1586/ 14760584.2014.892833 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1136/ emermed-2012-201193 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.2012.10.089 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1007/s00103-014-1976-6 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://www.immunisation.health.nsw.gov.au/ .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
35:35 –38.http://dx.doi.org/ 10.1097/INF.0000000000000928 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
11:72 –82.http://dx.doi.org/10.4161/hv.34313 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
:CD008145 http://dx.doi.org/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.2015.04.089 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
https://www.rki.de/DE/Content/Infekt/NRZ/MMR/ Berliner_Masernausbruch_aus_Sicht_des_NRZ.html .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1007/s13149-015-0455-4 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://www.stfm.org/Resources/Shots .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.drudis.2006.12.012 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.2105/AJPH.2011.300331 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.2015.02.034 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1007/s10995-015-1817-8 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.3851/IMP3034 .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
https://sites.google.com/site/immunizationcardrepository/ .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://www.chop.edu/centers-programs/parents-pack/vaccines-go-what- you-should-know .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
Women's Health (Larchmt) 19:71 –76.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://venice.cineca.org/ MMR_report_2010_1.0.pdf .249 L. Seeber et al.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://venice.cineca.org/Final_Vaccination_ Coverage_Assesment_Survey_2011_1.pdf; .,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1016/j.vaccine.2012.11.093 .,OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.org/10.1097/01.pec.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/b9/main.PMC5257187.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Depression Working memory updatingPrefrontal cortexVisual cortexRuminationfMRIFunctional connectivity 1.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.004 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
"Functional connectivity analysis The frontal functional connectivity with FFA and PPA was estimated using the psychophysiological interactions (PPI) ( Friston et al., 1997 ) using the gPPI toolbox ( McLaren et al., 2012 )(http://www.nitrc.org/ projects/gppi ).",OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/S1364-6613(00)01501-1 .,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/S0006-3223(03)01674- 8.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
B:1325 –1334 http://dx.doi.org/10.1098/rstb.2008.0312 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
11:1 –15.http://dx.doi.org/10.1167/11.10.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1017/S003329170003806X .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
Neural and behavioral effects of interfe r e n c er e s o l u t i o ni nd e p r e s s i o na n dr u m i - n a t i o n .C o g n .A f f e c t .B e h a v .N e u r o s c i .1 1 : 8 5 –96.http://dx.doi.org/10.3758/ s13415-010-0014-x .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1002/cne.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
NeuroImage 91:43 –51.http://dx.doi.org/10.1016/j.neuroimage.2014.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0184-12.2012 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1097/WNR.0b013e3283294159 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1007/ s10608-011-9352-4 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1093/cercor/bhv111 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/j.brat.2012.02.012 .,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3341-08.2009 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.08.061 .,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1038/ nrn3027 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1080/02643290042000215 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/ 10.1152/jn.00003.2007 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/ 10.1002/hbm.20414 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/ 10.1002/hbm.20630 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.0340-05.2005 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1176/appi.ajp.2010.09121718 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1162/0898929053279522 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1038/nn1543 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1093/cercor/bhm113 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1038/nrn3476 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/j.jad.2008.10.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1146/annurev.clinpsy.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1146/annurev-clinpsy-050212- 185553 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
NeuroImage 73:8 –15.http://dx.doi.org/10.1016/j.neuroimage.2013.01.055 .,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1038/nature07832 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/j.jpsychires.2004.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1037/0021-843X.117.1.182 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1177/0956797611415539 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10 .1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1176/appi.ajp.158.6.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1038/npp.2012.252 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/S0005-7967(98)00131-4 .,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1037/ a0020283.Updating .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1503/jpn.110180 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
Karolinska Institutet http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1097/WNR.0b013e328310425e .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1161/STROKEAHA.110.596155.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/j.psychres.2010.04.044 .,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1111/j.1745-6924.2008.00088.x .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/s0006-3223(02)01548-2 .,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1162/jocn.2009.21250 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0591-12.2012 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
70:91 –97.http://dx.doi.org/10.1016/j.neures.2011.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2009.187 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1037/ a0023204 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1126/science.1086025 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/j.jad.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0559-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2789-15.2016 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1111/j.1467-9280.2007.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1016/j.jbtep.2014.03.004 .,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1038/nn.2773 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
http://dx.doi.org/10.1093/brain/aws059 .,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
NeuroImage 113:13 –25.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
11: 1–18.http://dx.doi.org/10.1167/11.14.2 .53 T.M.,Non-OADS,/arxiv_data1/oa_pdf/de/f7/main.PMC5257188.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/e1/main.PMC5257191.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.01.007 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/71/e1/main.PMC5257191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 107 e110,Non-OADS,/arxiv_data1/oa_pdf/71/e1/main.PMC5257191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a5/main.PMC5257192.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.12.005,OADS,/arxiv_data1/oa_pdf/81/a5/main.PMC5257192.pdf
"On the basis of the results of themultivariable analysis, two nomograms were formulated by R 3.0.1(http://www.r-project.org ) with the survival and rms package.",OADS,/arxiv_data1/oa_pdf/81/a5/main.PMC5257192.pdf
"All data were analyzed using the SPSS statistical software,Version 17.0 (SPSS Inc., Chicago, IL, USA) and R software (version 3.0.1; http://www.Rproject.org ).Results Clinicopathologic Correlations Tables 1 and S1 –2 list the clinical characteristics of the patients and the clinicopathologic correlations with E-cadherin, CD44, andMSH2 in the training and validation cohorts.",OADS,/arxiv_data1/oa_pdf/81/a5/main.PMC5257192.pdf
Keywords Epilepsy; Africa; Qualitative; Developmental problems; Behavioral problems This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/ff/emss-67916.PMC5257264.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.nmd.2013.12.011 HHS Public Access Author manuscript Neuromuscul Disord .",OADS,/arxiv_data1/oa_pdf/82/74/nihms830415.PMC5258110.pdf
"E-mail: choyo@ncsu.edu †Randy L. Jirtle, http://orcid.org/0000-0003-1767-045X ‡Susan K. Murphy, http://orcid.org/0000-0001-8298-7272 §Cathrine Hoyo, http://orcid.org/0000-0002-2466-8617 Abstract Prenatal exposure to lead (Pb) is known to decrease fetal growth; but its effects on postnatal growth and mechanistic in- sights linking Pb to growth are not clearly deﬁned.",Non-OADS,/arxiv_data1/oa_pdf/f5/4d/dvv009.PMC5258134.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/4d/dvv009.PMC5258134.pdf
"http://www.cdc.gov/nceh/lead/tips.htm, 2012 (28 November 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/f5/4d/dvv009.PMC5258134.pdf
"&Marcus Schmitt-Egenolf marcus.schmitt-egenolf@umu.se; http://www.derma.org 1The Swedish Institute for Health Economics (IHE), Lund, Sweden 2Department of Public Health and Clinical Medicine, Dermatology, Umea ˚University, 901 87 Umea ˚, Sweden 3Department of Clinical Sciences, Malmo ¨, Lund University, Lund, Sweden BioDrugs (2017) 31:75–82 DOI 10.1007/s40259-016-0209-y",Non-OADS,/arxiv_data1/oa_pdf/77/04/40259_2016_Article_209.PMC5258782.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), whichpermits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/77/04/40259_2016_Article_209.PMC5258782.pdf
Regional Medical Guidelines—Psoriasis [Regional Medicinsk riklinje - Psoriasis]; 2011. http://epi.vgregion.se/ upload/L%C3%A4kemedel/MR/MR%20Psoriasis_TT.pdf .,Non-OADS,/arxiv_data1/oa_pdf/77/04/40259_2016_Article_209.PMC5258782.pdf
National Bureau of Eco- nomic Research; 2005. http://www.nber.org/papers/w11251 .,Non-OADS,/arxiv_data1/oa_pdf/77/04/40259_2016_Article_209.PMC5258782.pdf
National Bureau of Economic Research; 2009. http://www.nber.org/papers/w14865 .,Non-OADS,/arxiv_data1/oa_pdf/77/04/40259_2016_Article_209.PMC5258782.pdf
"Funding The SLR to support this manuscript was sponsored by Pﬁzer Inc. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d1/0d/40259_2016_Article_207.PMC5258783.pdf
2016 April 2016 [cited 2016 21 June]; Available from: https://morningconsult.com/wp-content/uploads/ 2016/04/IMS-Institute-US-Drug-Spending-2015.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d1/0d/40259_2016_Article_207.PMC5258783.pdf
2015 December 2015 [cited 2016 21 June]; Available from: http://www.imshealth.com/ ﬁles/web/Corporate/News/Top-Line%20Market%20Data/Top_20_ Global_Products_2015.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d1/0d/40259_2016_Article_207.PMC5258783.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b5/ae/10620_2016_Article_4397.PMC5258807.pdf
All dat aa n a l y s e sw e r ep e r f o r m e d by using established libraries and in-house programmesunder R 3.2.1 (https://www.r-project.org /).,Non-OADS,/arxiv_data1/oa_pdf/34/32/CJP2-3-3.PMC5259564.pdf
"The Cancer Genome Atlas (TCGA) database screening for T-cadherin gene expression in prostate cancer IlluminaHiSeq-RNASeqV2 expression data (level 3) for 550 samples of prostate adenocarcinoma and cor-responding clinical data were downloaded from theUCSC Cancer Browser (TCGA_PRAD_exp_Hi-SeqV2-2015-02-24, https://genome-cancer.ucsc.edu).Analysis and data visualisation were performed usingR software (version 3.2.3).",OADS,/arxiv_data1/oa_pdf/41/34/CJP2-3-44.PMC5259566.pdf
266 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
267 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
268 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
269 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
270 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
271 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
272 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
273 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
274 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
275 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
276 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
277 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
278 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
279 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
280 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
281 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
282 http://www.ismni.orgA.K.O.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
J Bone Miner Res 2015;30:Available at: http://www.asbmr.org/education/   AbstractDetail?aid=c8844053-995d-4768-9263- 457296822c3d .,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/JMNI-16-265.PMC5259568.pdf
284 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
285 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
286 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
287 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
288 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
289 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
290 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
291 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
292 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
293 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
294 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
295 http://www.ismni.orgL.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/JMNI-16-283.PMC5259569.pdf
297 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/4e/7a/JMNI-16-296.PMC5259570.pdf
298 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/4e/7a/JMNI-16-296.PMC5259570.pdf
299 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/4e/7a/JMNI-16-296.PMC5259570.pdf
300 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/4e/7a/JMNI-16-296.PMC5259570.pdf
301 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/4e/7a/JMNI-16-296.PMC5259570.pdf
303 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/c7/9a/JMNI-16-302.PMC5259571.pdf
304 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/c7/9a/JMNI-16-302.PMC5259571.pdf
305 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/c7/9a/JMNI-16-302.PMC5259571.pdf
306 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/c7/9a/JMNI-16-302.PMC5259571.pdf
307 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/c7/9a/JMNI-16-302.PMC5259571.pdf
308 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/c7/9a/JMNI-16-302.PMC5259571.pdf
309 http://www.ismni.orgT.,Non-OADS,/arxiv_data1/oa_pdf/c7/9a/JMNI-16-302.PMC5259571.pdf
311 http://www.ismni.orgE.C.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/JMNI-16-310.PMC5259572.pdf
312 http://www.ismni.orgE.C.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/JMNI-16-310.PMC5259572.pdf
313 http://www.ismni.orgE.C.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/JMNI-16-310.PMC5259572.pdf
314 http://www.ismni.orgE.C.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/JMNI-16-310.PMC5259572.pdf
315 http://www.ismni.orgE.C.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/JMNI-16-310.PMC5259572.pdf
316 http://www.ismni.orgE.C.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/JMNI-16-310.PMC5259572.pdf
317 http://www.ismni.orgE.C.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/JMNI-16-310.PMC5259572.pdf
319 http://www.ismni.orgC.M.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/JMNI-16-318.PMC5259573.pdf
320 http://www.ismni.orgC.M.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/JMNI-16-318.PMC5259573.pdf
321 http://www.ismni.orgC.M.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/JMNI-16-318.PMC5259573.pdf
322 http://www.ismni.orgC.M.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/JMNI-16-318.PMC5259573.pdf
323 http://www.ismni.orgC.M.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/JMNI-16-318.PMC5259573.pdf
324 http://www.ismni.orgC.M.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/JMNI-16-318.PMC5259573.pdf
325 http://www.ismni.orgC.M.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/JMNI-16-318.PMC5259573.pdf
326 http://www.ismni.orgC.M.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/JMNI-16-318.PMC5259573.pdf
328 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
329 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
330 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
331 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
332 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
333 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
334 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
335 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
336 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
337 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
338 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/8d/53/JMNI-16-327.PMC5259574.pdf
349 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/JMNI-16-348.PMC5259576.pdf
350 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/JMNI-16-348.PMC5259576.pdf
351 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/JMNI-16-348.PMC5259576.pdf
352 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/JMNI-16-348.PMC5259576.pdf
353 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/JMNI-16-348.PMC5259576.pdf
354 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/JMNI-16-348.PMC5259576.pdf
356 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
357 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
358 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
359 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
360 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
361 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
362 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
363 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
364 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
365 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
366 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
367 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
368 http://www.ismni.orgJ.B.,Non-OADS,/arxiv_data1/oa_pdf/20/9d/JMNI-16-355.PMC5259577.pdf
370 http://www.ismni.orgR.D.,Non-OADS,/arxiv_data1/oa_pdf/b7/f1/JMNI-16-369.PMC5259578.pdf
371 http://www.ismni.orgR.D.,Non-OADS,/arxiv_data1/oa_pdf/b7/f1/JMNI-16-369.PMC5259578.pdf
372 http://www.ismni.orgR.D.,Non-OADS,/arxiv_data1/oa_pdf/b7/f1/JMNI-16-369.PMC5259578.pdf
373 http://www.ismni.orgR.D.,Non-OADS,/arxiv_data1/oa_pdf/b7/f1/JMNI-16-369.PMC5259578.pdf
374 http://www.ismni.orgR.D.,Non-OADS,/arxiv_data1/oa_pdf/b7/f1/JMNI-16-369.PMC5259578.pdf
375 http://www.ismni.orgR.D.,Non-OADS,/arxiv_data1/oa_pdf/b7/f1/JMNI-16-369.PMC5259578.pdf
376 http://www.ismni.orgR.D.,Non-OADS,/arxiv_data1/oa_pdf/b7/f1/JMNI-16-369.PMC5259578.pdf
378 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/JMNI-16-377.PMC5259579.pdf
379 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/JMNI-16-377.PMC5259579.pdf
380 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/JMNI-16-377.PMC5259579.pdf
381 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/JMNI-16-377.PMC5259579.pdf
382 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/JMNI-16-377.PMC5259579.pdf
383 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/JMNI-16-377.PMC5259579.pdf
384 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/JMNI-16-377.PMC5259579.pdf
385 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/JMNI-16-377.PMC5259579.pdf
"Footnotes ahttp://www.statisticalsolutions.net/pss_calc.php bRandom Integer Generator, v2.0; O’Reilly Institute, Trinity Col- lege, Dublin 2, Ireland cCrananadin, Nutramax Laboratories Veterinary Sciences Inc.,Lancaster, SC dSensititre, Trek Diagnostic Systems, Thermo-Fisher, Oakwood Village, OH eSAS Institute, Cary, NC.",Non-OADS,/arxiv_data1/oa_pdf/94/4f/JVIM-31-60.PMC5259620.pdf
Vet Clin North Am Small Anim Pract 2011;41:31 –62.Available at: http://www.heska.com/ Documents/RenalHealthScreen/erd_data.aspx.,Non-OADS,/arxiv_data1/oa_pdf/56/ef/JVIM-31-93.PMC5259622.pdf
Avail- able at: http://www.iris-kidney.com/guidelines/guidelines_updates_2014-2015.aspx.,Non-OADS,/arxiv_data1/oa_pdf/56/ef/JVIM-31-93.PMC5259622.pdf
"However, an internet tool (http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html) that estimates the strength of splice donor signals based on maximum entropy modeling of thenucleotide sequences that surround the canonical “ GT” motifs 12indicated that none of the 3 “ GT” motifs near the splice donor mutation reside in potential crypticsplice sites (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/f5/aa/JVIM-31-149.PMC5259623.pdf
"14Since then, at least 70 additional variant alleles in or around PPT1 have been reported in human NCL patients (http://www.ucl.ac.uk/ ncl/CLN1mutationtable.htm).",Non-OADS,/arxiv_data1/oa_pdf/f5/aa/JVIM-31-149.PMC5259623.pdf
"Indeed, a TPP1 -deﬁcient canine model for the CLN2 form of NCL has been used to develop enzyme replacement treatment 25and paved the way for ongoing human trials (https://clinicaltrials.gov/ct2/show/NCT02678689).",Non-OADS,/arxiv_data1/oa_pdf/f5/aa/JVIM-31-149.PMC5259623.pdf
Available at: http://www.thekennel- club.org.uk/download/1533/hscavalierkingcharlesspaniel.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6d/b3/JVIM-31-9.PMC5259630.pdf
Available at: http://www.thecavalier- club.co.uk/health/hearts/mvd.html.,Non-OADS,/arxiv_data1/oa_pdf/6d/b3/JVIM-31-9.PMC5259630.pdf
Available at: http://www.thecavalier- club.co.uk/health/hearts/scheme2006.html.,Non-OADS,/arxiv_data1/oa_pdf/6d/b3/JVIM-31-9.PMC5259630.pdf
"Available at: http://www.the-kennel-clu- b.org.uk/services/public/mateselect/test/Default.aspx, then individ-ual dogs.",Non-OADS,/arxiv_data1/oa_pdf/6d/b3/JVIM-31-9.PMC5259630.pdf
"In: 2013, http://www.stateofpethealth.com/state-of-pet-health.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/JVIM-31-81.PMC5259637.pdf
Avail- able at: http://www.winsteps.com/winman/principalcomponents.,Non-OADS,/arxiv_data1/oa_pdf/15/c0/JVIM-31-134.PMC5259640.pdf
Our recent study in healthy Beagle dogs revealed a good correlation (r²= 0.81) between ICG clearance and a transcutaneous method determining the ICG plasma disappearance rate (ICG-PDR in %/ min) with a near infrared spectroscopy probe placed on the tail(http://www.sciencedirect.com/science/article/pii/S10900233150046 45).,Non-OADS,/arxiv_data1/oa_pdf/cd/b2/JVIM-31-186.PMC5259643.pdf
The minimum number of horses required for the study (n =25) was calculated to estimate the dif- ference between samples with precision of 0.2 mmol/L with 95%conﬁdence assuming the standard deviation of the diﬀerences was<0.5 mmol/L (http://epitools.ausvet.com.au/content.php?page= 1Mean) a.,OADS,/arxiv_data1/oa_pdf/9a/5d/JVIM-31-51.PMC5259646.pdf
"Footnotes aGastrointestinal Laboratory at Texas A&M University (available at: http://vetmed.tamu.edu/gilab/service/assays/b12folate) bCell-Dyn 3500 Automated Hematology Analyzer, Abbott Diag-nostics, Lake Forest, IL cCobas/C210c501 Clinical Chemistry Analyzer, Roche Diagnostics, Indianapolis, IN dImmulite/C2102000, Vitamin B 12, Siemens Healthcare Diagnostics Inc., Deerﬁeld, IL eImmulite/C2102000, Folic Acid, Siemens Healthcare Diagnostics Inc., Deerﬁeld, IL fL-homocystine, Sigma Chemical Co, St. Louis, MO gDL-Homocystine-3,3,3,3,4,4,4,4-d 8, C/D/N Isotopes Inc, Pointe- Claire, QC, Canada hPoly-Prep/C210disposable chromatography column, Bio-Rad, Her- cules, CA iAG/C2101-MP ion exchange resin, Bio-Rad, Hercules, CA jAgilent model 7890A gas chromatograph, Agilent Technologies,Santa Clara, CAkAgilent 5975C Series mass-selective detector, Agilent Technolo- gies, Santa Clara, CA lDB-1 ms 100% dimethylpolysiloxane column, Agilent Technolo- gies, Santa Clara, CA mBonferroni correction for multiple statistical comparisons (http://www.quantitativeskills.com/sisa/calculations/bonfer.htm) nGraphPad Prism v6, GraphPad Software, La Jolla, CA Acknowledgments Serum samples included in the study were collected at the Gastrointestinal Laboratory at Texas A&M Univer- sity or the College of Veterinary Medicine at the OhioState University.",OADS,/arxiv_data1/oa_pdf/cd/c7/JVIM-31-109.PMC5259649.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/ae/asjsm-07-04-35411.PMC5259671.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/6e/asjsm-07-04-35205.PMC5259672.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/18/asjsm-07-04-35181.PMC5259673.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/df/asjsm-07-04-35970.PMC5259674.pdf
Available from: http://www.e-stat.go.jp/SG1/ estat/NewList.do?tid=000001011648 .,OADS,/arxiv_data1/oa_pdf/d9/df/asjsm-07-04-35970.PMC5259674.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/1a/asjsm-07-04-41301.PMC5259682.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/5f/asjsm-07-04-38318.PMC5259683.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/f0/asjsm-07-04-38458.PMC5259684.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs317/en /.,Non-OADS,/arxiv_data1/oa_pdf/11/f0/asjsm-07-04-38458.PMC5259684.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/7f/asjsm-07-04-37008.PMC5259685.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/40/S1751731116001294a.PMC5259689.pdf
"For experiment 1, color images of an emotional face (i.e., 1 female and 1 male posing as fearful, angry,  sad, or happy) were taken from the ATR Facial Expression Image Database (DB99) (ATR-Promotions, Kyoto, Japan, http://www.atr-p.com/face-db.html).",OADS,/arxiv_data1/oa_pdf/61/f8/srep41019.PMC5259783.pdf
"Expression continua were created by morphing between 2 different expres-sions for one identity of the same facial color condition in 10 equal steps using SmartMorph software (MeeSoft, http://meesoft.logicnet.dk/).",OADS,/arxiv_data1/oa_pdf/61/f8/srep41019.PMC5259783.pdf
"Color images of an emotional face were taken from the ATR Facial Expression Image Database (DB99) (ATR-Promotions, Kyoto, Japan, http://www.atr-p.com/face-db.html).",OADS,/arxiv_data1/oa_pdf/61/f8/srep41019.PMC5259783.pdf
"Color images  of an emotional face were taken from the ATR Facial Expression Image Database (DB99) (ATR-Promotions, Kyoto, Japan, http://www.atr-p.com/face-db.html).",OADS,/arxiv_data1/oa_pdf/61/f8/srep41019.PMC5259783.pdf
"Color images of an emotional face were taken from the ATR Facial Expression Image Database (DB99) (ATR-Promotions, Kyoto, Japan, http://www.atr-p.com/face-db.html).",OADS,/arxiv_data1/oa_pdf/61/f8/srep41019.PMC5259783.pdf
"Color images of an emotional face were taken from the ATR Facial Expression Image Database (DB99) (ATR-Promotions, Kyoto, Japan, http://www.atr-p.com/face-db.html).",OADS,/arxiv_data1/oa_pdf/61/f8/srep41019.PMC5259783.pdf
"Color images of an emotional face were taken from the ATR Facial Expression Image Database (DB99) (ATR-Promotions, Kyoto, Japan, http://www.atr-p.com/face-db.html).",OADS,/arxiv_data1/oa_pdf/61/f8/srep41019.PMC5259783.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2017",Non-OADS,/arxiv_data1/oa_pdf/61/f8/srep41019.PMC5259783.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/f3/srep04482.PMC5259794.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4482 | DOI: 10.1038/srep04482 8",Non-OADS,/arxiv_data1/oa_pdf/6a/f3/srep04482.PMC5259794.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0  © The Author(s) 2017OPEN",Non-OADS,/arxiv_data1/oa_pdf/6a/f3/srep04482.PMC5259794.pdf
"Alkermes announces topline results of FORWARD-3 and FORWARD-4, two phase 3 studies of ALKS 5461 in major depressive disorder.<http://www.businesswire.com/news/ home/20160121005348/en/Alkermes- Announces-Topline-Results-FORWARD-3- FORWARD-4-Phase >(2016).",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/CPT-101-179.PMC5260335.pdf
An indepth investigation into causes of prescribing errors by foundation trainees in relation to their medical education: EQUIPstudy.<http://www.gmc-uk.org/FINAL_Report_prevalence_and_ causes_of_prescribing_errors.pdf_28935150.pdf >(2009).,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/CPT-101-281.PMC5260337.pdf
<http://dro.dur.ac.uk/10561/1/10561.,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/CPT-101-281.PMC5260337.pdf
21. WHO Model List of Essential Medicines 18thlist.<http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/CPT-101-281.PMC5260337.pdf
<http://apps.who.int/iris/bitstream/10665/37896/1/ 9241544821.pdf >(1996).,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/CPT-101-281.PMC5260337.pdf
"Dogs were randomized to treatment with either daily PO cbl tablets during the whole study period (cyanocobalamin (Behe- pan) 1 mg/tablet; dogs up to 10 kg received ¼tablet, dogs 10 to 20 kg ½tablet and dogs ≥20 kg 1 tablet/day) or PE cbl according to a protocol currently suggested by a diagnostic laboratory (http://vetmed.tamu.edu/gilab/research/cobalamin-information#- dosing).",Non-OADS,/arxiv_data1/oa_pdf/2e/fb/JVIM-30-1407.PMC5260423.pdf
"The pa- tient was placed in the dorsal lithotomy and Tren- delenberg position.Peritoneal access was obtained using the open Has- son technique with placement of the 12-mm camera V I D E O A B S T R A C T VIDEOSURGERY Cystoscopic light assisted mucosa sparing laparoscopic  urachal cyst excision Pawan Vasudeva, Gaurav Kumar, Harbinder Singh, Niraj Kumar, Mikir Patel Department of Urology, VMMC & Safdarjung Hospital, New Delhi, India  Key	Words:	urachal	cyst	‹›	laparoscopy	‹›	cystoscopyVideo	can	be	found	at:	http://ceju.online/journal/video.php?inp=855 Article	history Submitted: May 15, 2016 Accepted: Aug. 29, 2016Published online: Sept. 12, 2016Citation:	Vasudeva P , Kumar G, Singh H, Kumar N, Patel M. Cystoscopic light assisted mucosa sparing laparoscopic urachal cyst excision.",Non-OADS,/arxiv_data1/oa_pdf/4f/71/CEJU-69-00855.PMC5260450.pdf
http://www.auanet.org/education/ guidelines/benign-prostatic-hyperplasia.,Non-OADS,/arxiv_data1/oa_pdf/53/b6/CEJU-69-00879.PMC5260456.pdf
Available from: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS-Guidelines-2015-v2.pdf Accessed 03-Feb-2016 4.,Non-OADS,/arxiv_data1/oa_pdf/53/b6/CEJU-69-00879.PMC5260456.pdf
Available from: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Sexual-Dysfunction-2015-v2.pdf  6.,Non-OADS,/arxiv_data1/oa_pdf/53/b6/CEJU-69-00879.PMC5260456.pdf
http://www.asahq.org/~/media/sites/asahq/files/public/resources/standards-guidelines/asa-physical-status-classification-system.pdf.,OADS,/arxiv_data1/oa_pdf/95/4d/CEJU-69-00880.PMC5260457.pdf
European Association of Urology; 2014; Available from: http://uroweb.org/guideline/penile-cancer/ 9.,Non-OADS,/arxiv_data1/oa_pdf/4b/ce/CEJU-69-00890.PMC5260461.pdf
"Available online at: https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/  Corresponding author Stefan Buntrock, M.D.",Non-OADS,/arxiv_data1/oa_pdf/c9/54/CEJU-69-00939.PMC5260466.pdf
Available online   at: https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/ 3.,Non-OADS,/arxiv_data1/oa_pdf/5f/9c/CEJU-69-00944.PMC5260468.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Mitochondrial dysfunction in Fbox7 de ﬁciency M Delgado-Camprubi et al 131 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/6c/fa/cdd2016104a.PMC5260490.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Role of pro-survival proteins in human B cells V Peperzak et al 119 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/da/74/cdd2016105a.PMC5260491.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017Tp53 ArgPro SNP dictates vascularization after ICH C Rodríguez et al 154 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/01/de/cdd2016109a.PMC5260494.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017Regeneration and cancer M Charni et al 14 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/7c/1e/cdd2016117a.PMC5260496.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)RIP1 ubiquitination regulates necroptotic death M Cristina de Almagro et al 37 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/65/e7/cdd201678a.PMC5260504.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)CDK1-PDK1-Akt signaling in pluripotency of hESCs XQ Wang et al 48 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/e4/00/cdd201684a.PMC5260505.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)LH preserves ovarian reserve oocytes from cisplatin V Rossi et al 82 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/6b/82/cdd201697a.PMC5260508.pdf
"   Case Rep Dermatol 2016;8:369 –373  DOI: 10.1159/000455021   Published online: December 22, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a7/ec/cde-0008-0369.PMC5260511.pdf
"   Case Rep Gastroenterol 2016;10:800 –807  DOI: 10.1159/000454709   Published online: January 6, 2017  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This articl e is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c0/b5/crg-0010-0800.PMC5260512.pdf
"   Case Rep Neurol 2016;8:276 –281  DOI: 10.1159/000455022   Published online: January 3, 2017  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d9/5a/crn-0008-0276.PMC5260529.pdf
"   Case Rep Ophthalmol 2016;7:315 –324  DOI: 10.1159/000453606   Published online: December 28, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services /OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d6/52/cop-0007-0315.PMC5260530.pdf
"   Case Rep Ophthalmol 2016;7:308 –314  DOI: 10.1159/000452858   Published online: December 28, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccess License).",Non-OADS,/arxiv_data1/oa_pdf/46/8b/cop-0007-0308.PMC5260531.pdf
"   Case Rep Oncol 2016;9:854 –860  DOI: 10.1159/000453255   Published online: December 14, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licens ed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f4/dc/cro-0009-0854.PMC5260532.pdf
"   Case Rep Gastroenterol 2016;10:814 –818  DOI: 10.1159/000454674   Published online: January 6, 2017  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/25/4a/crg-0010-0814.PMC5260533.pdf
"© 2016 The Author(s) Published by S. Karger AG, BaselPublished online: De cember 22, 2016EX TR A Kazushi Suzuki, MD, PhD Center for Epidemiology and Preventive Medicine, the University of Tokyo Hospital 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 (Japan)E-Mail kazusuzuki-tky  @  umin.ac.jpwww.karger.com/dee This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/fa/ac/dee-0006-0580.PMC5260534.pdf
"   Case Rep Neurol 2016;8:264 –271  DOI: 10.1159/000454854   Published online: January 3, 2017  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative  Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/82/d8/crn-0008-0264.PMC5260535.pdf
"   Case Rep Gastroenterol 2016;10:775 –780  DOI: 10.1159/000448879   Published online: December 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e2/d3/crg-0010-0775.PMC5260539.pdf
"   Case Rep Gastroenterol 2016;10:781 –786  DOI: 10.1159/000453657   Published online: December 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/9f/b6/crg-0010-0781.PMC5260597.pdf
Available from:  http://www.ncbi.nlm.nih.gov/books/NBK7619/.,Non-OADS,/arxiv_data1/oa_pdf/9f/b6/crg-0010-0781.PMC5260597.pdf
New York Med J 2007. http://newyorkmedicaljournal.org/articles/atypical -presentation -of- legionnaires -disease/.,Non-OADS,/arxiv_data1/oa_pdf/9f/b6/crg-0010-0781.PMC5260597.pdf
"   Case Rep Gastroenterol 2016;10:819 –825  DOI: 10.1159/000453656   Published online: January 6, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ef/1b/crg-0010-0819.PMC5260598.pdf
"   Case Rep Gastroenterol 2016;10:787 –792  DOI: 10.1159/000453658   Published online: January 5, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  Internationa l License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/crg-0010-0787.PMC5260601.pdf
"   Case Rep Neurol 2016;8:258 –263  DOI: 10.1159/000452942   Published online: December 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is license d under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/7a/c7/crn-0008-0258.PMC5260602.pdf
"   Case Rep Gastroenterol 2016;10:808 –813  DOI: 10.1159/000454984   Published online: January 6, 2017  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed un der the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1f/17/crg-0010-0808.PMC5260603.pdf
"   Case Rep Oncol 2016;9:861 –868  DOI: 10.1159/000453660   Published online: December 14, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ac/ee/cro-0009-0861.PMC5260605.pdf
"   Case Rep Gastroenterol 2016;10:793 –799  DOI: 10.1159/000454708   Published online: January 6, 2017  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f0/c9/crg-0010-0793.PMC5260606.pdf
2015.  http://www.cancer.org/cancer/gastrointestinalcarcinoidtumor/detailedguide/gastrointestinal - carcinoid -tumors -key-statistics.,Non-OADS,/arxiv_data1/oa_pdf/f0/c9/crg-0010-0793.PMC5260606.pdf
"   Case Rep Oncol 2016;9:869 –873  DOI: 10.1159/000454760   Published online: December 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/18/36/cro-0009-0869.PMC5260607.pdf
"   Case Rep Ophthalmol 2016;7:301 –307  DOI: 10.1159/000452883   Published online: December 28, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is lice nsed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1d/1b/cop-0007-0301.PMC5260609.pdf
It was at this stage that the patient   was treated with ILUVIEN according to NICE TA301 (please see http://www.nice.org.uk/   guidance/ta301/chapter/1 -Guidance).,Non-OADS,/arxiv_data1/oa_pdf/1d/1b/cop-0007-0301.PMC5260609.pdf
"https://www.medicines.org.uk/emc/medicine/27636  (accessed June 22, 2016).",Non-OADS,/arxiv_data1/oa_pdf/1d/1b/cop-0007-0301.PMC5260609.pdf
"Chan, PhD Applied Cognitive Neuroscience Laboratory, Department of Rehabilitation Sciences The Hong Kong Polytechnic University, Hung Hom Kowloon, Hong Kong, SAR (China)E-Mail samcc.chan  @  polyu.edu.hkwww.karger.com/dee This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f8/90/dee-0006-0568.PMC5260610.pdf
A detailed histology protocol can be found at http://www.empress.har.mrc.ac.uk.,Non-OADS,/arxiv_data1/oa_pdf/d8/c9/EOS-125-8.PMC5260799.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/70/d2/aps201691a.PMC5260834.pdf
See http://creativecommons.org/licenses/by-nc/2.0/de/ Correspondence to: Riina Peltonen.,Non-OADS,/arxiv_data1/oa_pdf/f7/26/nihms843745.PMC5260839.pdf
"[and earlier publications  during 1987–2013] https://www.thl.fi/fi/web/thlfi-en/research-and-expertwork/population-studies/ health-behaviour-and-health-among-the-finnish-adult-population-avtk Helmert U, Shea S. Family status and self-reported health in West Germany.",Non-OADS,/arxiv_data1/oa_pdf/f7/26/nihms843745.PMC5260839.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/33/rjw194.PMC5260848.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/a9/rjx002.PMC5260851.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/rjx001.PMC5260854.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/81/btt-11-001.PMC5260940.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e6/81/btt-11-001.PMC5260940.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Biologics: Targets and Therapy 2017:11 1–3Biologics: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  1 EDITORIAL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S126684Book review: Safety of Biologics Therapy Tadeusz Robak Department of Hematology, Medical  University of Lodz and Copernicus Memorial Hospital, Lodz, Poland Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins,  Hormones, Enzymes, Coagulation Proteins, V accines, Botulinum Toxins  (Cham,   Switzerland: Springer International Publishing; 2016) by Brian A Baldo from the  Molecular Immunology Unit, Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, and the Department of Medicine, University of Sydney, Australia, is a book that belongs on the shelf of everyone in the field of biologic therapies research and clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/e6/81/btt-11-001.PMC5260940.pdf
"The first chapter reviews adverse reactions to the drugs and provides definitions and a classification of such adverse reactions, including those that may be associated with  Correspondence: Tadeusz Robak Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Ciolkowskiego 2 St, 94-127 Lodz, Poland Email robaktad@csk.umed.lodz.pl Journal name: Biologics: Targets and Therapy Article Designation: EDITORIALY ear: 2017V olume: 11Running head verso: RobakRunning head recto: Book review: Safety of Biologics TherapyDOI: http://dx.doi.org/10.2147/BTT.S126684",Non-OADS,/arxiv_data1/oa_pdf/e6/81/btt-11-001.PMC5260940.pdf
"Biologics: Targets and Therapy 2017:11submit your manuscript | www.dovepress.com Dovepress Dovepress Biologics: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/biologics-targets-and-therapy-journalBiologics: Targets and Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica-tion of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/e6/81/btt-11-001.PMC5260940.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 3 Book review: Safety of Biologics Therapyins by Brian A. Baldo is an informative and easily readable  book.,Non-OADS,/arxiv_data1/oa_pdf/e6/81/btt-11-001.PMC5260940.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b2/80/amep-8-085.PMC5260941.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b2/80/amep-8-085.PMC5260941.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 85–88Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 85 SHORT REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S124648 Cadaver-based abscess model for  medical training Michael Stanley Ellis1 Joseph T Nelson2 Jeffrey Zane Kartchner1 Karl Andrew Y ousef1 William J Adamas-Rappaport3 Richard Amini4 1College of Medicine, The University  of Arizona, T ucson, AZ, USA;   2Department of Orthopedic Surgery,   The University of Michigan, Ann Arbor,   MI, USA; 3Department of Surgery,   4Department of Emergency Medicine,   The University of Arizona, T ucson,  AZ, USAAbstract: Ultrasound imaging is a rapid and noninvasive tool ideal for the imaging of soft tissue  infections and is associated with a change of clinician management plans in 50% of cases.",Non-OADS,/arxiv_data1/oa_pdf/b2/80/amep-8-085.PMC5260941.pdf
"9,10 In  addition to a fresh cadaver, the following materials are needed to prepare this training model: a latex balloon, ultrasound gel, normal saline, a number 11 or 15 blade, and an 18-guage needle with 10 cc syringe.Correspondence: Richard Amini Department of Emergency Medicine, The University of Arizona, PO Box 245057, Tucson, AZ 85724-5057, USATel +1 520 626 9604Fax +1 520 626 2480Email richardamini@gmail.comJournal name: Advances in Medical Education and Practice Article Designation: SHORT REPORTY ear: 2017V olume: 8Running head verso: Ellis et alRunning head recto: Cadaver-based abscess model for medical trainingDOI: http://dx.doi.org/10.2147/AMEP .S124648",Non-OADS,/arxiv_data1/oa_pdf/b2/80/amep-8-085.PMC5260941.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/b2/80/amep-8-085.PMC5260941.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 88 Ellis et al abscess.,Non-OADS,/arxiv_data1/oa_pdf/b2/80/amep-8-085.PMC5260941.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/52/dc/amep-8-079.PMC5260942.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/52/dc/amep-8-079.PMC5260942.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 79–84Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 79 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S124851 Contextualizing the relevance of basic sciences:  small-group simulation with debrief for first-  and second-year medical students in an   integrated curriculum Samara B Ginzburg1  Judith Brenner1  Michael Cassara2  Thomas Kwiatkowski1  Joanne M Willey1 1Department of Science Education,   Hofstra Northwell School of  Medicine, Hempstead, 2Department  of Emergency Medicine, Northwell Health, Great Neck, NY, USAAim: There has been a call for increased integration of basic and clinical sciences during   preclinical years of undergraduate medical education.",Non-OADS,/arxiv_data1/oa_pdf/52/dc/amep-8-079.PMC5260942.pdf
"3,5 Among the variety of pedagogies that have been adopted to  address this need,1 little attention has been paid to simulation in the preclinical years,  despite the fact that simulation has been proposed to promote “translational scientific Correspondence: Samara B Ginzburg   Department of Science Education,  Hofstra Northwell School of Medicine, 500 Hofstra University, Hempstead, NY 11549, USA Tel +1 516 463 7501   Fax +1 516 463 5631   Email Samara.Ginzburg@hofstra.eduJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Ginzburg et alRunning head recto: Simulation in an integrated curriculumDOI: http://dx.doi.org/10.2147/AMEP .S124851",Non-OADS,/arxiv_data1/oa_pdf/52/dc/amep-8-079.PMC5260942.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/52/dc/amep-8-079.PMC5260942.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 84 Ginzburg et al  8.,Non-OADS,/arxiv_data1/oa_pdf/52/dc/amep-8-079.PMC5260942.pdf
Available from: https://www.aamc.org/download/259760/data.,OADS,/arxiv_data1/oa_pdf/52/dc/amep-8-079.PMC5260942.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/dc/44/amep-8-089.PMC5260943.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/dc/44/amep-8-089.PMC5260943.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 89–97Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 89 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S123410 Is there a way for clinical teachers to assist  struggling learners?",Non-OADS,/arxiv_data1/oa_pdf/dc/44/amep-8-089.PMC5260943.pdf
"4 As a result, the supervision of struggling learners has been associated with  reactions from clinical teachers ranging from helplessness to frustration and avoid-ance, 2,5 as clinical teachers often perceive that they are ill equipped to supervise  these learners efficiently.6Correspondence: Elisabeth Boileau Department of Family and Emergency Medicine, Université de Sherbrooke, 3001 12e Avenue N, Sherbrooke, Qc J1H 5H3, CanadaTel +1 819 821 8000 ext 74274Email elisabeth.boileau@usherbrooke.caJournal name: Advances in Medical Education and Practice Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: Boileau et alRunning head recto: Assisting struggling learnersDOI: http://dx.doi.org/10.2147/AMEP .S123410",Non-OADS,/arxiv_data1/oa_pdf/dc/44/amep-8-089.PMC5260943.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/dc/44/amep-8-089.PMC5260943.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 97 Assisting struggling learners  49.,Non-OADS,/arxiv_data1/oa_pdf/dc/44/amep-8-089.PMC5260943.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f1/94/ceor-9-075.PMC5261548.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f1/94/ceor-9-075.PMC5261548.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 75ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/f1/94/ceor-9-075.PMC5261548.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 75 CORRIGENDUM open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S118835Potential resource and cost saving analysis of subcutaneous versus  intravenous administration for rituximab in non-Hodgkin’s lymphoma  and for trastuzumab in breast cancer in 17 Italian hospitals based on a  systematic survey [Corrigendum] Ponzetti C, Canciani M, Farina M, Era S, Walzer S. Clinico- Economics and Outcomes Research.",Non-OADS,/arxiv_data1/oa_pdf/f1/94/ceor-9-075.PMC5261548.pdf
"On page 232, Table 5, second column: The public price (hospi- tal price) for subcutaneous administration should be: €2.89/mg.Journal name: ClinicoEconomics and Outcomes Research Article Designation: CORRIGENDUMY ear: 2017V olume: 9Running head verso: Ponzetti et alRunning head recto: Short TitleDOI: http://dx.doi.org/10.2147/CEOR.S118835",Non-OADS,/arxiv_data1/oa_pdf/f1/94/ceor-9-075.PMC5261548.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d5/b0/clep-9-019.PMC5261549.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d5/b0/clep-9-019.PMC5261549.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 19–30Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 19 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S124054 Assessment of channeling bias among initiators of  glucose-lowering drugs: A UK cohort study Mikkel Z Ankarfeldt1,2 Brian L Thorsted1 Rolf HH Groenwold2,3 Erpur Adalsteinsson1 M Sanni Ali2–4 Olaf H Klungel2,3 1Novo Nordisk A/S, Bagsvaerd,   Denmark; 2Julius Center for  Health Sciences and Primary Care,   University Medical Center Utrecht,  Utrecht, the Netherlands;  3Division  of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences,  University of Utrecht, Utrecht, the Netherlands;  4Nuffield Department  of Orthopaedics, Rheumatology,  Musculoskeletal Sciences, University of Oxford, Oxford, UKBackground: Channeling bias may occur when a newly marketed drug and an established drug,  despite similar indications, are prescribed to patients with different prognostic characteristics  (ie, confounding).",Non-OADS,/arxiv_data1/oa_pdf/d5/b0/clep-9-019.PMC5261549.pdf
"Correspondence: Mikkel Z Ankarfeldt Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Department 056, Kettegård Allé 30,   2650 Hvidovre, DenmarkTel +45 3862 3350Email mikkelza@gmail.com Journal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Ankarfeldt et alRunning head recto: Channeling bias and glucose-lowering drugsDOI: http://dx.doi.org/10.2147/CLEP .S124054",Non-OADS,/arxiv_data1/oa_pdf/d5/b0/clep-9-019.PMC5261549.pdf
Access to CPRD data was gained through approval of protocol by the ISAC (https://www.cprd.com/isac/).,OADS,/arxiv_data1/oa_pdf/d5/b0/clep-9-019.PMC5261549.pdf
Available from: https://www.cprd.com.,Non-OADS,/arxiv_data1/oa_pdf/d5/b0/clep-9-019.PMC5261549.pdf
Available from: https://pathways.nice.org.uk/pathways/type-2-diabetes-in-adults#path= view%3A/pathways/type- 2-diabetes-in-adults/managing-blood-glucose-in-adults-with-type-2-di-abetes.xml&content= view-node%3Anodes-insulin-based-treatments/.,Non-OADS,/arxiv_data1/oa_pdf/d5/b0/clep-9-019.PMC5261549.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/d5/b0/clep-9-019.PMC5261549.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/70/de/copd-12-313.PMC5261550.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 313–322International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  313OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12138 9 seasonality, risk factors and burden of  community-acquired pneumonia in COPD  patients: a population database study using  linked health care records nicholas P Williams1,2 ngaire a Coombs3 Matthew J Johnson4 lynn K Josephs3,4 lucy a rigge2,4 Karl J staples2 Mike Thomas1,3,4 T om M a Wilkinson1,2,4 1southampton nIhr respiratory  Biomedical research Unit,   southampton general hospital,   2Clinical and experimental sciences,   Faculty of Medicine, University  of southampton, southampton  general hospital, 3Primary Care  and Population sciences, Faculty  of Medicine, southampton general  hospital, 4nIhr ClahrC Wessex,   Faculty of health sciences, University  of southampton, southampton  general hospital, southampton, UKBackground:  Community-acquired pneumonia (CAP) is more common in patients with COPD  than in the adult general population, with studies of hospitalized CAP patients consistently  reporting COPD as a frequent comorbidity.",Non-OADS,/arxiv_data1/oa_pdf/70/de/copd-12-313.PMC5261550.pdf
"Keywords:  COPD exacerbations, exacerbation frequency, community-acquired pneumonia,  comorbidity Introduction Community-acquired pneumonia (CAP) is a major cause of morbidity, mortality and  health care burden globally.1,2 Certain population groups are more susceptible, particularly  the elderly and those with chronic conditions such as COPD.3,4 The prevalence of COPD  increases with age and is estimated to affect ~210 million people globally, and therefore  this population contributes significantly to the overall disease burden of CAP.5,6Correspondence: nicholas P Williams Clinical and experimental sciences,  Faculty of Medicine, sir henry  Wellcome laboratories, University of  southampton, southampton general  hospital, Mailpoint 810, Tremona road,  southampton sO16 6YD, UK Tel +44 23 8120 4479 email npwilliams@doctors.org.u k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Williams et al Running head recto: Seasonality, risk factors and burden of CAP in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S121389",Non-OADS,/arxiv_data1/oa_pdf/70/de/copd-12-313.PMC5261550.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/70/de/copd-12-313.PMC5261550.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/de/copd-12-313.PMC5261550.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/44/copd-12-331.PMC5261551.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 331–337International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  331OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12020 7 Prevalence of swallowing dysfunction screened in  swedish cohort of COPD patients Margareta gonzalez lindh1,2 Monica Blom Johansson1 Margareta Jennische1 hirsh Koyi2,3 1Department of neuroscience, speech  and language Pathology, Uppsala  University, Uppsala, sweden; 2Centre  for research and Development  (CFUg), Uppsala University, County  Council of gävleborg, gävle, sweden;   3Department of respiratory Medicine,   gävle hospital, gävle, swedenBackground:  COPD is a common problem associated with morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/77/44/copd-12-331.PMC5261551.pdf
"The etiology of a COPD exacerbation is unclear in one-third of the cases.4 Swallowing and breathing are two complex processes that require a closely  coordinated interaction of shared anatomical structures and physiological function.6  A normal swallow usually occurs in the beginning or middle of an exhalation when Correspondence: Margareta gonzalez  lindh Department of neuroscience, speech and  language Pathology, Uppsala University,  Box 593, 75124 Uppsala, sweden Tel +46 26 155 195 email margareta.gonzalez.lind@ regiongavleborg.s e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Gonzalez Lindh et al Running head recto: Prevalence of swallowing dysfunction in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S120207",Non-OADS,/arxiv_data1/oa_pdf/77/44/copd-12-331.PMC5261551.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/77/44/copd-12-331.PMC5261551.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/44/copd-12-331.PMC5261551.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/dddt-11-241.PMC5261554.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 241–251Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  241Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12467 0 effect of roll compaction on granule size  distribution of microcrystalline cellulose–mannitol  mixtures: computational intelligence modeling and  parametric analysis Pezhman Kazemi1 Mohammad hassan Khalid1 ana Pérez gago2 Peter Kleinebudde2 renata Jachowicz1 Jakub Szlęk1 aleksander Mendyk1 1Department of Pharmaceutical  T echnology and Biopharmaceutics,   Faculty of Pharmacy, Jagiellonian  University Medical college,   Krakow, Poland; 2institute of  Pharmaceutics and Biopharmaceutics,   heinrich-heine-University,   Düsseldorf, germanyAbstract:  Dry granulation using roll compaction is a typical unit operation for producing solid  dosage forms in the pharmaceutical industry.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/dddt-11-241.PMC5261554.pdf
"The ribbon properties are the result of multivariate interactions between  various process parameters, configuration and conditions of roll compaction process correspondence: Pezhman Kazemi Department of Pharmaceutical  Technology and Biopharmaceutics,  Faculty of Pharmacy, Jagiellonian  University Medical college, Medyczna 9,  Krakow 30-688, Poland Tel +48 12 620 5604 email pezhman.kazemi@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Kazemi et al Running head recto: MCC–mannitol mixtures: roll compaction effect on GSD DOI: http://dx.doi.org/10.2147/DDDT.S124670",OADS,/arxiv_data1/oa_pdf/ad/7b/dddt-11-241.PMC5261554.pdf
Available from: http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/ad/7b/dddt-11-241.PMC5261554.pdf
"Available from: http://cran.r-project.org/ web/packages/monmlp/index.htm l. Accessed August 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/dddt-11-241.PMC5261554.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/dddt-11-241.PMC5261554.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7b/dddt-11-241.PMC5261554.pdf
"Available from: https://cran.r-project.org/web/packages/ caret/index.htm l. Accessed August 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/dddt-11-241.PMC5261554.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/77/copd-12-323.PMC5261555.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 323–329International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  323OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11608 6 The role of tuberculosis in COPD halil Ibrahim Yakar1 hakan gunen2 erkan Pehlivan3 selma aydogan2 1Department of Pulmonology,   Faculty of Medicine, Istanbul  Medeniyet University, 2Department of  Pulmonology, sureyyapasa Training and  research Center for Chest Disease  and Thoracic surgery, Istanbul,   3Department of Public health, Faculty  of Medicine, Inonu University, Malatya,   T urkeyBackground:  Influence of tuberculosis (TB) on the natural course of COPD has not been well  known.",Non-OADS,/arxiv_data1/oa_pdf/04/77/copd-12-323.PMC5261555.pdf
"Similarly, airway obstruction was seen to be 4.1 times and 2.3 times  more common among men and women with a history of TB, respectively.1 A study  in South Africa revealed that airway obstruction was more common in those with  TB history, while the decline of forced expiratory volume in 1 second (FEV1) was  accelerated in recurrent TB cases.2 A study in Colombia showed that the association  between TB and airway obstruction was stronger than that observed between cigarette  smoking and airway obstruction.3Correspondence: halil Ibrahim Yakar Department of Pulmonology, Faculty of  Medicine, Istanbul Medeniyet University,  34722 Kadıköy Istanbul, Turkey Tel +90 216 566 40 00 Fax +90 216 566 66 14 email halil_yakar@hotmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Y akar et al Running head recto: TB in COPD DOI: http://dx.doi.org/10.2147/COPD.S116086",Non-OADS,/arxiv_data1/oa_pdf/04/77/copd-12-323.PMC5261555.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/04/77/copd-12-323.PMC5261555.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/77/copd-12-323.PMC5261555.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/01/ijn-12-645.PMC5261556.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 645–658International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  645OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12415 8 Paclitaxel-loaded hyaluronan solid nanoemulsions  for enhanced treatment efficacy in ovarian cancer Joo-eun Kim Y oung-Joon Park college of Pharmacy, ajou University,   suwon city, republic of KoreaAbstract:  Paclitaxel-loaded hyaluronan solid nanoemulsions (PTX-HSNs) were successfully  fabricated for the delivery of PTX to improve ovarian cancer treatment via active tumor targeting.",Non-OADS,/arxiv_data1/oa_pdf/b9/01/ijn-12-645.PMC5261556.pdf
"206, World cup-ro, Yeongtong-gu,  suwon-si, gyeonggi-do 16499,  republic of Korea Tel +82 31 219 3493 Fax +82 31 219 3432 email parkyj64@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Kim and Park Running head recto: Paclitaxel-loaded hyaluronan solid nanoemulsion for ovarian cancer efficacy DOI: http://dx.doi.org/10.2147/IJN.S124158",Non-OADS,/arxiv_data1/oa_pdf/b9/01/ijn-12-645.PMC5261556.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b9/01/ijn-12-645.PMC5261556.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/01/ijn-12-645.PMC5261556.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 367–381International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  367OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11990 8 Comparative efficacy of long-acting β2-agonists as  monotherapy for chronic obstructive pulmonary  disease: a network meta-analysis James F Donohue1 Keith a Betts2 Ella Xiaoyan Du2 Pablo Altman3 Pankaj Goyal4 Dorothy L Keininger4 Jean-Bernard Gruenberger4 James E Signorovitch5 1Department of Pulmonary Diseases  and Critical Care Medicine, The  University of North Carolina, Chapel  hill, nC, 2Analysis Group, Inc., Los  Angeles, CA, 3novartis Pharmaceutical  Corporation, east hanover, nJ,   Usa; 4novartis Pharma ag, Basel,   switzerland; 5Analysis Group, Inc.,   Boston, M a, UsaPurpose:  Long-acting β2-agonists (LABAs) have demonstrated efficacy in patients with COPD  in clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
"Keywords:  COPD, long-acting β2-agonists, network meta-analysis, systematic literature  review, indacaterol Introduction COPD is a chronic, progressive disease of the lung characterized by poor airflow,  shortness of breath, and cough, and leads to long-term decline in lung function.1  Approximately 5% of the world population ( ~329 million people) are affected by  COPD,2 which is correlated with tobacco use,3 older age,4 pollution,5,6 and genetics.1,7,8  This disease is a major cause of morbidity and mortality, and was responsible for 3  million deaths globally as estimated by the World Health Organization in 2012.1,6,9,10  The World Health Organization also estimates that over one-third of premature deaths  attributable to COPD in low- and middle-income countries are due to indoor exposure  to smoke.11 In addition, COPD patients may experience frequent exacerbations, respi - ratory infections, and COPD-related hospitalizations that contribute to a substantial Correspondence: James F Donohue Division of Pulmonary Medicine,  University of North Carolina,  420 Burnett-Womack Building CB-7020,  Chapel Hill, NC 27599-7020, USA Tel +1 919 718 9512 Fax +1 919 718 9516 email jdonohue@med.unc.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Donohue et al Running head recto: Network meta-analysis of long-acting β2-agonist monotherapies for COPD DOI: http://dx.doi.org/10.2147/COPD.S119908",Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs315/en /.,Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs292/e n/.,Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
Available from: http://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
"Available from: http://www.fda.gov/Drugs/ DrugSafety /PostmarketDrugSafetyInformationforPatientsandProvid - ers/ucm200776.ht m. Accessed September 27, 2016.",Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/1e/copd-12-367.PMC5261557.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/2d/copd-12-339.PMC5261570.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 339–349International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  339OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12505 8 Indacaterol/glycopyrronium versus salmeterol/ fluticasone in Asian patients with COPD at a  high risk of exacerbations: results from the  FlaMe study Jadwiga A Wedzicha1 Nanshan Zhong2 Masakazu Ichinose3 Michael Humphries4 Robert Fogel5 Chau Thach5 Francesco Patalano6 Donald Banerji5 1national heart and lung Institute,   Imperial College london, london, UK;   2State Key Laboratory of Respiratory  Disease, National Clinical Research  Center of respiratory Disease,   Guangzhou Institute of Respiratory  Disease, The First Affiliated Hospital  of Guangzhou Medical University,   Guangzhou, Guangdong, People’s  Republic of China; 3Department  of Respiratory Medicine, Tohoku  University Graduate School of  Medicine, sendai, Japan; 4Beijing  Novartis Pharma Co. Ltd., Shanghai,   People’s Republic of China; 5novartis  Pharmaceuticals Corporation, East  hanover, nJ, Usa; 6Novartis Pharma  ag, Basel, switzerlandBackground:  The FLAME study demonstrated that indacaterol/glycopyrronium (IND/GLY),  the fixed-dose combination of a long-acting β2-agonist (LABA, IND) and a long-acting mus - carinic antagonist (LAMA, GLY), was superior to salmeterol/fluticasone combination (SFC)  in preventing exacerbations in COPD patients with a high risk of exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/df/2d/copd-12-339.PMC5261570.pdf
"Keywords:  Asia, bronchodilator agents, chronic obstructive pulmonary disease, exacerbations,  indacaterol/glycopyrronium Introduction COPD is a progressive disease characterized by partially reversible airflow limitation  and poses a major health care and socioeconomic burden.1–4 Differences in disease  prevalence and clinical practice for COPD exist between Asian and other populations,  including higher rates of COPD-associated mortality and morbidity due to differ - ences in exposure to tobacco use, environmental pollutants, health care management  structure, and cultural differences.5,6 Patients with COPD are prone to experiencing  exacerbations, which clinically manifest as an acute worsening of symptoms that is Correspondence: Jadwiga A Wedzicha national heart and lung Institute,  Imperial College london, g05, emmanuel  Kaye Building, royal Brompton Campus,  1b Manresa Road, London SW3 6LR, UK Tel +44 20 7594 7947 email j.wedzicha@imperial.ac.u k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wedzicha et al Running head recto: Asian cohort analysis of FLAME study DOI: http://dx.doi.org/10.2147/COPD.S125058",Non-OADS,/arxiv_data1/oa_pdf/df/2d/copd-12-339.PMC5261570.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/df/2d/copd-12-339.PMC5261570.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/df/2d/copd-12-339.PMC5261570.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/2d/copd-12-339.PMC5261570.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/41/ijn-12-659.PMC5261598.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 659–670International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  659OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12452 3 effect of noncovalent interaction on the self- assembly of a designed peptide and its potential  use as a carrier for controlled bFgF release Yanfei liu ling Zhang Wei Wei Key laboratory of cell engineering of  guizhou Province, affiliated hospital  of Zunyi Medical college, Zunyi,   guizhou, People’s republic of chinaAbstract:  Peptide self-assembly is one of the promising bottom-up approaches for creating  synthetic supermolecular architectures.",Non-OADS,/arxiv_data1/oa_pdf/ec/41/ijn-12-659.PMC5261598.pdf
"Generally, these systems involve designing a peptide correspondence: Yanfei liu Key laboratory of cell engineering of  Guizhou Province, Affiliated Hospital  of Zunyi Medical college, 149 Dalian  road, huichuan, Zunyi, guizhou,  563000, People’s republic of china Tel +86 851 2860 8217 email l_yfei@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liu et al Running head recto: Peptide self-assembly as a carrier for controlled bFGF release DOI: http://dx.doi.org/10.2147/IJN.S124523",Non-OADS,/arxiv_data1/oa_pdf/ec/41/ijn-12-659.PMC5261598.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ec/41/ijn-12-659.PMC5261598.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/41/ijn-12-659.PMC5261598.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/copd-12-351.PMC5261599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 351–365International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  351OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11737 3 A randomized trial of once-daily fluticasone  furoate/vilanterol or vilanterol versus placebo to  determine effects on arterial stiffness in COPD surya P Bhatt1 Mark T Dransfield1 John r Cockcroft2 Jie Wang-Jairaj3 Dawn a Midwinter3 David B rubin4 Catherine a scott-Wilson4 Courtney Crim4 1Division of Pulmonary, allergy and  Critical Care Medicine and U aB  lung health Center, University of  alabama at Birmingham, Birmingham,   al, Usa; 2Department of Cardiology,   Wales heart research Institute,   Cardiff, 3gsK, stockley Park, Uxbridge,   UK; 4gsK, research Triangle Park,   nC, UsaIntroduction:  Chronic obstructive pulmonary disease (COPD) is associated with increased  cardiovascular morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/copd-12-351.PMC5261599.pdf
"Keywords:  aortic pulse wave velocity, chronic obstructive pulmonary disease, fluticasone  furoate, vilanterol Introduction Chronic obstructive pulmonary disease (COPD) is associated with accelerated  atherosclerosis, and the majority of mild-to-moderate COPD-related mortality is  due to cardiovascular disease (CVD).1,2 Airflow obstruction is independently associ - ated with CVD.3–7 Structural and functional elements of COPD (emphysema/airflow  obstruction) are associated with increased arterial stiffness,8–11 which is associated  with atherosclerosis and CVD.12–14 Although the mechanisms underlying these associations are not well defined,  pulmonary and systemic inflammation are potential contributors.1,15,16 Systemic  endothelial dysfunction and vascular re-modeling (including proliferation of smooth Correspondence: Courtney Crim gsK, research Triangle Park,  nC 27709-3398, Usa Tel +1 919 483 3765 Fax +1 919 483 4300 email courtney.c.crim@gsk.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bhatt et al Running head recto: Effects of fluticasone/vilanterol on arterial stiffness DOI: http://dx.doi.org/10.2147/COPD.S117373",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/copd-12-351.PMC5261599.pdf
"Available at http://www.gsk-clinical - studyregister.com/study/113108?study_ids=hzc113108#p s. Accessed  April 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/copd-12-351.PMC5261599.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/copd-12-351.PMC5261599.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/copd-12-351.PMC5261599.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 299–311International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  299OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12129 4 The view of pulmonologists on palliative care  for patients with COPD: a survey study rg Duenk1 C Verhagen1 Pnr Dekhuijzen2 KCP Vissers1 Y engels1,* Y heijdra2,* 1Department of anesthesiology, Pain  and Palliative Medicine, 2Department  of lung Diseases, radboud University  nijmegen Medical Centre, nijmegen,   the netherlands *These authors contributed equally  to this workIntroduction:  Early palliative care is not a common practice for patients with COPD.",Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
"Keywords:  proactive palliative care, pulmonologists, identification, organization, cooperation Introduction COPD is a progressive life-threatening disease and the third leading cause of death  worldwide.1 Symptoms at the end of life are as severe as or even worse than those  of patients with advanced cancer.2 Even so, compared to patients with cancer, pallia - tive care is not a common practice for patients with COPD.3 This may be due to the  fact that historically the focus of palliative care has been based on oncology.4 But,  according to the definition of the World Health Organization (WHO), palliative care is  intended for any life-threatening disease by means of early identification, assessment,  and treatment of pain and other problems, such as physical, psychosocial, and spiritual  in order to prevent and relieve suffering.5 The palliative phase, thus, comprises of a Correspondence: rg Duenk Department of anesthesiology, Pain and  Palliative Medicine, radboud University  nijmegen Medical Centre, PO Box 9101,  6500 hB nijmegen, the netherlands Tel +31 24 366 6254 Fax +31 24 361 3585 email ria.duenk@radboudumc.n l Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Duenk et al Running head recto: View of pulmonologists on palliative care in COPD DOI: http://dx.doi.org/10.2147/COPD.S121294",Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
"The abstract of this paper was presented at the European  Association for Palliative Care (EAPC) 9th World Research  Congress, 9–11 June 2016 in Dublin, Ireland as print only  abstract and published online in a special edition of Palliative  Medicine: http://pmj.sagepub.com/content/30/6/NP1.full.",Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
Available from: http://www.who.int/cancer/palliative/ definit ion/en /.,Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
"Available from: http://www.onco - line.nl/uploaded/docs/COPD/LAN% 20Richtlijn %20Palliatieve%20 Zorg%20COPD%20(Pallialine).pd f. Accessed December 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
Available from: https://www.iknl.,Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
Available from: http://www.nvmo.org/ files/SONCOS/SONCOS-normeringsrapport_feb_2015.pdf.,OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/a5/copd-12-299.PMC5261600.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/57/tcrm-13-087.PMC5261601.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 87–94Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  87ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11706 3 Comparison of outcomes between minimally  invasive transforaminal lumbar interbody fusion  and traditional posterior lumbar intervertebral  fusion in obese patients with lumbar disk prolapse Ya-Peng Wang* Ji-long an* Ya-Peng sun* Wen-Yuan Ding Y ong shen Wei Zhang Department of spinal surgery, The  Third hospital of hebei Medical  University, shijiazhuang, hebei,   People’s Republic of China *These authors contributed equally  to this workObjective:  The aim of this study was to compare the curative effect between minimally invasive  transforaminal lumbar interbody fusion (MIS-TLIF) and the posterior lumbar interbody fusion  (PLIF) in obese patients with lumbar disk prolapse.",Non-OADS,/arxiv_data1/oa_pdf/fc/57/tcrm-13-087.PMC5261601.pdf
"Notably, a number of studies3–5 have Correspondence: Wei Zhang Department of spinal surgery, The Third  hospital of hebei Medical University,  139 Ziqiang Road, shijiazhuang 050000,  hebei, People’s Republic of China Tel +86 185 3311 2826 email zwzw_zwei@163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Wang et al Running head recto: Comparison of outcomes between MIS-TLIF and PLIF in obese patients DOI: http://dx.doi.org/10.2147/TCRM.S117063",Non-OADS,/arxiv_data1/oa_pdf/fc/57/tcrm-13-087.PMC5261601.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/fc/57/tcrm-13-087.PMC5261601.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/57/tcrm-13-087.PMC5261601.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/23/tcrm-13-095.PMC5261602.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 95–100Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  95ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12578 1 effects of bariatric surgery on urinary  incontinence nurullah Bulbuller1 Mani habibi1,2 Mustafa Yuksel3 Onur Ozener1 Mehmet Tahir Oruc1 Osman Zekai Oner1 Mehmet altug Kazak1 1general surgery Department,   antalya Training and Research  hospital, antalya, 2general surgery  Department, esenler Maternity  and Child health hospital, istanbul,   3Urology Department, antalya Training  and Research hospital, antalya, T urkeyIntroduction:  Obesity is an important modifiable etiological factor associated with several  diseases.",Non-OADS,/arxiv_data1/oa_pdf/ca/23/tcrm-13-095.PMC5261602.pdf
"Correspondence: Mani habibi general surgery Department, esenler  Maternity and Child health hospital,  Havaalanı Mahallesi, Taşocag ˘ı Caddesi,  no 19, esenler, istanbul 34230, Turkey Tel +90 555 678 8927 email manihabibi@gm ail.comJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Bulbuller et al Running head recto: Bariatric surgery and urinary incontinence DOI: http://dx.doi.org/10.2147/TCRM.S125781",Non-OADS,/arxiv_data1/oa_pdf/ca/23/tcrm-13-095.PMC5261602.pdf
Available from: http://www.who.int/ mediacentre/factsh eets/fs311/en /.,Non-OADS,/arxiv_data1/oa_pdf/ca/23/tcrm-13-095.PMC5261602.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ca/23/tcrm-13-095.PMC5261602.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/23/tcrm-13-095.PMC5261602.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/28/bb/ceg-10-009.PMC5261603.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/28/bb/ceg-10-009.PMC5261603.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2017:10 9–18Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  9 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S101440Autoimmune hepatitis: current challenges and  future prospects Y oshio Aizawa   Atsushi Hokari Division of Gastroenterology and  Hepatology, Department of Internal Medicine, Jikei University Katsushika Medical Center, Katsushika-ku, T okyo,  JapanAbstract:  Autoimmune hepatitis (AIH) is a chronic progressive liver disease characterized by  high levels of aminotransferases and autoantibodies, hypergammaglobulinemia, and interface  hepatitis.",Non-OADS,/arxiv_data1/oa_pdf/28/bb/ceg-10-009.PMC5261603.pdf
"The titer of LKM is associated Correspondence: Yoshio Aizawa   Division of Gastroenterology and  Hepatology, Department of Internal Medicine, Jikei University Katsushika Medical Center, 6-41-2 Aoto, Katsushika-ku, Tokyo 125-8506, Japan   Tel +81 3 3603 2111   Fax +81 3 3753 3024   Email aichanyoshi@yahoo.co.jpJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Aizawa and HokariRunning head recto: Autoimmune hepatitisDOI: http://dx.doi.org/10.2147/CEG.S101440",Non-OADS,/arxiv_data1/oa_pdf/28/bb/ceg-10-009.PMC5261603.pdf
"Clinical and Experimental Gastroenterology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/28/bb/ceg-10-009.PMC5261603.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 18 Aizawa and Hokari  53.,Non-OADS,/arxiv_data1/oa_pdf/28/bb/ceg-10-009.PMC5261603.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2b/ea/dddt-11-253.PMC5261604.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 253–264Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  253Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9416 5 Plitidepsin: design, development, and potential  place in therapy Sara Alonso-Álvarez1  emilia Pardal2 Diego Sánchez-Nieto3  Miguel Navarro4 Maria Dolores Caballero1 Maria victoria Mateos1 Alejandro Martín1 1Hematology Department, iBSAL- CiC-USAL, Hospital Universitario  de Salamanca, Salamanca, Spain;   2Hematology Department, Hospital  virgen del Puerto, Plasencia, Spain;   3Pharmacy Department, Hospital  Universitario de Salamanca, Salamanca,   Spain; 4Oncology Department,   Hospital Universitario de Salamanca,   iBSAL, Salamanca, SpainAbstract:  Plitidepsin is a cyclic depsipeptide that was first isolated from a Mediterranean  marine tunicate ( Aplidium albicans ) and, at present, is manufactured by total synthesis and  commercialized as Aplidin®.",Non-OADS,/arxiv_data1/oa_pdf/2b/ea/dddt-11-253.PMC5261604.pdf
"The reconstituted solution contains 0.5 mg/mL of plitidepsin (Table 1) and Correspondence: Alejandro Martín;  Maria victoria Mateos Department of Hematology, University  Hospital of Salamanca, Paseo de San  vicente, 58-182, Salamanca, 37007, Spain Tel +34 923 291 100 ext 55384 Fax +34 923 294 624 email amartingar@usal.e s;   mvmateos@usal.e s Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Alonso-Álvarez et al Running head recto: Plitidepsin review DOI: http://dx.doi.org/10.2147/DDDT.S94165",Non-OADS,/arxiv_data1/oa_pdf/2b/ea/dddt-11-253.PMC5261604.pdf
"Table 3  Phase ii studies of plitidepsin as single-agent or in combination Diagnosis Schedule N (evaluable) Median survival (months) Response Single agent studies APL-B-001-0141Renal or advanced  colorectal cancerPlitidepsin 5 mg/m2 (24-h iv) d1,15 q4wk Renal cancer 19PFi =2.1; OS =7.0 Renal cancer: 2 PR, 1 SD APL-B-002-0240Medullary thyroid carcinoma Plitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk 16 TTP =5.3; PFS =5.5 11 SD APL-B-004-0242Non-small-cell lung cancer Plitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk 17 TTP/PFS =1.2; OS =4.3 3 SD APL-B-005-0244Transitional cell carcinoma  of the urotheliumPlitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk 18 TTP/PFS =1.4; OS =2.3 1 SD APL-B-007-0239Melanoma Plitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk 35 TTP/PFS =1.3; OS =3.5 2 PR, 3 SD APL-B-011-02aProstate adenocarcinoma Plitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk https://clinicaltrials.gov/ct2/show/ results/NCT0078097 5 APL-B-014-0337MM Plitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk 47 NA 2 PR, 4 MR (iwG-MRT) APL-B-020-1041Myelofibrosis (primary and  secondary)Plitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk 12 PFS =4.6 1 clinical improvement APLiPO45Liposarcoma Plitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk 14 PFS =1.6; OS =9.2 2 SD APL-B-006-0243Small-cell lung cancer Plitidepsin 3.2 mg/m2 (1-h iv) (d1,8,15 q4wk) 17 TTP/PFS =1.3; OS =4.8 1 SD APL-B-012-02aindolent NHL Plitidepsin 3.2 mg/m2 (1-h iv) (d1,8,15 q4wk) http://www.clinicaltrialsregister.eu/ ctr-search/trial/2004-002692-16/e S",Non-OADS,/arxiv_data1/oa_pdf/2b/ea/dddt-11-253.PMC5261604.pdf
"Results from  other malignancies comprised: two PRs and one SD among  19 patients with unresectable advanced renal cell carci - noma, with a 2.1-month progression-free interval (PFI)  (APL-B-001-01);41 11 SDs out of 16 patients with unresect - able advanced medullary thyroid carcinoma, with a clinical  benefit noted in only one patient (APL-B-002-02);42 three SDs  in 17 patients with locally advanced or metastatic non-small- cell lung cancer, with a TTP of 1.2 months (APL-B-004-02);43  no responses in another trial of 19 patients with small-cell  lung cancer pretreated with one line (APL-B-006-02);44 one  SD as second-line therapy for 18 patients with advanced  or metastatic transitional cell carcinoma of the urothelium  (APL-B-005-02),45 two SDs among 22 assessable patients  with advanced dedifferentiated liposarcomas, with a median APL-B-013-0238Aggressive NHL Plitidepsin 3.2 mg/m2 (1-h iv) (d1,8,15 q4wk) PTCL: 29 Other: 30PTCL: TTP/PFS =1.6; OS =10.2 Other: TTP/PFS =1.3; OS =4.5PTCL: 2 CR, 4 PR Other: no responses APL-B-015-04aAcute lymphoblastic  leukemiaPlitidepsin 3.2 mg/m2 (1-h iv) (d1,8,15 q4wk) http://www.clinicaltrials.gov/ct2/ show/NCT0078014 3 APL-B-016-0532Melanoma Plitidepsin 2.4 mg/m2 (1-h iv) (d1,8,15 q4wk) 16 TTP/PFS =1.5; OS =4.1 2 SD Combination studies APL-B-001-0141Renal or advanced  colorectal cancerPlitidepsin 7 mg/m2 (24-h iv) + L-carnitine Renal: 18 Colorectal: 18Renal: PFi =2.1; OS =7.6 Colorectal: PFi =1.7; OS =8.2Renal: 2 SD Colorectal: no responses APL-B-014-0336MM Plitidepsin 5 mg/m2 (3-h iv) d1,15 q4wk +  dexamethasone 20 mg po d1–4 q4wk18 TTP =4.2; PFS =3.8 2 PR, 2 MR (iwG-MRT) APL-B-016-0532Melanoma Plitidepsin 2.4 mg/m2 (1-h iv)  (d1,8,15 q4wk) + dacarbazine 800 mg/m2  d1 q4wk (1-h iv)28 TTP/PFS =3.3 1 CR, 5 PR, 9 SD Note:  aOngoing clinical trials or unpublished results.",Non-OADS,/arxiv_data1/oa_pdf/2b/ea/dddt-11-253.PMC5261604.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2b/ea/dddt-11-253.PMC5261604.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/ea/dddt-11-253.PMC5261604.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT01102426.,Non-OADS,/arxiv_data1/oa_pdf/2b/ea/dddt-11-253.PMC5261604.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/e5/cia-12-153.PMC5261605.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 153–160Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  153OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12182 3 Outcomes of renal function in elderly patients  with acute kidney injury Qinglin li1 Meng Zhao2 Jing Du1 Xiaodan Wang1,3 1Department of geriatric nephrology,   2Department of Clinical Data  repository, 3Department of health  Care, Chinese P lA general hospital,   Beijing, People’s republic of ChinaObjectives:  The aim of this study was to explore the prognostic impact of clinical factors  on the short-term outcomes of renal function (RF) in very elderly patients with acute kidney  injury (AKI).",Non-OADS,/arxiv_data1/oa_pdf/2f/e5/cia-12-153.PMC5261605.pdf
"However,  focusing on the long-term RF outcomes of geriatric AKI individuals may often be  difficult because the prognosis is significantly poor following hospital discharge, and  survivors are often left with multiple chronic conditions.3,7 Since long-term survival  rates may be reduced significantly, short-term consequences, such as mortality and  RF outcome, may be more important and practical.Correspondence: Xiaodan Wang Department of geriatric nephrology,  Chinese PlA general hospital, 28 Fuxing  road, Beijing 100853, People’s republic  of China Tel +86 10 6693 9613 Fax +86 10 6693 9575 email xdwang111@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: Recovery after AKI in elderly patients DOI: http://dx.doi.org/10.2147/CIA.S121823",Non-OADS,/arxiv_data1/oa_pdf/2f/e5/cia-12-153.PMC5261605.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2f/e5/cia-12-153.PMC5261605.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2f/e5/cia-12-153.PMC5261605.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fa/91/mder-10-011.PMC5261834.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fa/91/mder-10-011.PMC5261834.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2017:10 11–15Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 11 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S125605 Mechanical characteristics of plastic base Ports  and impact on flushing efficacy Gérard Guiffant1 Patrice Flaud1 Laurent Royon1 Espérie Burnet2 Jacques Merckx1–3 1University Paris Diderot, Biofluidic  Group, UMR CNRS, 2Pulmonary  Department and Adult Cystic Fibrosis  Centre, Cochin Hospital, 3University  T eaching Hospital, Necker-Enfants Malades, Paris, FranceBackground: Three types of totally implantable venous access devices, Ports, are currently  in use: titanium, plastic (polyoxymethylene, POM), and mixed (titanium base with a POM  shell).",Non-OADS,/arxiv_data1/oa_pdf/fa/91/mder-10-011.PMC5261834.pdf
"Given that Port access guidelines clearly state that when inserting an NCN, the Port’ s Correspondence: Gérard Guiffant University Paris Diderot, MSC, UMR CNRS 7057, 10 rue Alice, Domon et Léonie Duquet, Cedex 13, 75205 Paris, FranceFax +33 1 5727 6211Email gerard.guiffant@univ-paris-diderot.frJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Guiffant et alRunning head recto: Mechanical characteristics of plastic base PortsDOI: http://dx.doi.org/10.2147/MDER.S125605",Non-OADS,/arxiv_data1/oa_pdf/fa/91/mder-10-011.PMC5261834.pdf
"Medical Devices: Evidence and Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/fa/91/mder-10-011.PMC5261834.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/7c/opth-11-185.PMC5261835.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 185–191Clinical Ophthalmology Dovepress submit your manuscript | www.dovepress.co m Dovepress 185Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8047 5 Herpes simplex keratitis: challenges in diagnosis  and clinical management Tayaba N Azher1 Xiao-Tang Yin1 Deena Tajfirouz1 Andrew Jw Huang2 Patrick M Stuart1 1Department of Ophthalmology, Saint  Louis University, 2Department of  Ophthalmology and visual Sciences,   washington University, St Louis,   MO, USAAbstract:  Herpes simplex virus is responsible for numerous ocular diseases, the most common  of which is herpetic stromal keratitis.",Non-OADS,/arxiv_data1/oa_pdf/77/7c/opth-11-185.PMC5261835.pdf
"10 Pathophysiology HSV is a linear double-stranded DNA virus that is classified as an α-member of the  Herpesviridae family.5,11 Primary infection results after HSV spread via direct con - tact with mucous membrane of the host.5,11 In the case of ocular infections, the virus Correspondence: Patrick M Stuart Department of Ophthalmology,  Saint Louis University, 1402 South Grand Boulevard, St Louis, MO 63104-1004, USATel +1 314 977 6304 email p stuart2@slu.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Azher et al Running head recto: Challenges in herpes simplex keratitis DOI: http://dx.doi.org/10.2147/OPTH.S80475",Non-OADS,/arxiv_data1/oa_pdf/77/7c/opth-11-185.PMC5261835.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/77/7c/opth-11-185.PMC5261835.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/7c/opth-11-185.PMC5261835.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/64/8a/jpr-10-203.PMC5261837.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/64/8a/jpr-10-203.PMC5261837.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 203–209Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  203 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S123894Analysis of perioperative pain management in  vascular surgery indicates that practice does   not adhere with guidelines: a retrospective  cross-sectional study Krste Boric1 Matija Boric1,2 T eo Boric3 Livia Puljak1 1Laboratory for Pain Research,   University of Split School of Medicine,   Split, Croatia; 2Department of  Abdominal Surgery, 3Department of  Vascular Surgery, University Hospital Split, Split, CroatiaBackground: Inadequate treatment of pain related to surgery may be associated with complica- tions and prolonged recovery time and increased morbidity and mortality rates.",Non-OADS,/arxiv_data1/oa_pdf/64/8a/jpr-10-203.PMC5261837.pdf
"Therefore, appropriate pain control after surgery Correspondence: Livia Puljak Laboratory for Pain Research, University of Split School of Medicine, Soltanska 2, 21000 Split, Croatia Tel +385 21 557 807 Fax +385 21 557 811Email livia@mefst.hr Journal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Boric et alRunning head recto: Analysis of perioperative pain management in vascular surgeryDOI: http://dx.doi.org/10.2147/JPR.S123894",Non-OADS,/arxiv_data1/oa_pdf/64/8a/jpr-10-203.PMC5261837.pdf
Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress 205 Analysis of perioperative pain management in vascular surgery Raw data Raw data generated in the study are available in the open access  repository Figshare (DOI: 10.6084/m9.figshare.3510233; URL: https://figshare.com/s/790b362b29fb178c47ef).,Non-OADS,/arxiv_data1/oa_pdf/64/8a/jpr-10-203.PMC5261837.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/64/8a/jpr-10-203.PMC5261837.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 209 Analysis of perioperative pain management in vascular surgery Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/64/8a/jpr-10-203.PMC5261837.pdf
Available from: http://nursingandndnqi.weebly.com/ndnqi-indicators.html.,Non-OADS,/arxiv_data1/oa_pdf/64/8a/jpr-10-203.PMC5261837.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/81/ott-10-447.PMC5261838.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 447–452OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  447Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12661 3 apatinib as post second-line therapy in eGFr  wild-type and aLK-negative advanced lung  adenocarcinoma shen-Cun Fang1,2 Hai-Tao Zhang1 Ying-Ming Zhang1 Wei-Ping Xie2 1Department of respiratory Medicine  Center, Nanjing Chest Hospital,   2Department of respiratory and  Critical Care Medicine, The First  affiliated Hospital of Nanjing Medical  University, Nanjing, Jiangsu, People’s  republic of ChinaAbstract:  In the absence of a driver mutation, chemotherapy is the standard treatment option as  first- and second-line therapy for advanced non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/f3/81/ott-10-447.PMC5261838.pdf
"Herein,  we report three cases of advanced NSCLC with EGFR wild-type and ALK-negative  status, wherein the patients showed partial response (PR) to apatinib.Correspondence: Wei-Ping Xie Department of respiratory and Critical  Care Medicine, The First Affiliated  Hospital of Nanjing Medical University,  300, Guangzhou road, Nanjing, Jiangsu,  People’s republic of China email wpxie@njmu.edu.c n  Ying-Ming Zhang Department of respiratory Medicine  Center, Nanjing Chest Hospital,  215 Guangzhou road, Nanjing, Jiangsu,  People’s republic of China email zhang-yingming@sohu.co m Journal name: OncoTargets and Therapy Article Designation: Case Series Y ear: 2017 Volume: 10 Running head verso: Fang et al Running head recto: Apatinib in advanced lung adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S126613",Non-OADS,/arxiv_data1/oa_pdf/f3/81/ott-10-447.PMC5261838.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f3/81/ott-10-447.PMC5261838.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/81/ott-10-447.PMC5261838.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2017:10 1–6Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 1 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S121737 Management of obstetric postpartum  hemorrhage: a national service evaluation   of current practice in the UK Bassel H Al Wattar1,* Jennifer A Tamblyn2,* William Parry-Smith2,* Mathew Prior3,* Helen Van Der Nelson4,* On behalf of UK Audit and Research  trainee Collaborative in Obstetrics and Gynaecology (UKARCOG) 1Women’s Health Research Unit, Barts  and the London School of Medicine and Dentistry, Queen Mary University London, London, UK;  2Institute of  Metabolism and Systems Research (IMSR), University of Birmingham,  Birmingham, UK;  3Division of Child  Health, Obstetrics & Gynaecology,  School of Medicine, University of Nottingham, Nottingham, UK;   4Academic Centre for Women’s  Health, North Bristol NHS Trust,  Bristol, UK *UKARCOGBackground: Postpartum hemorrhage (PPH) continues to be one of the major causes of mater - nal mortality and morbidity in obstetrics.",Non-OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
"1 National guidelines have been developed to standardize care and provide  a clear evidence-based framework for clinicians and health care workers addressing Correspondence: Bassel H Al Wattar Women’s Health Research Unit, Blizard Institute, Barts and the London School of Medicine, Queen Mary University London, London E1 2DD, UKEmail b.wattar@qmul.ac.ukJournal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Al Wattar et alRunning head recto: Management of postpartum hemorrhage in the UKDOI: http://dx.doi.org/10.2147/RMHP .S121737",Non-OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
Available from: http://www.hscic.gov.uk/catalogue/PUB16725/nhs-mate-eng-2013-14-summ-repo-rep.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
"Risk Management and Healthcare Policy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 6 Al Wattar et al  6.,Non-OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
Available from: https://www.rcog.org.uk/globalassets/documents/guide-lines/gt52postpartumhaemorrhage0411.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
Available from: https://www.nice.org.uk/guidance/cg190?unlid= 105541892016715182537.,Non-OADS,/arxiv_data1/oa_pdf/3b/41/rmhp-10-001.PMC5261839.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/73/c9/jpr-10-157.PMC5261840.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/73/c9/jpr-10-157.PMC5261840.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 157–165Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  157 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S125914Increased local expressions of CX3CL1 and  CCL2 are related to clinical severity in lumbar  disk herniation patients with sciatic pain Zhen-Yu Peng1,2 Rui Chen3 Zuo-Zhong Fang2 Bin Chen2 Zhi-Hua Wang4 Xi-Yang Wang1 1Department of Spine Surgery,   Xiangya Hospital, Central South  University, Changsha, 2Department  of Spine Surgery, Chenzhou No.1 People’s Hospital, Chenzhou,   3Department of Neurosurgery,   Nanhua Hospital Affiliated to Nanhua University, Hengyang,  4Department of  Orthopedics, Chenzhou No.1 People’s Hospital, Chenzhou, Hunan, People’s Republic of ChinaBackground: Chemokines have been identified to be involved in the modulation of pain  through both peripheral and central mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/73/c9/jpr-10-157.PMC5261840.pdf
"87 Xiangya Road, Changsha, Hunan 410008, People’s Republic of ChinaTel +86 731 8432 8888Email wxyorthoxy@163.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Peng et alRunning head recto: Increased local expressions of CX3CL1 and CCL2 in LDH patientsDOI: http://dx.doi.org/10.2147/JPR.S125914",Non-OADS,/arxiv_data1/oa_pdf/73/c9/jpr-10-157.PMC5261840.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/73/c9/jpr-10-157.PMC5261840.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 165 Increased local expressions of CX3CL1 and CCL2 in LDH patients Supplementary material 160A B 140 120Serum CX3CL1 levels (pg/mL ) Serum CCL2 levels (pg/mL ) 100 80 406080100120140 SP M-MPNS NS Con SP M-MP Con Figure S1 Investigation of serum CX3CL1 (A) and CCL2 (B) among three groups.,Non-OADS,/arxiv_data1/oa_pdf/73/c9/jpr-10-157.PMC5261840.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/67/ott-10-397.PMC5261841.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 397–407OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  397Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11373 6 Primary neuroendocrine breast carcinomas:  a retrospective analysis and review of literature Xin Yang1 Y oude cao2 chen chen1 lin liu1 cheng Wang1 shengchun liu1 1Department of endocrine and Breast  surgery, The First affiliated hospital  of chongqing Medical University,   2Department of Pathology, chongqing  Medical University, chongqing,   People’s republic of chinaBackground:  Primary neuroendocrine breast carcinomas (NEBCs) are a rare type of breast  carcinomas that lack comprehensive recognition, including the clinicopathological features,  therapeutic strategies, and prognostic significance.",Non-OADS,/arxiv_data1/oa_pdf/c5/67/ott-10-397.PMC5261841.pdf
"In 2003, the World Health Organization (WHO) classification of breast tumors  explicitly defined and classified NEBC; establishing that the neuroendocrine markers  were detected by immunohistochemical staining in .50% of the tumor cell population,  is the unique requisite for the diagnosis of NEBC.8 The current 2012 WHO classification correspondence: shengchun liu Department of endocrine and Breast  Surgery, The First Affiliated Hospital of  chongqing Medical University, 1 Youyi  road, Yuanjiagang, Yuzhong District,  chongqing 400016, People’s republic  of china Tel +86 23 890 184 63 Fax +86 23 890 111 22 email liushengchun1968@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Y ang et al Running head recto: A retrospective analysis of NEBC DOI: http://dx.doi.org/10.2147/OTT.S113736",Non-OADS,/arxiv_data1/oa_pdf/c5/67/ott-10-397.PMC5261841.pdf
"This work was also supported by grants from the National  Natural Science Foundation of China (NSFC, 81272265 and  81472658, URL: http://www.nsfc.gov.cn /).",Non-OADS,/arxiv_data1/oa_pdf/c5/67/ott-10-397.PMC5261841.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c5/67/ott-10-397.PMC5261841.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/67/ott-10-397.PMC5261841.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/95/ppa-11-107.PMC5261842.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 107–119Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  107Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7804 2 Peripherally acting µ-opioid receptor antagonists  as treatment options for constipation in noncancer  pain patients on chronic opioid therapy Joseph v Pergolizzi Jr1 Robert B Raffa2,3 Marco Pappagallo4 Charles Fleischer1 Joseph Pergolizzi iii1 Gianpietro Zampogna5 elizabeth Duval1 Janan Hishmeh1 Jo Ann LeQuang1 Robert Taylor Jr1 1NeMA Research, inc., Naples, FL,   2University of Arizona College of  Pharmacy, University of Arizona,   T ucson, AZ, 3T emple University School  of Pharmacy, T emple University,   Philadelphia, PA, 4Department of  Medicine, Albert einstein College of  Medicine, New Y ork, NY, 5Department  of Medicine, St. Luke’s Hospital,   Cleveland, OH, USAAbstract:  Opioid-induced constipation (OIC), a prevalent and distressing side effect of  opioid therapy, does not reliably respond to treatment with conventional laxatives.",Non-OADS,/arxiv_data1/oa_pdf/0d/95/ppa-11-107.PMC5261842.pdf
"A new class of agents addresses OIC that does not Correspondence: Joseph v Pergolizzi Jr NeMA Research, inc., 868-106 Avenue  N, Naples, FL 34108, USA Tel +1 239 597 3564 email jpjmd@msn.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Pergolizzi Jr et al Running head recto: Laxative-refractory OIC treatments DOI: http://dx.doi.org/10.2147/PPA.S78042",Non-OADS,/arxiv_data1/oa_pdf/0d/95/ppa-11-107.PMC5261842.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/0d/95/ppa-11-107.PMC5261842.pdf
"Available from: http://www.fda.gov/Safety/MedWatch/ SafetyInformation/ucm194328.ht m. Accessed January 27, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0d/95/ppa-11-107.PMC5261842.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2d/31/ppa-11-121.PMC5261843.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 121–129Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  121OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12513 7 subcutaneous sumatriptan delivery devices:  comparative ease of use and preference among  migraineurs Anthony D Andre1 elimor Brand-schieber2 Margarita ramirez1 sagar Munjal2 rajesh Kumar2 1interface Analysis Associates,   saraftoga, cA, 2Dr reddy’s  laboratories inc., Princeton, nJ, UsABackground:  Several sumatriptan subcutaneous autoinjector devices for acute treatment  of migraine patients are available, each device differs with respect to design and features.",Non-OADS,/arxiv_data1/oa_pdf/2d/31/ppa-11-121.PMC5261843.pdf
"Keywords:  human factors, autoinjector, sumatriptan, migraine, preference Introduction Episodic migraine is a neurologic disease characterized by occasional attacks that  involve moderate-to-severe headaches and associated symptoms, such as nausea,  photophobia, and phonophobia, the combination of which often leads to functional  disability.1,2 In the USA, ~17% of women and 6% of men have migraine, with peak  prevalence occurring in both sexes between the ages of 25 and 55 years.3,4 Medications  that produce agonist effects on serotonin 5-HT1B and 5-HT1D receptors, collectively  known as “triptans”, are the most widely used prescription treatment for the acute correspondence: Anthony D Andre interface Analysis Associates, 1821  saratoga Ave, suite 200, saratoga,  cA 95070, UsA Tel +1 408 342 9052 email 800usability@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Andre et al Running head recto: Sumatriptan autoinjector preference by migraineurs DOI: http://dx.doi.org/10.2147/PPA.S125137",Non-OADS,/arxiv_data1/oa_pdf/2d/31/ppa-11-121.PMC5261843.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2d/31/ppa-11-121.PMC5261843.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/db/40/jaa-10-009.PMC5261844.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/db/40/jaa-10-009.PMC5261844.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 9–15Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 9 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S90265Para-phenylenediamine allergy: current  perspectives on diagnosis and management Krishna Sumanth  Mukkanna1 Natalie M Stone2 John R ingram3 1Dermatology Department, Abertawe  Bro Morgannwg University Health  Board, Swansea, 2Dermatology  Department, Aneurin Bevan University Health Board, Newport,  3Division  of infection and immunity, Cardiff  University, Cardiff, UKAbstract:  Para-phenylenediamine (PPD) is the commonest and most well-known component  of hair dyes.",Non-OADS,/arxiv_data1/oa_pdf/db/40/jaa-10-009.PMC5261844.pdf
"10 In India, PPD use was initially restricted to disguising Correspondence: Krishna Sumanth  MukkannaDermatology Department, Abertawe Bro Morgannwg University Health Board, Singleton Hospital, Sketty Lane, Sketty, Swansea SA2 8QA, UKTel +44 1792 205 666email ksumanth@doctors.org.uk Journal name: Journal of Asthma and Allergy Article Designation: ReviewY ear: 2017V olume: 10Running head verso: Mukkanna et alRunning head recto: Para-phenylenediamine allergyDOI: http://dx.doi.org/10.2147/JAA.S90265",Non-OADS,/arxiv_data1/oa_pdf/db/40/jaa-10-009.PMC5261844.pdf
Available from: http://www.dermnetnz.org/topics/allergy-to-paraphenylenediamine/.,Non-OADS,/arxiv_data1/oa_pdf/db/40/jaa-10-009.PMC5261844.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/db/40/jaa-10-009.PMC5261844.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2a/ce/opth-11-179.PMC5261845.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 179–184Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  179Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12133 2 Circulating monocytes and B-lymphocytes in  neovascular age-related macular degeneration sven Magnus hector1 T orben lykke sørensen1,2 1Clinical eye research Unit, Zealand  University hospital, roskilde,   2Faculty of health and Medical  sciences, University of Copenhagen,   Copenhagen, DenmarkBackground:  Individuals with neovascular age-related macular degeneration (AMD) have  altered number and distribution of retinal macrophages and show changes in circulating  antibodies.",Non-OADS,/arxiv_data1/oa_pdf/2a/ce/opth-11-179.PMC5261845.pdf
"The role of the immune system  in AMD pathogenesis is currently under investigation by several groups, and a previous  study has reported the potentially important role of monocytes in AMD pathogenesis,  even though the role of both resident macrophages and peripheral monocytes is still  not known.1 The peripheral monocyte population is functionally divided into three subtypes of  monocytes: classical monocytes (cluster of differentiation [CD]14 ++CD16 -), gener - ally considered scavenger cells; intermediate monocytes (CD14 ++CD16 +), which are Correspondence: sven Magnus hector Clinical eye research Unit, Zealand  University hospital, Køgevej 7-13, 4000  roskilde, Denmark Tel +45 46 32 3200 email sven.hector@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Hector and Sørensen Running head recto: Circulating monocytes and B-lymphocytes in neovascular AMD DOI: http://dx.doi.org/10.2147/OPTH.S121332",Non-OADS,/arxiv_data1/oa_pdf/2a/ce/opth-11-179.PMC5261845.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2a/ce/opth-11-179.PMC5261845.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/ce/opth-11-179.PMC5261845.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/57/ff/oajsm-8-001.PMC5261846.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/57/ff/oajsm-8-001.PMC5261846.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2017:8 1–8Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 1 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S120058Association between sensory function and hop  performance and self-reported outcomes in  patients with anterior cruciate ligament injury Anna Cronström1 Ewa M Roos2 Eva Ageberg1 1Department of Health Sciences, Lund  University, Lund, Sweden; 2Research  Unit for Musculoskeletal Function and  Physiotherapy, Department of Sports Science and Clinical Biomechanics,  University of Southern Denmark,  Odense, DenmarkBackground: In patients with anterior cruciate ligament (ACL) deficiency (ACLD) or  reconstruction (ACLR), sensory deficits are commonly assessed as knee kinesthesia using  time-consuming laboratory equipment.",Non-OADS,/arxiv_data1/oa_pdf/57/ff/oajsm-8-001.PMC5261846.pdf
"A clinically feasible alternative Correspondence: Anna Cronström Department of Health Sciences, Lund University, PO Box 157, SE-221 00 Lund, SwedenTel +46 70 748 8770Email anna.cronstrom@med.lu.seJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Cronström et alRunning head recto: Association between sensory function and functional performanceDOI: http://dx.doi.org/10.2147/OAJSM.S120058",Non-OADS,/arxiv_data1/oa_pdf/57/ff/oajsm-8-001.PMC5261846.pdf
"Open Access Journal of Sports Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/57/ff/oajsm-8-001.PMC5261846.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/ff/oajsm-8-001.PMC5261846.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/3a/ott-10-417.PMC5261847.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 417–428OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  417Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12720 2 Downregulation of Dcr3 sensitizes hepatocellular  carcinoma cells to Trail-induced apoptosis chaojie liang* Yingchen Xu* guangming li T uanjie Zhao Feng Xia guanqun li Dongxin Zhang Jixiang Wu Department of general surgery,   Beijing T ongren hospital, capital  Medical University, Beijing,   People’s republic of china *These authors contributed equally  to this workAbstract:  Decoy receptor 3 (DcR3) has been recently described as an antiapoptosis and  prometastasis factor since it can competitively bind to FasL, TL1A, and LIGHT, and it is  highly expressed in many malignant tumors.",Non-OADS,/arxiv_data1/oa_pdf/15/3a/ott-10-417.PMC5261847.pdf
"Development of new cancer treatments is gradually becoming a research hotspot  in recent years.2–5correspondence: Jixiang Wu;   guangming li  Department of general surgery, Beijing  Tongren hospital, capital Medical  University, no 2 chongwenmennei  street, Dongcheng, Beijing 100730,  People’s republic of china Tel +86 138 0101 5118;   +86 135 0112 2244 email trwujixiang2016@126.co m;  liguangming2016@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Liang et al Running head recto: Downregulation of DcR3 sensitizes hepatocellular carcinoma cells DOI: http://dx.doi.org/10.2147/OTT.S127202",Non-OADS,/arxiv_data1/oa_pdf/15/3a/ott-10-417.PMC5261847.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/15/3a/ott-10-417.PMC5261847.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/3a/ott-10-417.PMC5261847.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/c0/ott-10-409.PMC5261848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 409–415OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  409Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12412 4 elevated serum levels of vascular endothelial  growth factor predict a poor prognosis of  platinum-based chemotherapy in non-small cell  lung cancer Jialan Zang,1–3,* Y ong hu,1,2,*  Xiaoyue Xu,1,2 Jie ni,1,2 Dali Yan,1,2  siwen liu,4 Jieyu he,5 Jing Xue,4  Jianzhong Wu,4 Jifeng Feng2 1The Fourth clinical school of nanjing  Medical University, 2Department of  chemotherapy, nanjing Medical University  affiliated cancer hospital, nanjing,  3Department of Oncology, The First hospital  of harbin city, harbin, 4center of clinical  laboratory, nanjing Medical University  affiliated cancer hospital, 5Department of  Public health, southeast University, nanjing,  People’s republic of china *These authors contributed equally  to this workAim:  This study was designed to investigate the predictive and prognostic values of serum  vascular endothelial growth factor (VEGF) level in non-small cell lung cancer (NSCLC) patients  treated with platinum-based chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/7f/c0/ott-10-409.PMC5261848.pdf
"The median survival of advanced NSCLC patients treated with chemotherapy alone  is ~10 months.3 While selecting patients who may benefit from chemotherapeutic correspondence: Jifeng Feng Department of chemotherapy, nanjing Medical  University Affiliated Cancer Hospital, Number  42, Baiziting road, Xuanwu, nanjing, Jiangsu  210009, People’s republic of china Tel +86 25 139 0158 1264 email jifeng_feng@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zang et al Running head recto: Serum VEGF predicts a poor prognosis in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S124124 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/7f/c0/ott-10-409.PMC5261848.pdf
Or use: http://youtu.be/gc8RXzWuv1 MVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/ott-10-409.PMC5261848.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7f/c0/ott-10-409.PMC5261848.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/ott-10-409.PMC5261848.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/7b/ott-10-439.PMC5261849.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 439–446OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  439Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12578 9 inhibition of skp2 sensitizes lung cancer cells  to paclitaxel T onghai huang lin Yang guangsuo Wang guanggui Ding Bin Peng Yuxin Wen Zheng Wang Department of Thoracic surgery,   shenzhen People’s hospital, shenzhen,   guangdong Province, People’s  republic of chinaAbstract:  S-phase kinase-associated protein 2 (Skp2) is an E3 ubiquitin ligase and plays an  important role in the control of cell cycle progression.",Non-OADS,/arxiv_data1/oa_pdf/2c/7b/ott-10-439.PMC5261849.pdf
"High-level Mad2 expression in human non-small-cell lung cancer (NSCLC) corre - lates with tumor progression, and patients with tumors with elevated Mad2 expres - sion demonstrate significantly shorter survival time.8 Similarly, overexpression  of Mad2 in transgenic mice results in a wide variety of tumors.9 It was suggested  that high-level Mad2 expression might be an independent prognostic factor for  NSCLC.8 However, the mechanism by which Mad2 is deregulated in lung cancer  is largely unknown.correspondence: Tonghai huang Department of Thoracic surgery,  shenzhen People’s hospital, no 1017  east gate road, shenzhen 518020,  guangdong Province, People’s  republic of china email tonghaihuan@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Huang et al Running head recto: Regulation of MAD2 by SKP2 DOI: http://dx.doi.org/10.2147/OTT.S125789",Non-OADS,/arxiv_data1/oa_pdf/2c/7b/ott-10-439.PMC5261849.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2c/7b/ott-10-439.PMC5261849.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/7b/ott-10-439.PMC5261849.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/08/d4/rru-9-005.PMC5261850.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/08/d4/rru-9-005.PMC5261850.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2017:9 5–13Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  5 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S126134Prophylactic furosemide infusion decreasing early  major postoperative renal dysfunction in on-pump  adult cardiac surgery: a randomized clinical trial Solmaz Fakhari1 Fariba Mirzaei Bavil2 Eissa Bilehjani1  Sona Abolhasani3  Moussa Mirinazhad2  Bahman Naghipour2  1Department of Anesthesiology,   2Department of Physiology, 3Tabriz  University of Medical Sciences,   Tabriz,  IranIntroduction: Acute renal dysfunction is a common complication of cardiac surgery.",Non-OADS,/arxiv_data1/oa_pdf/08/d4/rru-9-005.PMC5261850.pdf
"RIFLE  (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) clas-sification has been employed since 2004, 7 however, owing to a number of difficulties Correspondence: Eissa Bilehjani Department of Anesthesiology, TabrizUniversity of Medical Sciences, MadaniHeart Hospital, Cardiovascular Research Center, Daneshqhah Street, Tabriz 5166615573, IranTel +98 914 116 0647Fax +98 411 337 3950Email isadavod@gmail.com Journal name: Research and Reports in Urology Article Designation: CLINICAL TRIAL REPORTY ear: 2017V olume: 9Running head verso: Fakhari et alRunning head recto: Furosemide and renal dysfunction in cardiac surgeryDOI: http://dx.doi.org/10.2147/RRU.S126134",Non-OADS,/arxiv_data1/oa_pdf/08/d4/rru-9-005.PMC5261850.pdf
"Research and Reports in Urology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/08/d4/rru-9-005.PMC5261850.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 13 Furosemide and renal dysfunction in cardiac surgery 23.,Non-OADS,/arxiv_data1/oa_pdf/08/d4/rru-9-005.PMC5261850.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/12/b8/rru-9-015.PMC5261851.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/12/b8/rru-9-015.PMC5261851.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2017:9 15–17Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  15 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S124200Upward migration of a ureteric stone in a military  trainer: a case report Moayid Fallatah1  Sakher Tahaineh2  Rawan Abu Mughli3  Seddig M Fallatah1 1College of Medicine, Umm Al-Qura  University, 2Urology Department,   3Radiology Department, Security  Forces Hospital, Makkah, Saudi ArabiaAbstract:  Retrograde ureteric stone migration is an extremely rare phenomenon with only one  previously reported case in the literature.",Non-OADS,/arxiv_data1/oa_pdf/12/b8/rru-9-015.PMC5261851.pdf
"Thereafter, treatment options  Correspondence: Moayid Fallatah   College of Medicine, Umm Al-Qura  University, Makkah 21955, Saudi Arabia   Tel +966 59 594 4422   Email Moayidomar@gmail.comJournal name: Research and Reports in Urology Article Designation: CASE REPORTY ear: 2017V olume: 9Running head verso: Fallatah et alRunning head recto: Upward migration of ureteric stone in a military trainerDOI: http://dx.doi.org/10.2147/RRU.S124200",Non-OADS,/arxiv_data1/oa_pdf/12/b8/rru-9-015.PMC5261851.pdf
"Research and Reports in Urology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/12/b8/rru-9-015.PMC5261851.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 17 Upward migration of ureteric stone in a military trainer stone to the reversed ureteral peristalsis.,Non-OADS,/arxiv_data1/oa_pdf/12/b8/rru-9-015.PMC5261851.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/97/b7/jpr-10-197.PMC5261852.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/97/b7/jpr-10-197.PMC5261852.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 197–201Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  197 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S128500Xiaozhi decoction reduced  posthemorrhoidectomy pain and analgesic  medication consumption: a prospective study Jianbin Shen1,*  Xiagang Luo2,*  Xiao Zhou3  Chengwu Tang1  Huanyu Ju2  Y ongqiang Xu1  Lianjin Qin1 1Department of General Surgery, First  People’s Hospital Affiliated to Huzhou  Normal College, Huzhou, Zhejiang,   2Department of General Surgery, The  Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu,   3Department of Orthopedics, People’s  Hospital of Zhangqiu, Jinan, Shandong,  People’s Republic of China *These authors contributed equally to  this workObjective: The aim of this study was to investigate the effect of Xiaozhi decoction (XZD) on  posthemorrhoidectomy pain and analgesic medication consumption.",Non-OADS,/arxiv_data1/oa_pdf/97/b7/jpr-10-197.PMC5261852.pdf
"7,8 However, recent studies have revealed that Correspondence: Lianjin Qin  Department of General Surgery, First People’s Hospital Affiliated to Huzhou Normal College, No 158, Guangchang Hou Road, Huzhou 313000, Zhejiang, People’s Republic of China   Tel +86 572 203 9347   Fax +86 572 202 3728   Email qin_lianjin@sina.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Shen et alRunning head recto: Xiaozhi decoction relieved posthemorrhoidectomy painDOI: http://dx.doi.org/10.2147/JPR.S128500",Non-OADS,/arxiv_data1/oa_pdf/97/b7/jpr-10-197.PMC5261852.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/97/b7/jpr-10-197.PMC5261852.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 201 Xiaozhi decoction relieved posthemorrhoidectomy pain to figure out the potential mechanisms of therapeutic effects  of XZD.,Non-OADS,/arxiv_data1/oa_pdf/97/b7/jpr-10-197.PMC5261852.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/97/1d/oaem-9-023.PMC5261853.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/97/1d/oaem-9-023.PMC5261853.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2017:9 23–26Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 23 COMMEnt Ary open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S122646 High stakes and high emotions: providing safe care  in Canadian emergency departments Samina Ali1,2 Denise thomson3 timothy A D Graham4 Sean E rickard3 Antonia S Stang5 1Women and Children’s Health  research Institute, 2Department of  Pediatrics, 3Cochrane Child Health  Field, Department of Pediatrics,   University of Alberta, Edmonton,   4Department of Emergency Medicine,   5Section of Emergency Medicine,   Department of Pediatrics, University of Calgary, Calgary, AB, CanadaBackground: The high-paced, unpredictable environment of the emergency department (ED)  contributes to errors in patient safety.",Non-OADS,/arxiv_data1/oa_pdf/97/1d/oaem-9-023.PMC5261853.pdf
"6–8 In fact, the ED has been described as a “natural laboratory for the study  of error”.9 The unpredictable nature of the ED becomes even more challenging when  dealing with the critically ill patient, particularly with children, where variations in Correspondence: Samina Ali Department of Pediatrics, Edmonton Clinic Health Academy, 11405 – 87 Avenue, Edmonton, AB t6G 1C9, Canadatel +1 780 248 5574Fax +1 888 775 8876Email sali@ualberta.ca Journal name: Open Access Emergency Medicine Article Designation: CommentaryY ear: 2017V olume: 9Running head verso: Ali et alRunning head recto: High stress and safe ED careDOI: http://dx.doi.org/10.2147/OAEM.S122646",Non-OADS,/arxiv_data1/oa_pdf/97/1d/oaem-9-023.PMC5261853.pdf
Available from: http://www.hfes.org/web/HFESMeetings/HCS2012/Resnick-ProviderSafety-poster-1.19.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/1d/oaem-9-023.PMC5261853.pdf
"Open Access Emergency Medicine 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/97/1d/oaem-9-023.PMC5261853.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 26 Ali et al,Non-OADS,/arxiv_data1/oa_pdf/97/1d/oaem-9-023.PMC5261853.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/8e/ott-10-429.PMC5261854.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 429–437OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  429Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12558 7 add-on bevacizumab can prevent early clinical  deterioration and prolong survival in newly  diagnosed partially resected glioblastoma patients  with a poor performance status nobuhiro hata1,2 Koji Y oshimoto1 ryusuke hatae1 Daisuke Kuga1 Y ojiro akagi1 Yuhei sangatsuda1 satoshi O suzuki3 Tadahisa shono1,4 Masahiro Mizoguchi1,5 Koji iihara1 1Department of n eurosurgery,   graduate school of Medical sciences,   Kyushu University, 2Department of  neurosurgery, clinical research  institute, national hospital  Organization Kyushu Medical center,   3Department of n europathology,   graduate school of Medical sciences,   Kyushu University, 4Department  of neurosurgery, harasanshin  hospital, Fukuoka, 5Department of  neurosurgery, Kitakyushu Municipal  Medical center, Kitakyushu, JapanPurpose:  The AVAglio trial established the beneficial effect of add-on bevacizumab (BEV)  for the treatment of newly diagnosed glioblastomas (nd-GBMs) that led to the approval of BEV  for the treatment of these patients in Japan.",Non-OADS,/arxiv_data1/oa_pdf/5d/8e/ott-10-429.PMC5261854.pdf
"However, no significant improvements in  overall  survival (OS) rates were reported.2 In the Japanese population of the AVAglio trial,3 correspondence: nobuhiro hata Department of neurosurgery, clinical  research institute, national Kyushu  Medical center, 1-8-1 Jigyohama,  chuo-ku, Fukuoka 810-8563, Japan Tel +81 92 852 0700  Fax +81 92 846 8485 email hatanobu@kyumed.j p Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Hata et al Running head recto: Add-on BEV for newly diagnosed pr-GBMs DOI: http://dx.doi.org/10.2147/OTT.S125587",Non-OADS,/arxiv_data1/oa_pdf/5d/8e/ott-10-429.PMC5261854.pdf
Primer sequences for  the amplification of genomic DNA were designed using  Primer3Plus1 (http://bioinformatics.nl/cgi-bin/primer3plus/ primer3plus.cgi /).,OADS,/arxiv_data1/oa_pdf/5d/8e/ott-10-429.PMC5261854.pdf
In silico polymerase chain reaction (PCR)  applications ( http://genome.ucsc.edu/cgi-bin/hgPc r) were used  to verify the theoretical specificity of the forward and reverse  primers.,OADS,/arxiv_data1/oa_pdf/5d/8e/ott-10-429.PMC5261854.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5d/8e/ott-10-429.PMC5261854.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/8e/ott-10-429.PMC5261854.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nanotechnology, Science and Applications 2017:10 23–33submit your manuscript | www.dovepress.com Dovepress 23 Nanotechnology, Science and Applications Dovepress ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSA.S113030 Synthesis, characterization, and cytocompatibility  of potential cockle shell aragonite nanocrystals  for osteoporosis therapy and hormonal delivery Alhaji Zubair Jaji1,2 Md Zuki Bin Abu Bakar1,3 Rozi Mahmud4 Mohamad Yusof Loqman5 Mohamad Noor Mohamad  Hezmee1 Tijani Isa3 Fu Wenliang3 Nahidah Ibrahim Hammadi1 1Department of Veterinary Pre- Clinical Science, Universiti Putra  Malaysia, Serdang, Selangor, Malaysia;   2Department of Veterinary Anatomy,   Faculty of Veterinary Medicine,  University of Ilorin, Ilorin, Kwara,  Nigeria;  3Molecular Biomedicine  Laboratory, Institute of Bioscience,  Universiti Putra Malaysia, Serdang,  Selangor, Malaysia;  4Department of  Imaging, Faculty of Medicine and Health Science, Universiti Putra Malaysia, Serdang, Selangor, Malaysia;   5Department of Companion Animal  Medicine and Surgery, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaAbstract: Calcium carbonate is a porous inorganic nanomaterial with huge potential in  biomedical applications and controlled drug delivery.",Non-OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
"3Correspondence: Md Zuki Bin Abu Bakar  Molecular Medicine Laboratory,Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, MalaysiaTel +60 3 89 462 102Fax +60 3 89 472 101Email zuki@upm.edu.myJournal name: Nanotechnology, Science and Applications Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Jaji et alRunning head recto: Antiosteoporotic aragonite nanocrystals for hormonal deliveryDOI: http://dx.doi.org/10.2147/NSA.S113030",Non-OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
Available from: http://pi.lilly.com/us/forteo-pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
Available from: http://www.medicinenet.com/calcium_carbonate/article.htm.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
Available from: http://www.merriam-webster.com/dictionary/calcium%20carbonate.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
"Nanotechnology, Science and Applications 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Nanotechnology, Science and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nanotechnology-science-and-applications-journalNanotechnology, Science and Applications is an international, peer-reviewed, open  access journal that focuses on the science of nanotechnology in a wide range of industrial and academic applications.",Non-OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 33 Antiosteoporotic aragonite nanocrystals for hormonal delivery Figure S1 PTH 1-34 calibration curve.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/nsa-10-023.PMC5261855.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601542/DC1Supplementary Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/d6/b5/1601542.PMC5262442.pdf
"U.S. Geological Survey, National Earthquake Information Center earthquake catalog; http://earthquake.usgs.gov/earthquakes/search/.",OADS,/arxiv_data1/oa_pdf/d6/b5/1601542.PMC5262442.pdf
Earthquake catalog: http://earthquake.usgs.gov/earthquakes/search/.,OADS,/arxiv_data1/oa_pdf/d6/b5/1601542.PMC5262442.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600954/DC1 Details of the GA GA parametersParameter optimizationMOFF-GA parameter valuesStructure preparation and constructionMolecular simulations Parasitic energy Top-performing structuresfig.,Non-OADS,/arxiv_data1/oa_pdf/ad/07/1600954.PMC5262444.pdf
"Finally, when the integration is completed, we estimate the maximum Lyapunov exponent as L¼1 500∑500 n¼1logjWjðnÞ ðÞ SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601679/DC1fig.",Non-OADS,/arxiv_data1/oa_pdf/1c/fd/1601679.PMC5262445.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601473/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/de/c3/1601473.PMC5262446.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601572/DC1Supplementary Text fig.,Non-OADS,/arxiv_data1/oa_pdf/27/34/1601572.PMC5262447.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601591/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/54/c4/1601591.PMC5262448.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600746/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/63/98/1600746.PMC5262449.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601609/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/a3/61/1601609.PMC5262450.pdf
"For this modeling, we used the Microsoft Excel plug-in StatPlus and a python script using the pandas and statsmodels.api libraries (available athttps://github.com/kaylai/LinearR egression).",OADS,/arxiv_data1/oa_pdf/b3/97/1600913.PMC5262451.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600913/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/b3/97/1600913.PMC5262451.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601185/DC1note S1.,Non-OADS,/arxiv_data1/oa_pdf/62/a4/1601185.PMC5262452.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600690/DC1Sequence of photos of electrochemical reactions in PEMEC micro-openings Preliminary results for the new catalyst fabrication method fig.,Non-OADS,/arxiv_data1/oa_pdf/62/2b/1600690.PMC5262453.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1501662/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/56/5c/1501662.PMC5262454.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600925/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/56/76/1600925.PMC5262455.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601625/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/fc/ce/1601625.PMC5262456.pdf
SPADE was performed on http://cytobank.org/.,Non-OADS,/arxiv_data1/oa_pdf/f0/df/1600874.PMC5262457.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600874/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/f0/df/1600874.PMC5262457.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600998/DC1Sequence diagram and correlated motion groupsInteractions between tyrosine and silicaEnergetic contributions on silicaRMSF of CsgAB-Factor loss in response to surface contact Equilibration results of chiral models fig.,Non-OADS,/arxiv_data1/oa_pdf/85/a4/1600998.PMC5262458.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600974/DC1note S1.,Non-OADS,/arxiv_data1/oa_pdf/e4/5b/1600974.PMC5262459.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601777/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/8f/18/1601777.PMC5262460.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601019/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/47/76/1601019.PMC5262461.pdf
"H. Strobl, Special Snapology: A Simple and Cheap Method to Make Convex Polyhedra Models (2010); http://www.knotology.eu/PPP-Jena2010e/start.html.",Non-OADS,/arxiv_data1/oa_pdf/47/76/1601019.PMC5262461.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601335/DC1Supplementary Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/1601335.PMC5262462.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601661/DC1movie S1.,Non-OADS,/arxiv_data1/oa_pdf/8e/03/1601661.PMC5262464.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601574/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/08/bb/1601574.PMC5262465.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600445/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/c8/6d/1600445.PMC5262466.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601113/DC1Supplementary Materials and Methodsscheme S1.,Non-OADS,/arxiv_data1/oa_pdf/67/3c/1601113.PMC5262467.pdf
"SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600225/DC1 Supplementary Methods Dataset construction, validation, and provenancefig.",Non-OADS,/arxiv_data1/oa_pdf/4c/42/1600225.PMC5262468.pdf
"Wehner, L. Rocher, T. Megies, L. P. Coelho, E. Ziegler, T. Hoppe, S. Seabold, S. Pascual, P. Cloud, M. Koskinen, C. Hausler, kjemmett, D. Milajevs, A. Qalieh, D. Allan, K. Meyer, seaborn ; http://dx.doi.org/10.5281/zenodo.19108.Acknowledgments: W.S.",Non-OADS,/arxiv_data1/oa_pdf/4c/42/1600225.PMC5262468.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600844/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/88/4f/1600844.PMC5262469.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600894/DC1note S1.,Non-OADS,/arxiv_data1/oa_pdf/4a/6b/1600894.PMC5262470.pdf
"Further details of ADNI methods for CSF acquisition and CSF measurement can be found at www.adni-info.org (accessed January 2016).MRI/PET methods ADNI, MRI and PET standard acquisition protocols are detailed elsewhere(http://adni.loni.usc.edu/methods; accessed January 2016).",Non-OADS,/arxiv_data1/oa_pdf/23/c0/mp201637a.PMC5262471.pdf
Statistical methods Statistical analyses were performed using the R Statistical Software Packageversion 3.0.2 with the RMINC library (http://www.r-project.org/; accessed January 2016).,OADS,/arxiv_data1/oa_pdf/23/c0/mp201637a.PMC5262471.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Amyloid- βand tau synergy drives hypometabolism TA Pascoal et al 311 Molecular Psychiatry (2017), 306 –311",Non-OADS,/arxiv_data1/oa_pdf/23/c0/mp201637a.PMC5262471.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/e9/main.PMC5262499.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.01.010 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/e9/main.PMC5262499.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 113 e115,Non-OADS,/arxiv_data1/oa_pdf/1d/e9/main.PMC5262499.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.01.005 2211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/99/59/main.PMC5262500.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/59/main.PMC5262500.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/99/59/main.PMC5262500.pdf
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6229a4.,OADS,/arxiv_data1/oa_pdf/99/59/main.PMC5262500.pdf
http://dx.doi.org/10.1111/j.1525-1446.2011.00958.x (Epub 2011 Jun 6).,OADS,/arxiv_data1/oa_pdf/99/59/main.PMC5262500.pdf
https://hints.cancer.gov .,Non-OADS,/arxiv_data1/oa_pdf/99/59/main.PMC5262500.pdf
http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/PDF/ PCP_Annual_Report_2012-2013.pdf (Accessed 7/1/2016).,OADS,/arxiv_data1/oa_pdf/99/59/main.PMC5262500.pdf
http://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx Last updated 06/02/2014.,OADS,/arxiv_data1/oa_pdf/99/59/main.PMC5262500.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/e8/main.PMC5262501.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.01.009 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/e8/main.PMC5262501.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 111 e112,Non-OADS,/arxiv_data1/oa_pdf/6e/e8/main.PMC5262501.pdf
"While systemic BP treatment is often given to these patients, several complications such http://dx.doi.org/10.1016/j.jbo.2017.01.001 Received 6 October 2016; Received in revised form 7 January 2017; Accepted 7 January 2017⁎Correspondence to: McGill University Health Centre, Montreal General Hospital, 1650 Cedar Ave, A5-169, Montreal, Quebec, Canada H3G 1A4.",Non-OADS,/arxiv_data1/oa_pdf/5a/db/main.PMC5262502.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5a/db/main.PMC5262502.pdf
CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/f2/3d/cir-135-352.PMC5262523.pdf
"Study Design This was a Phase 1, placebo-controlled, single-blind, single-sequence, 2-period study (http://www.clinicaltrials.gov .",Non-OADS,/arxiv_data1/oa_pdf/f2/3d/cir-135-352.PMC5262523.pdf
The online-only Data Supplement is available with this arti- cle at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/ CIRCULATIONAHA.116.025253/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f2/3d/cir-135-352.PMC5262523.pdf
Circulation is available at http://circ.ahajournals.org.,Non-OADS,/arxiv_data1/oa_pdf/f2/3d/cir-135-352.PMC5262523.pdf
"Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Ofﬁce on Smoking and Health; 2014, http://www.surgeongeneral.gov/ library/reports/50-years-of-progress/ [Accessed 14 July 2016] .",Non-OADS,/arxiv_data1/oa_pdf/7a/1e/aids-31-553.PMC5263172.pdf
"8      http://www.jcancer .org 1  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 1-8. doi: 10.7150/ jca.16602  Research Paper   Downregulation  of ARID1A, a component of the  SWI/SNF chromatin remodeling complex, in breast  cancer   Chika Takao1, Akemi Morikawa1,2, Hiroshi Ohkubo3, Yusuke Kito3, Chiemi Saigo3, Takuji Sakuratani1,  Manabu  Futamura1,4, Tamotsu  Takeuchi3, Kazuhiro  Yoshida1   1.",Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
8    http://www.jcancer .org 2  recruitment of its chromatin remodeling activity by  binding to transcription factors and transcriptional  coactivator/corepressor complexes [7].,Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
"8    http://www.jcancer .org 3  Cell culture and siRNA -mediated RNA  interference   A breast cancer cell line, MDA -MB-157 (ATCC  HTB -24) was obtained from the ATCC ( Manassas,  VA, USA).",Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
8    http://www.jcancer .org 4  α5β1Integrin expression and Matrigel invasion  assay   Cell surface integrin α5β1 expression was  evaluated by immunocytochemical staining using  specific antibody ( Biorbyt LLC.,OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
8    http://www.jcancer .org 5    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
8    http://www.jcancer .org 6  5% [24].,Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
8    http://www.jcancer .org 7  Subsequent comprehensive gene expression  analysis unraveled that most protein -encodi ng genes  were repressed by a 20% reduction of the ARID1A  mRNA level in breast cancer cells.,Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
8    http://www.jcancer .org 8  10.,Non-OADS,/arxiv_data1/oa_pdf/33/26/jcav08p0001.PMC5264034.pdf
"8      http://www.jcancer .org 9  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 9-18. doi: 10.7150/ jca.16550  Research Paper   Epidemiology of cancer in end -stage renal disease  dialysis patients: a national cohort study in  Taiwan   Chih -Chiang Chien1,2, Ming -Ming Han3, Yu-Hsien Chiu4, Jhi-Joung Wang5, Chin -Chen Chu6,7, Chien -Ya  Hung2, Yih-Min Sun8, Nai-Cheng Yeh9, Chung -Han Ho5, Chih -Ching Lin10, Hao -Yun Kao4, Shih -Feng  Weng4  1.",Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
8    http://www.jcancer .org 10  ESRD  patients on long -term renal dialysis for those  with various types of cancer [6].,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
8    http://www.jcancer .org 11  groups with or without a diagnosis of new cancer  were done using χ2 tests for categorical variables.,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
8    http://www.jcancer .org 12    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
"8    http://www.jcancer .org 13  showed that being ≥ 35, being male, having DM, and  having CVD were independent predictors  of all -cause  mortality in patients with cancer (Table 3 ).",Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
8    http://www.jcancer .org 14    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
8    http://www.jcancer .org 15  geographic area worldwide [18].,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
8    http://www.jcancer .org 16    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
8    http://www.jcancer .org 17  dialysis (dialytic age) has been demonstrated as an  independent risk factor.,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
"8    http://www.jcancer .org 18  Acknowledgment   This study was supported by grant  CMFHR 10402 from Chi -Mei Medical Center, grant  NHRI -NHIRD -99182 and NHRI -NHIRD -101111 from  the Taiwan National Health Research Institutes , and  grant KMU -Q105015 from Kaohsiung Medical  University Research Foundation.",Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
http://tcr.cph.ntu.edu.tw/main.php?Page=N1 .,Non-OADS,/arxiv_data1/oa_pdf/83/00/jcav08p0009.PMC5264035.pdf
"8      http://www.jcancer .org 29  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 29-38. doi: 10.7150/ jca.16822  Research Paper   Research progress in the treatment of small cell lung  cancer   Yan-fang Qiu*, Zhi -gang Liu*, Wen -juan Yang, Yu Zhao, Jiao Tang, Wei -zhi Tang, Yi Jin, Fang Li, Rui  Zhong, Hui Wang  Key Laboratory of Translational Radiation Oncology, Hunan Province.",Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
This is an open access article distributed under the term s of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
"8    http://www.jcancer .org 30  late), radiation dose and fractionation, target volumes,   prophylactic cranial irradiation (PCI) and progress in   molecular  targeted therapy and immunotherapy for  SCLC.",Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
"8    http://www.jcancer .org 31  Gy delivered twice- daily,  a clinical trial of EORTC  08072 (CONVERT) reported the median OS in  once -daily and twice -daily  groups were 25 months  and 30 months, respectively (P=0.15), the median PFS  were 14 months and 15 months, respectively  (P=0.",Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
8    http://www.jcancer .org 32  treatment for LD -SCLC patients with  good PS and  a  good response to initial therapy.,Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
8    http://www.jcancer .org 33  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
"8    http://www.jcancer .org 34  In some phase II studies, bevacizumab combined with  standard chemotherap y showed efficacy as a first line  treatment in ED -SCLC.",Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
8    http://www.jcancer .org 35  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
8    http://www.jcancer .org 36  significant differences between the two groups  (P=0.13).,Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
8    http://www.jcancer .org 37  chronic neurotoxicity and quality of life  for patients with limited -disease  small -cell lung cancer.,Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
8    http://www.jcancer .org 38  93.,Non-OADS,/arxiv_data1/oa_pdf/7b/fd/jcav08p0029.PMC5264037.pdf
This is an open access article distributed under the terms of the Creative Comm ons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5d/32/jcav08p0039.PMC5264038.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/5d/32/jcav08p0039.PMC5264038.pdf
"8      http://www.jcancer .org 48  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 48-56. doi: 10.7150/ jca.16644  Research Paper   Identification of A Panel of S erum microRNAs as  Biomarkers for E arly Detection of L ung  Adenocarcinoma   Shaogang Lv*, Jian Xue*, Chuanyong Wu, Lin Wang, Jing Wu, Shujun  Xu, Xiaohui Liang  and Jiatao Lou  Department of Laboratory  Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai  200030, China .",OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
8    http://www.jcancer .org 49  are closely associated with tumor stage at first  diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
8    http://www.jcancer .org 50  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
8    http://www.jcancer .org 51  difference between AD patients and the control  g r o u p s  a n d  h a d  a  T h r e s h o l d  c y c l e  ( C p )  v a l u e  ≤  3 5 .,Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
8    http://www.jcancer .org 52    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
"8    http://www.jcancer .org 53  Three of the six miRNAs were optimized as a  serum biomarker for AD screening   To further evaluate the diagnostic value of the  screening test for AD, we examined the sensitivity  and specificity of the test using the above mentioned  six differentially expressed miRNAs (Figure S2) .",Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
8    http://www.jcancer .org 54    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
"8    http://www.jcancer .org 55  there are three types of membranous vesic les that  contain extracellular miRNA: apoptotic bodies,  shedding vesicles, and exosomes [37-39].",Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
8    http://www.jcancer .org 56  27.,Non-OADS,/arxiv_data1/oa_pdf/fc/72/jcav08p0048.PMC5264039.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4f/ac/jcav08p0057.PMC5264040.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/4f/ac/jcav08p0057.PMC5264040.pdf
"8      http://www.jcancer .org 65  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 65-73. doi: 10.7150/ jca.16739  Research Paper   Comparative analysis of Notch1 and Notch2  binding  sites in the genome of BxPC3 pancreatic cancer cells   Hao Liu1, Ping Zhou2, Hong Lan1, Jia Chen1, Yu-xiang Zhang1,3,4    1.",Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
"8    http://www.jcancer .org 66  Hairless, Lag1) which is then converted from a  transcriptional repressor to a transcriptional activator  [8] (Fig.",Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
8    http://www.jcancer .org 67    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
"8    http://www.jcancer .org 68  region detection, peak count s, average peak length,  median peak length; (iii) The associated genes with  sample peaks; (iv) The depth of coverage distribution  of the mapped reads of the samples in the gene  region; (v) GO function notability enrichment analysis  of peak -related genes.",OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
"After  filtering, and aligning read tags to reference  sequences http://hgdownload.cse.ucsc.edu/   goldenPath/hg19/ database/refGene.txt.gz), we  calculated the average read coverage for all  non- overlapping 50 -bp slide windows of the genome.",OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
"Pathway annotations of the Notch1, Notch2  and CSL target genes were obtained from KEGG  (http://www.genome.jp/kegg/).",OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
8    http://www.jcancer .org 69  each set.,Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
"8    http://www.jcancer .org 70  Besides the PI3K -AKT p athway, we identified  transcriptional misregulation in cancer , metabolic  pathways, the Ras pathway and the MAP kinase  pathway as the most significant pathways linked to  the Notch1 target genes.",Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
8    http://www.jcancer .org 71  Table  3.,Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
"8    http://www.jcancer .org 72  signals are present, p53 increases and stimulates  transcription of the p21 gene.",Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
8    http://www.jcancer .org 73  define them as oncogenes or TSGs.,Non-OADS,/arxiv_data1/oa_pdf/68/fe/jcav08p0065.PMC5264041.pdf
This  is an open  access  article  distributed  under  the terms  of the Creative  Commons  Attribution  (CC BY-NC)  license   (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/01/62/jcav08p0074.PMC5264042.pdf
See  http://ivyspring.com/terms  for full terms  and  conditions.,Non-OADS,/arxiv_data1/oa_pdf/01/62/jcav08p0074.PMC5264042.pdf
This is an open access article distributed under the terms of the  Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/47/a0/jcav08p0085.PMC5264043.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/47/a0/jcav08p0085.PMC5264043.pdf
"8      http://www.jcancer .org 97  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 97-103.  doi: 10.7150/ jca.16819  Research Paper   High Expression of LINC01420 indicates  an unfavorable  prognosis and modulates cell migration and invasion in  nasopharyngeal carcinoma   Liting Yang1,2,3, Yan yan Tang1,2, Yi He2,4, Yumin Wang1,2, Yu Lian2, Fang Xiong1, Lei Shi2,5, Shanshan  Zhang1, Zhaojian Gong2,5, Yujuan Zhou4, Qianjin Liao2,4, Ming Zhou1,2,3, Xiaoling L i1,2, Wei Xiong1,2,3, Yong  Li1,2,6, Guiyuan Li1,2,3, Zhaoyang Zeng1,2,3, Can Guo1,2,3  1.",Non-OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
"8    http://www.jcancer .org 98  To find functional lncRNAs in NPC, we  analyzed 2 previously published online datasets to  find dysregulated lncRNAs in head and neck cancer.",OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
"8    http://www.jcancer .org 99  had migrated to the lower face of the filters were fixed  with 100% methanol and stained with 0.5% crystal  violet and counted  [24, 25] .",Non-OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
8    http://www.jcancer .org 100    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
"8    http://www.jcancer .org 101    To assess prognostic value of LINC01420   expression in NPC patients, we examined the  association between LINC01420 expression and  overall survival using Kaplan -Meier analysis with the  log-rank test.",Non-OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
8    http://www.jcancer .org 102  Discussion   Cancer is still the major cause of morbidity and  mortality in most areas in the world  [35].,Non-OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
"8    http://www.jcancer .org 103  21 Wang Y, Xue D, Li Y, et al.",OADS,/arxiv_data1/oa_pdf/2f/ff/jcav08p0097.PMC5264044.pdf
"8      http://www.jcancer .org 104  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 104-110. doi: 10.7150/ jca.16856  Research Paper   Clinical Significance of Folate Receptor -positive  Circulating Tumor Cells Detected by L igand-targeted  Polymerase Chain Reaction in Lung Cancer   Lin Wang1, Chuanyong Wu1, Lihua Qiao1, Wenjun Yu1, Qiaomei Guo1, Mingna Zhao1, Guohua Yang2,  Hang Zhao3, Jiatao Lou1  1.",Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
8    http://www.jcancer .org 105  cancer  [4].,Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
"8    http://www.jcancer .org 106  annealing at 35°C for 30 seconds, and extension at   72°C for 10 seconds.",Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
8    http://www.jcancer .org 107    Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
"8    http://www.jcancer .org 108  sensitivity of the method for NSCLC and SCLC  patients was 77.2% (125/162) and 80.8% (21/26),  respectively.",Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
"8    http://www.jcancer .org 109  The folate receptor (FR), a cell -surface receptor  glycoprotein, which is highly expressed in a variety of  cancers, especially in ovarian and lung cancers, has  become an important potential drug target for  patients with NSCLC [10,23] .",Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
8    http://www.jcancer .org 110  5.,Non-OADS,/arxiv_data1/oa_pdf/a8/7b/jcav08p0104.PMC5264045.pdf
"8      http://www.jcancer .org 111  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 111-116. doi: 10.7150/ jca.17060  Research Paper   Association between expression of C arboxypeptidase 4   and stem cell markers and their clinical significance in  liver cancer  development   Lichao Sun 1, Chunguang Guo3, Joseph Burnett2, Jian Pan4, Zhihua  Yang1, Yuliang Ran1, Duxin Sun2  1.",Non-OADS,/arxiv_data1/oa_pdf/37/c1/jcav08p0111.PMC5264046.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/c1/jcav08p0111.PMC5264046.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/37/c1/jcav08p0111.PMC5264046.pdf
8    http://www.jcancer .org 112  tumor progression and p oor prognosis [6].,Non-OADS,/arxiv_data1/oa_pdf/37/c1/jcav08p0111.PMC5264046.pdf
8    http://www.jcancer .org 113    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/37/c1/jcav08p0111.PMC5264046.pdf
8    http://www.jcancer .org 114  survival.,Non-OADS,/arxiv_data1/oa_pdf/37/c1/jcav08p0111.PMC5264046.pdf
8    http://www.jcancer .org 115    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/37/c1/jcav08p0111.PMC5264046.pdf
"8    http://www.jcancer .org 116  a glycophosphatidylinositol (GPI) -anchored protein  expressed in many normal cells including neurons,  endothelial cells and fibroblast [10, 16] .",Non-OADS,/arxiv_data1/oa_pdf/37/c1/jcav08p0111.PMC5264046.pdf
"8      http://www.jcancer .org 117  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 117-123. doi: 10.7150/ jca.17326  Research Paper   Worse Prognosis in Papillary, Compared to Tubular,  Early Gastric  Carcinoma   Huiping Yu1*, Cheng Fang1,2,4*, Lin Chen1, Jiong Shi1, Xianshan Fan1, Xiaoping Zou2, Qin Huang1,2,3  1.",Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
This is an open access article distributed under the terms of the Creative Commons Attributio n (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
8    http://www.jcancer .org 118  with small micropapillary and tubular components in  some tumors [1].,Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
"8    http://www.jcancer .org 119  estimated tumor volume on the same slide[10,11]; 2)  the micropapillary pattern, featuring small  pseudopapillary tumor clusters surrounded by empty  lacuna spaces without a fibrovascular core (Figure 2),  if found in over 5% of the estimated tumor volume[9].",Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
"8    http://www.jcancer .org 120  Statistical Analysis   Differences in clinicopathology, endoscopy, and  survival between papillary and tubular EGC groups  were assessed with the Chi -square and Student’s t   tests.",Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
"8    http://www.jcancer .org 121  Differences in Risk Factors of Lymph Node  Metastasis   By univariate analysis, advanced age, male  gender, tumor proximal gastric location, and tumor  size over 2 cm were not statistically significant risk  factors for nodal metastasis in either the papillary or  tubular EGC group (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
"8    http://www.jcancer .org 122  Discussion   In this comparison study, our data illustrate  significantly worse prognosis in papillary EGC with a  significantly lower 5 -year survival rate of 80.5%,  compared to 96.8% in tubular EGC.",Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
"8    http://www.jcancer .org 123  5-year survival rates, compared with tubular EGCs  [9,13,18,20].",Non-OADS,/arxiv_data1/oa_pdf/94/8d/jcav08p0117.PMC5264047.pdf
"8      http://www.jcancer .org 124  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(1): 124-130. doi: 10.7150/ jca.17437  Research Paper   Strong Correlation of Indoleamine 2,3 -Dioxygenase 1  Expression with Basal -Like Phenotype and I ncreased  Lymphocytic Infiltration in Triple-Negative Breast  Cancer   Sewha Kim1, Sanghui Park3, Min Sun Cho3, Woosung Lim2, Byung -In Moon2, Sun Hee Sung3  1.",Non-OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
"8    http://www.jcancer .org 125  tumor immunity, which is one of several immune  checkpoint proteins involved in tumor immune  escape.",Non-OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
8    http://www.jcancer .org 126  entrapped in tumor were internal positive control in  some cases.,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
8    http://www.jcancer .org 127  IDO1(+) TNBCs were characterized by a smaller  tumor size ( p = 0.012) and exhibited significantly more  dense stromal lymphocytic infiltration than did  IDO1(−) TNBCs ( p < 0.001) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
8    http://www.jcancer .org 128   Table 2.,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
8    http://www.jcancer .org 129  positivit y was observed in 37.0% of TNBCs and was  significantly more prevalent in the BL type than in  LAR and CL types.,OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
"8    http://www.jcancer .org 130  Acknowledgements    This study was supported by a grant of the  Korean Health Technology R&D Project, Ministry of  Health & Welfare, Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/f4/a4/jcav08p0124.PMC5264048.pdf
[39] Participating teams are invited to join collaborative  monthly webinars and receive E‑mails and updates  through the Johns Hopkins CUSP 4 MVP project web portal  (https://armstrongresearch.hopkinsmedicine.org/cusp4mvp.,Non-OADS,/arxiv_data1/oa_pdf/23/7c/ATM-12-11.PMC5264166.pdf
Available from: http://www.ihi.org.,Non-OADS,/arxiv_data1/oa_pdf/23/7c/ATM-12-11.PMC5264166.pdf
Available  from: http://www.cdc.gov/nhsn/PDFs/pscManual/10‑VAE_ FINAL.pdf.,OADS,/arxiv_data1/oa_pdf/23/7c/ATM-12-11.PMC5264166.pdf
Available from: http://www.ahrq.gov/ professionals/education/curriculum‑tools/cusptoolkit/index.,Non-OADS,/arxiv_data1/oa_pdf/23/7c/ATM-12-11.PMC5264166.pdf
Available from: http://www.ahrq.gov/professionals/ quality‑patient‑safety/hais/index.html.,Non-OADS,/arxiv_data1/oa_pdf/23/7c/ATM-12-11.PMC5264166.pdf
Available from: http://www.ecdc.europa.eu/ en/healthtopics/Healthcare‑associated_infections/guidance‑ infection‑prevention‑control/Pages/guidance‑on‑healthcare‑ associated‑and‑ventilator‑associated‑pneumonia.aspx.,Non-OADS,/arxiv_data1/oa_pdf/23/7c/ATM-12-11.PMC5264166.pdf
Available from: http://www.nhmrc.gov.au/ guidelines‑publications/cd33.,Non-OADS,/arxiv_data1/oa_pdf/23/7c/ATM-12-11.PMC5264166.pdf
Available from: http://www.cdc.gov/getsmart/community/ for‑hcp/outpatient‑hcp/pediatric‑treatment‑rec.html.,Non-OADS,/arxiv_data1/oa_pdf/76/89/ATM-12-51.PMC5264174.pdf
Available  from: http://www.medicaldevicedaily.com/servlet/com.accumedia.web.,Non-OADS,/arxiv_data1/oa_pdf/9b/4d/IJU-33-1.PMC5264184.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/0f/83/IJU-33-19.PMC5264186.pdf
[Last cited on 2016 Jan 10] Available from: http://www.uroweb.org/gls/pdf/21_Urolithiasis_LR.pdf.,OADS,/arxiv_data1/oa_pdf/86/95/IJU-33-48.PMC5264193.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2015-209057).,Non-OADS,/arxiv_data1/oa_pdf/7c/d7/annrheumdis-2015-209057.PMC5264210.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Schoels M, Knevel R, Aletaha D, et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/d7/annrheumdis-2015-209057.PMC5264210.pdf
"To view,please visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2015-208913).",Non-OADS,/arxiv_data1/oa_pdf/9f/a7/annrheumdis-2015-208913.PMC5264211.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Dillon CF, Rasch EK, Gu Q, et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/a7/annrheumdis-2015-208913.PMC5264211.pdf
http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisDrugsAdvisoryCommittee/UCM295203.pdf (accessed 10 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/9f/a7/annrheumdis-2015-208913.PMC5264211.pdf
http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ ArthritisDrugsAdvisoryCommittee/UCM295205.pdf (accessed 10 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/9f/a7/annrheumdis-2015-208913.PMC5264211.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2016-210094).,OADS,/arxiv_data1/oa_pdf/4b/7c/annrheumdis-2016-210094.PMC5264214.pdf
https://clinicaltrials.gov/show/NCT01711359 NLM identi ﬁer: NCT01711359 7 Eli Lilly and Company.,Non-OADS,/arxiv_data1/oa_pdf/4b/7c/annrheumdis-2016-210094.PMC5264214.pdf
"https://clinicaltrials.gov/show/NCT01710358 NLM identi ﬁer: NCT01710358 94 Dougados M, et al .Ann Rheum Dis 2017; 76:88–95.",Non-OADS,/arxiv_data1/oa_pdf/4b/7c/annrheumdis-2016-210094.PMC5264214.pdf
https://clinicaltrials.gov/show/ NCT01721057 NLM identi ﬁer: NCT01721057 9 Eli Lilly and Company.,Non-OADS,/arxiv_data1/oa_pdf/4b/7c/annrheumdis-2016-210094.PMC5264214.pdf
"https://clinicaltrials.gov/show/NCT01721044 NLM identi ﬁer: NCT01721044 10 Genovese MC, Kremer J, Zamani O, et al .",OADS,/arxiv_data1/oa_pdf/4b/7c/annrheumdis-2016-210094.PMC5264214.pdf
"https://clinicaltrials.gov/show/NCT01885078 NLM identi ﬁer: NCT01885078 12 Felson DT, Anderson JJ, Boers M, et al.",OADS,/arxiv_data1/oa_pdf/4b/7c/annrheumdis-2016-210094.PMC5264214.pdf
http://www.das-score.nl/das28/ (accessed 28 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/4b/7c/annrheumdis-2016-210094.PMC5264214.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2015-209031).,OADS,/arxiv_data1/oa_pdf/ba/7c/annrheumdis-2015-209031.PMC5264215.pdf
"Correspondence to Dr Marco Gattorno, UOPediatria 2, Istituto G. Gaslini, Via G. Gaslini 5, Genova 16147, Italy; marcogattorno@ospedale-gaslini.ge.it Received 15 December 2015 Revised 27 April 2016 Accepted 17 May 2016Published Online First7 June 2016 ▸http://dx.doi.org/10.1136/ annrheumdis-2016-209335 To cite: Gattorno M, Obici L, Cattalini M, et al.",Non-OADS,/arxiv_data1/oa_pdf/ba/7c/annrheumdis-2015-209031.PMC5264215.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 McDermott MF, Aksentijevich I, Galon J, et al.",Non-OADS,/arxiv_data1/oa_pdf/ba/7c/annrheumdis-2015-209031.PMC5264215.pdf
https://clinicaltrials.gov/ct2/show/NCT02059291.,Non-OADS,/arxiv_data1/oa_pdf/ba/7c/annrheumdis-2015-209031.PMC5264215.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2016-209709).,Non-OADS,/arxiv_data1/oa_pdf/1c/a4/annrheumdis-2016-209709.PMC5264219.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Gladman DD.,Non-OADS,/arxiv_data1/oa_pdf/1c/a4/annrheumdis-2016-209709.PMC5264219.pdf
"Bethesda, MD: National Cancer Institute, 2006. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf (accessed 14 Jun 2010).",Non-OADS,/arxiv_data1/oa_pdf/1c/a4/annrheumdis-2016-209709.PMC5264219.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2015-207588).,OADS,/arxiv_data1/oa_pdf/b6/64/annrheumdis-2015-207588.PMC5264222.pdf
"Correspondence to Professor Paul Emery, Leeds Institute of Rheumatic andMusculoskeletal Medicine,University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK;p.emery@leeds.ac.uk Received 13 March 2015 Revised 11 May 2015 Accepted 6 June 2015 Published Online First6 July 2015 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-207613▸http://dx.doi.org/10.1136/ annrheumdis-2015-207764 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-208113 To cite: Emery P, Vencovský J, Sylwestrzak A, et al.Ann Rheum Dis 2017; 76:51–57.ABSTRACT Objectives To compare the ef ﬁcacy and safety of SB4 (an etanercept biosimilar) with reference product etanercept (ETN) in patients with moderate to severe rheumatoidarthritis (RA) despite methotrexate (MTX) therapy.Methods This is a phase III, randomised, double-blind, parallel-group, multicentre study with a 24-week primaryendpoint.",Non-OADS,/arxiv_data1/oa_pdf/b6/64/annrheumdis-2015-207588.PMC5264222.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Murray KM, Dahl SL.",Non-OADS,/arxiv_data1/oa_pdf/b6/64/annrheumdis-2015-207588.PMC5264222.pdf
http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000262/WC500027361.pdf (27 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/64/annrheumdis-2015-207588.PMC5264222.pdf
http://www.fda.gov/downloads/Drugs/Guidances/UCM202140.pdf (27 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/64/annrheumdis-2015-207588.PMC5264222.pdf
Guidance for Industry: Immunogenicity assessment for therapeutic protein products.http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/ guidances/ucm338856.pdf (27 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/64/annrheumdis-2015-207588.PMC5264222.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2015-209064).,OADS,/arxiv_data1/oa_pdf/ee/58/annrheumdis-2015-209064.PMC5264225.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Meda F, Folci M, Baccarelli A, et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/58/annrheumdis-2015-209064.PMC5264225.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2015-208577).,Non-OADS,/arxiv_data1/oa_pdf/1d/63/annrheumdis-2015-208577.PMC5264226.pdf
Lentiviral particle produc-tion and transduction of target cells were performed as recom-mended (https://www.addgene.org/tools/protocols/plko/#E).,OADS,/arxiv_data1/oa_pdf/4e/cb/jmedgenet-2016-104194.PMC5264227.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Shoubridge EA.,Non-OADS,/arxiv_data1/oa_pdf/4e/cb/jmedgenet-2016-104194.PMC5264227.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2015-207764).,OADS,/arxiv_data1/oa_pdf/1d/ca/annrheumdis-2015-207764.PMC5264229.pdf
"Received 10 April 2015 Revised 7 August 2015Accepted 12 August 2015 Published Online First 28 August 2015 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-207588▸http://dx.doi.org/10.1136/ annrheumdis-2015-207613 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-208113 To cite: Choe J-Y, Prodanovic N, Niebrzydowski J, et al.Ann Rheum Dis 2017; 76:58–64.ABSTRACT Objectives To compare the ef ﬁcacy, safety, immunogenicity and pharmacokinetics (PK) of SB2 to theinﬂiximab reference product (INF) in patients with moderate to severe rheumatoid arthritis (RA) despitemethotrexate therapy.Methods This is a phase III, randomised, double-blind, multinational, multicentre parallel group study.",Non-OADS,/arxiv_data1/oa_pdf/1d/ca/annrheumdis-2015-207764.PMC5264229.pdf
Graphical ﬁgures were made using R 3.0.1 (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/1d/ca/annrheumdis-2015-207764.PMC5264229.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Birnbaum H, Pike C, Kaufman R, et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/ca/annrheumdis-2015-207764.PMC5264229.pdf
2010. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/1d/ca/annrheumdis-2015-207764.PMC5264229.pdf
1998. http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Products/Guidelines/ Efﬁcacy/E9/Step4/E9_Guideline.pdf (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/1d/ca/annrheumdis-2015-207764.PMC5264229.pdf
2014. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/1d/ca/annrheumdis-2015-207764.PMC5264229.pdf
"T o validate the sample proven- ance, a parallel SNP panel was applied to con ﬁrm data identity.16 Patients 4, 5 and 6 were referred to regional Clinical Genetics services across the UK, where they were recruited to the deci-phering developmental disorders (DDD) study (http://www.ddduk.org).",Non-OADS,/arxiv_data1/oa_pdf/0e/61/jmedgenet-2016-103942.PMC5264232.pdf
"2016. https://www.pymol.org/27 Bellanger JM, Estrach S, Schmidt S, Briançon-Marjollet A, Zugasti O, Fromont S, Debant A.",Non-OADS,/arxiv_data1/oa_pdf/0e/61/jmedgenet-2016-103942.PMC5264232.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Horowitz M, Levy E, Sauvageau E, et al.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/neurintsurg-2016-012508.PMC5264233.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Brinjikji W, Murad HM, Lanzino G, et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/d1/neurintsurg-2016-012502.PMC5264236.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Molyneux A, Kerr R, Stratton I, et al .",Non-OADS,/arxiv_data1/oa_pdf/78/02/neurintsurg-2016-012539.PMC5264237.pdf
http://www.ejmint.org/original-article/1244000088 (accessed 11 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/78/02/neurintsurg-2016-012539.PMC5264237.pdf
A differential impact of drug families and individual drugs hasEBioMedicine 13 (2016) 31 –32 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.10.009 .,Non-OADS,/arxiv_data1/oa_pdf/d4/32/main.PMC5264241.pdf
"The goal of achieving durable sup- pression of HIV replication and long-standing undetectable viral load, with a well-tolerated, non-toxic regimen is now an accessible task for http://dx.doi.org/10.1016/j.ebiom.2016.10.015 2352-3964/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/32/main.PMC5264241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/32/main.PMC5264241.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Inﬂammation Immune activationBiomarkersTenofovir alafenamide 1.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.009 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1016/S0140- 6736(08)61113-7 .,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.3851/IMP2305 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"45 (1), 5 –32.http://dx.doi.org/10.1023/ A:1010933404324 .",Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"http://dx.doi.org/10.1093/infdis/jir520 .D'Agostino Sr., R.B., Vasan, R.S., Pencina, M.J., et al., 2008.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1161/01.CIR.97.18.1837 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1001/jama.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/ 10.1089/apc.2007.0052 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1053/j.ajkd.2011.01.022 .,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"AIDS 30 (1), 65 –73.http://dx.doi.org/10.1097/ QAD.0000000000000885 .",Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1001/jama.2014.8722 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1093/infdis/jiu238 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1086/652750 .,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1161/01.ATV.0000222983.73369.c8 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1093/infdis/jir507 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1016/B978-0-12-407707-2.00002-3 .,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1097/QAD.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1093/infdis/jir188 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.7326/0003-4819-155-4- 201108160-00358 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"16 (1),43–52.http://dx.doi.org/10.1016/S1473-3099(15)00348-5 .",OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"Brussels, Belgium [online] Available athttps://www.intmedpress.com/serveFile.cfm?sUID=bc75b62c-c206-437a-b725- a75baa67f5b2 Accessed 01 April 2016.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1089/ aid.2014.0239 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"National Center for Biotechnology Information, d. PubChem Compound Database; CID = 6398764[online] Available at https://pubchem.ncbi.nlm.nih.gov/compound/ Tenofovir_Disoproxil_Fumarate#section=Top [Accessed 28 August 2016].",OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"National Center for Biotechnology Information, d. PubChem Compound Database; CID = 9574768[online] Available at https://pubchem.ncbi.nlm.nih.gov/compound/9574768 [Accessed 28 August 2016].",OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1097/ QAD.0000000000000946 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1056/NEJM200010193431603 .,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents [online] Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1371/journal.pone.0105653 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"55 (1), 49 –57.http://dx.doi.org/10.1097/QAI.0b013e3181dd911e .",Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1016/j.jacc.2015.11.037 .,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1373/ clinchem.2011.180281 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"http://dx.doi.org/10.1093/cid/civ296 .Sax, P.E., Wohl, D., Yin, M.T., et al., 2015.",OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1016/S0140- 6736(15)60616-X .,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1002/phar.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1086/656417 .,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1093/infdis/jiu515 .,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1097/QAD.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
[online] Available at https://aidsinfo.nih.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"U.S. Food and Drug Administration, Silver Spring, MD [online] Available at http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm426799.htm Accessed 01 April 2016.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
"72 (1), 58 –64.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
http://dx.doi.org/10.1097/QAI.0000000000000566 .327 N.T.,OADS,/arxiv_data1/oa_pdf/53/2f/main.PMC5264242.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chronic renal diseaseCircadian clock G0s2 Small compound inhibitor 1.,Non-OADS,/arxiv_data1/oa_pdf/28/f0/main.PMC5264248.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.008 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/28/f0/main.PMC5264248.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/f0/main.PMC5264248.pdf
Supplementary Data Additional methods and reagents are described in the supplementary methods available at http://www.ebiomedicine.com/ .,Non-OADS,/arxiv_data1/oa_pdf/28/f0/main.PMC5264248.pdf
"Supplementary data associated with this article can be found in the online version, at http://dx.doi.org/10.1016/j.ebiom.2016.10.008 .",OADS,/arxiv_data1/oa_pdf/28/f0/main.PMC5264248.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Breast transformationCancerGRK2HDAC6 Pin1 Acetylation 1.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.030 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1172/JCI57100.prognosis .,OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1093/carcin/bgl190 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1074/jbc.M112.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1126/scisignal.2000576 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.0550-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"33, 154– 164. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"Cancer Cell 20, 79 –91.http://dx.doi.org/10.1016/j.ccr.2011.",OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.013 .Innes, B.T., Bailey, M.L., Brandl, C.J., Shilton, B.H., Litch ﬁeld, D.W., 2013.",OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"4, 18. http://dx.doi.org/10.3389/fphys.2013.00018 .",Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1158/1535-7163.MCT-09-0560 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/ 10.1038/emboj.2011.466 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.4161/cam.21585 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"10, 47 –60.http://dx.doi.org/10.1038/ nrd3320 .",Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1038/cdd.,OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"280, 775– 793. http://dx.doi.org/10.1111/febs.",Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1007/s10571-012- 9876-5 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.4161/cc.10.6.15076 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1111/j.1476-5381.2010.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1091/mbc.E08-05-0448 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1146/ annurev.physiol.69.022405.154731 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1172/JCI67333.4714 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"25, 2831– 2839. http://dx.doi.org/10.1016/j.cellsig.2013.08.031 .",OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"79, 34 –74.http://dx.doi.org/10.1016/j.phrs.2013.11.002 .",OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1002/JCP .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1016/j.cell.2008.03.025 .,OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
"http://dx.doi.org/10.1186/ bcr3192 .Thomassen, M., Tan, Q., Kruse, T.a., 2008.",Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1038/nrc2193 .,Non-OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
http://dx.doi.org/10.1038/sj.emboj.7600323 .145 L. Nogués et al.,OADS,/arxiv_data1/oa_pdf/92/17/main.PMC5264252.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gut MicrobiomeDysbiosisTherapeuticFecalTransplant Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.029 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
"Advancing Bio, 2016. https://http://www.advancingbio.org .",Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://www.gastro.org/press_releases/aga- establishes-nih-funded-registry-to-track-fecal-microbiota-transplants .,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://www.fda.gov/downloads/ BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/ Vaccines/UCM361393.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://www.hqontario.ca/evidence-to-improve- care/recommendations-and-reports/OHTAC/fecal-microbiota-therapy .,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://ansm.sante.fr/var/ansm_site/storage/original/application/ 5e5e01018303790194275ded0e02353c.pdf .,OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://www.gesa.org.au/news.asp?id=541 .,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://www.idsociety.org/FMT .,OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
http://www.nice.org.uk/ guidance/ipg485 .44 C. Carlucci et al.,Non-OADS,/arxiv_data1/oa_pdf/f0/77/main.PMC5264253.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ProgranulinHSP70β-glucocerebrosidase Gaucher disease Lysosomal storage diseasesPcgin 1.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.010 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.2353/ajpath.2010.090915 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1038/ nature05016 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1002/bies.200900086 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1038/nature05017 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1084/jem.20071008 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
"Rep. 5, 10903. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1056/ NEJM200502173520719 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1096/fj.09-144659 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/ 10.1194/jlr.M043802 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
"90, 43 –50.http://dx.doi.org/10.1016/ j.nbd.2015.09.006 .",OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1007/s00401-014-1262-6 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1182/ asheducation-2012.1.13 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1038/nm816 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1194/jlr.R048090 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1189/jlb.,OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1016/j.febslet.2013.09.,OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
EBioMedicine http://dx.doi.org/10.1016/j.ebiom.2016.08.004 .,OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1080/14789450.2016.1174583 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1038/ nature08710 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1007/s12035-012-8380-8 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1371/journal.pone.0092743 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
"2, 57. http://dx.doi.org/10.3389/fmolb.",Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1038/nature14884 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1038/mt.2015.62 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1371/ journal.pone.0129910 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1016/j.tins.2014.04.003 .,OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1083/jcb.201208152 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
"Cell 131, 770 – 783. http://dx.doi.org/ 10.1016/j.cell.2007.10.018 .",OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
"http://dx.doi.org/10.1016/j.cell.2011.08.041 .Sanchez-Fernandez, E.M., Garcia Fernandez, J.M., Mellet, C.O., 2016.",OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1039/c6cc01564f .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
"2, 78. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
http://dx.doi.org/10.1007/s10620-014-3089-3 .,Non-OADS,/arxiv_data1/oa_pdf/50/54/main.PMC5264254.pdf
